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Scope of this thesis
Regulation of gene expression is necessary for the control of complex developmental processes. In or-
der to unravel gene regulation, it is necessary to understand the chromatin structure and organization. 
Furthermore, developmental procedures are controlled by complex combinatorial transcription factor 
(TF) networks. Hence, unveiling those networks will provide a better insight towards understanding 
those developmental procedures. The work described in this thesis aims to contribute to decode the 
genome structure and organization and understand the complex mechanisms controlling developmen-
tal pathways.
Chapter 1 provides an introduction to the basic concepts of the DNA, gene regulation and the role 
of TFs. Subsequently, it describes the aspects of chromatin compaction and its implications towards 
tethering together genes with their regulatory elements and presents the methods to unravel the 3D 
genome structure. Finally, it presents insights into the hematopoietic development and its association 
with combinatorial TF networks.
Chapters 2 to 7 contain the experimental work performed during this PhD study. Chapter 2 contains 
the development of 3C-seq; a method to depict the close proximity of DNA segments in the 3D nuclear 
organization. Chapter 3 describes the development of T2C; a method to unveil the chromatin interac-
tome and the spatial organization of genome in high resolution with low sequencing costs. Chapter 4 
provides evidence about the rearrangement of nucleosomes along the DNA fiber upon TNFα signaling, 
to allow establishment of new transcriptional programs. In Chapter 5 we extend this study to assess 
the effect of developmental signaling cues such as the TNFα singalling, in the dynamics of NFκB TF, 
the spatiotemporal chromatin architecture and the interactome of the genome. Chapter 6 describes 
the role of the LDB1 complex in hematopoietic development and the dynamics of the “GATA” switch. 
Chapter 7 describes a combinatorial TF network, its dynamics and properties in erythropoiesis.
In Chapter 8 I summarize the results of the experimental research conducted in Chapter 2 to 7. Ad-
ditionally, I highlight important findings and consider the effect of these results in our understand-
ing of genome structure and organization and the complex mechanisms controlling developmental 
procedures. Finally I propose future perspectives for the continuation and evolvement of the current 
findings.

Chapter 1
Introduction
Parts of this chapter 
were published in
Epigenetics & Chromatin
2012; 9;5(1):1
10
Chapter 1
Cell, the “brick” of life
DNA, the “computer” of life
It is estimated there are approximately 8.7 million eukaryotic species on Earth today, with everyone to 
be different from the other1. However, all of them share a common purpose in life; reproduction and 
inheritance of their genetic information into their offspring. All such species, from the simplest to the 
most complex ones, originate from single cells which are the vehicles of their hereditary information. 
The latter is stored in the DeoxyriboNucleic Acid, or most commonly known as DNA2, 3. 
DNA has been evolving the last 3.5 billion years and enabled to store all the necessary information to 
build an organism in a format consisting of long strings of nucleotides. Each nucleotide consists of sug-
ar (deoxyribose) with a phosphate group attached to it and a base which may be adenine (A), cytosine 
(C), guanine (G) and thymine (T)4, with A and G to be complementary with T and C, respectively3 (Figure 
1).  DNA was first discovered by Friedrich Miescher in 18695 and the three dimensional (3D) structure 
of the helix was solved in 1953 by James Watson and Francis Crick3  (a left-handed, anti-parallel dou-
ble-helix structure) after the pioneering work by Rosalind Franklin6 and Maurice Wilkins7. The bonds 
between the two DNA strands are weaker than the covalent bonds between the sugar-phosphates 
which allows the DNA strands to be pulled apart and serve as a template for DNA replication8 and tran-
scription9, 10. Like the notes of music which in a specific order produce a specific melody, nucleotides 
are arranged in a specific order making up the genes, the functional units of heredity11. Genes are long 
stretches of (usually short) DNA segments (exons) which carry the encoding information, interrupted 
in most genes by non-coding DNA (introns) (Figure 1). Genes encode a usually single-strand functional 
transcript containing ribose instead of deoxyribose12 the Ribonucleic Acid (RNA)13, where T is replaced 
by uracil (U) with A, G and C to remain the same. 
One of the most important stepping stones of biology, proposed by Francis Crick in 195814 and refor-
mulated in 197015, is The Central Dogma (Figure 1) which postulates that DNA encodes RNA which 
codes for proteins, and not the other way around. The dogma (Francis Crick later admitted the catch 
name of Central Dogma would better have been called Central Hypothesis) defines also that DNA can 
replicate itself to be maintained. When a cell needs a particular protein, the stretch of DNA that en-
codes that protein, the gene, is used as a template to synthesize RNA (a process called transcription). 
After removing the introns (splicing) the mature mRNA is used as a template for protein synthesis (a 
process outside of the cell’s nucleus known as translation)12, 14, 15. However, there are many genes which 
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Figure 1: The Central Dogma of Biology as it was postulated by Francis Crick and updated by Howard Martin Temin and David 
Baltimore, illustrating the typical process of DNA (A and G to be complementary to T or C) to proteins. Regions of the genome 
encoding proteins termed genes (Gene A and B) contain promoter, exons and introns and transcribed into RNA which is subse-
quently translated into a protein. Activity (green circle) or silencing (red circle) of Genes A and B and their respective proteins, 
typify specific cell types, giving the transcriptome of each cell type its unique properties.
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encode non-coding RNA (ncRNAs), which are not 
translated into a protein16. Howard Martin Temin 
and David Baltimore determined in 1970 that DNA 
is transcribed into RNA and not vice versa. RNA 
can be converted to DNA via a process defined as 
reverse transcription10, 17. Furthermore, RNA can 
replicate itself, a phenomenon often seen in RNA 
viruses18. 
All the genes of an organism, with the exception 
of e.g. yeast and of mitochondrial and chloroplast 
DNA, form its genome which is divided into sever-
al long DNA molecules, the chromosomes. Joe Hin 
Tjio at 195519 correctly determined that humans 
(Homo sapiens) have 46 chromosomes (22 auto-
somes and 2 sex chromosomes, XX in females and 
XY in males) with two copies of each autosome (1 
Assembly
Base pairs 
(bp)
Coding 
genes
Non-coding 
genes
Human Mouse
GRCh38.p2 GRCm38.p3
3.221 x 109 2.8 x 109
2254320300
25159 12420
Table 1: General information about the size and number of 
coding vs non coding genes of the human and mouse ge-
nome.
inherited from the father, 1 from the mother) and sex chromosomes, with the haploid genome to-
talling 3.2 x 109 base pairs (bp). Mouse (Mus musculus) has 40 chromosomes (19 autosomes, and XX 
in females, XY in males)20 totalling  2.8 x 109 bp (Table 1). In 2004, the human genome was (almost) 
fully sequenced. It is still not completely finished as some regions are very repetitive in nature and 
extremely difficult to sequence properly. Nevertheless it revealed somewhat disappointingly that we 
have more than 20000 coding genes21-23 (and not the previously anticipated 100000) with median size 
of approximately 3.5Kb, making up only 2.2% of the genome. The remainder (initially called “junk” 
DNA) contains regulatory regions responsible to e.g. activate or silence a gene as well as “gene des-
erts”; genomic regions with as yet no apparent functional role. 
Comparing the human genome to the invertebrate C.elegans (a nematode worm, 9.7 x 107 bp contain-
ing about 20000 genes), an apparent conundrum concerning the smaller size of this genome and the 
number of protein-coding genes is revealed24. Apparently, the human genome is quite parsimonious 
(Table 1). A potential explanation may be that those “gene deserts” contain ncRNAs important for 
gene regulation25, and it has also become clear that the spacing of regulatory sequences is important. 
Complex organisms such as human would then have more sophisticated and complicated ways of gene 
regulation26, which would require more “DNA space”. Interestingly, 94% of the human exons undergo 
alternative splicing (AS), thereby limiting the genome size, while increasing genome complexity. The 
relationship between protein-coding genes and genome size follows a logarithmic pattern for eukary-
otes compared to non-eukaryotes, which follow a linear pattern27. Hence, we observe a positive cor-
relation between the number of ncRNAs, AS events and complex regulatory networks with eukaryotic 
complexity28. 
Cellular heterogeneity: gene expression and protein production
Although the DNA that is present in all the somatic cells of an organism is identical, specific genes 
are expressed in specific cells, in addition to many other genes that are expressed in every cell and 
fulfill more general functions required in each cell (Figure 1). We estimate humans have 411 different 
cell types29, each encoding a subset of the >100000 possible proteins coded for by 20000 genes. The 
8000 protein-coding genes (including many genes encoding transcription factors (TFs)) ubiquitously 
expressed in all different cell types are called housekeeping genes30. Thus the pattern of gene expres-
sion (the transcriptome) of each cell ultimately provides the cell’s unique identity. Cells are under a 
tight gene regulation control program31-34, with activation or repression of genes to modulate the tran-
scriptome and hence the cell’s identity and function.  Fairly subtle differences in gene expression, the 
so-called “spatiotemporal expression of the genes”35, suffice for this. The gene regulation program is 
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controlled by cell extrinsic (e.g. environmental stimulations) and intrinsic signals. Cell-to-cell communi-
cations via extracellular signal molecules and downstream signal transduction pathways (like those of 
the BMP/TGFβ family) are types of stimulation which can install and/or maintain the control of specific 
transcriptional programs36, 37. Another example is the NFκB pathway, which is strongly active in stress-
ful, inflammatory and innate immune responses38-40. SAMD4A is among the first genes to respond to 
TNFα stimulation41-43, a cytokine that signals through NFκB to orchestrate the inflammatory response38 
(discussed in Chapter 4 and 5).
Key features of transcription
 
Gene transcription: stepping stones of a complex procedure
Transcription is a complex mechanism, which precedes translation13,15,16 and requires many essential 
elements for its completion. Many groups have joined Roger Kornberg’s pioneering studies in the 
unravelling of the molecular mechanisms of eukaryotic transcription10, 44, 45 (Figure 2). This process is 
highly mediated by DNA-dependent RNA polymerase whose enzymatic activity was identified by Weis 
and Gladstone at 1959 in rat liver nuclei46, 47. Eukaryotes have in fact three DNA dependent RNA poly-
merases: RNA Polymerase I (RNAPI), RNA Polymerase II (RNAPII) and RNA Polymerase III (RNAPIII)48 
and they were first described by Pierre Chambon49 and Jam Tata50. Their chromatographic separation 
was achieved around 1969 by Roeder and Rutter51, 52. The enzyme responsible for eukaryotic DNA tran-
scription of most studied genes is the RNAPII, also known as “polII” or “RNA polII”53. 
RNAPII binds to a sequence of DNA at the start of a gene to initiate transcription. This region is func-
tionally known as the promoter and contains any combination of a number of sequence elements (see 
below) with a starting sequence that is often also containing ATG39. They contain specific nucleotide 
sequence elements and provide the necessary “space” required to harbour not only RNAPII, but also 
the Mediator (a large complex of proteins) and TFs necessary for the initiation of transcription54-56 
(Figure 2). Transcription initiation studies have unveiled two types of promoter, i.e. the focused and 
dispersed promoter, respectively54, 57. In focused initiation, transcription starts either at single nucleo-
tide or over a narrow segment of nucleotides. Dispersed promoters have multiple start sites over 50 to 
100 nucleotides most commonly found in CpG islands on the one hand and in constitutively expressed 
genes on the other hand54, 57. It should be clarified that dispersed promoters should not be confused 
with alternative promoters which are distinct and are often located far apart from each other. There 
are promoters which exhibit the properties of both the two aforementioned types of promoter; mul-
tiple dispersed start sites, but with one particularly strong and hence predominant start site. Focused 
promoters could be characterized as “ancient” as they appear to be predominant in simple organisms. 
However, 70% of the vertebrate genes have dispersed promoters. Biological interest in specific cell 
types was the main reason why most of studies for RNAPII have been conducted on focused promot-
ers even though they are a minority in vertebrates when compared to dispersed promoters. Those 
studies led to the discovery of recognition motifs that are enriched in core promoters (Figure 2) such 
as the TATA box, Inr (initiator), BREu (upstream TFIIB recognition element), DPE (downstream promot-
er element), MTE (motif ten element), DCE (downstream core element) and XCPE1 (X core promoter 
element 1). Dispersed promoters generally lack TATA, BRE, DPE and MTE motifs56, 58 with TATA-lacking 
promoters also being deficient in ATG triplets59. 
These aforementioned elements are recognized by some additional general TFs (GTFs, Figure 2)60, such 
as TFIIA (TF for RNAPII), TFIIB, TFIID, TFIIE, TFIIF and TFIIH to promote the unwinding of DNA at the 
early steps of transcription54, 57. TFIID consists of the TBP subunit, which recognizes the TATA box, and 
the TAF subunits which recognize the Inr (TAF1, TAF2), the DCE (TAF1) and the DPE (TAF6, TAF9). In 
summary, RNAPII and GTFs are recruited to the promoter to form the pre-initiation complex (PIC)39, 61, 
62. Furthermore, the multi-protein complex Mediator facilitates the localization of the PIC to the pro-
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moters63, 64. Briefly, TFIIA promotes the binding of TBP to the TATA box65 and subsequently TFIID binds 
to the TATA box. TFIIB (interacts with TBP and promotes the recruitment of RNAPII to the promoter65) 
followed by TFIIF (stabilizes TBP/TFIIB interaction66, attracts TFIIE and TFIIH67)  and RNAPII are recruited 
to the promoter68. Then, TFIIE joins the PIC and facilitates the enzymatic functions of TFIIH69 and they 
both promote the transition from transcription initiation to elongation60, 69. TATA-less promoters have 
the TFIID recruited at the 30bp upstream region from the promoter through direct or indirect interac-
tions with TBP associated factors70.
Often RNAPII will fail to initiate transcription after already a few nucleotides (also referred as “abortive 
initiation”)71. Successful initiation is mediated by TFIIH72. CDK7, which is part of TFIIH, phosphorylates 
(P) the fifth serine (Ser5) of the RNAPII carboxy-terminal domain (CTD)73 (also known as RNA PolII 
Ser5P) and triggers the disengagement of RNAPII from the promoter to initiate transcription72, 74. That 
TATA Inr DPE
TFIIHTFIIETFIIF
TFIIB
TBP
TAFs
TFIIA
GTFs
Mediator
RNAPII 
GTFs
Mediator
RNAPII 
poly(A)
Ser2P
TFs GTFs
Mediator
RNAPII 
CDK9
poly(A)
RNAPII 
TFs
Ser5P CDK7
GTFs
Mediator
poly(A)
CTDTFs
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RNAPII 
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Figure 2: An example of tran-
scription process by RNAPII. PIC 
(pre-initiation complex) is assem-
bled by RNAPII, the Mediator and 
GTFs and recruited to the promoter 
(TSS) of the gene, which is going 
to be transcribed. TFs are recruit-
ed to the vicinity of PIC, CDK7 
phosphorylates Ser5 of RNAPII to 
escape the promoter with the sub-
sequent release of Mediator and 
GTFs resulting in the initiation of 
transcription with the formation 
the initiation complex. Subsequent-
ly, CDK9 phosphorylates Ser2 of 
RNAPII resulting in the elongation 
of the transcription. When RNAPII 
transcribes through a poly(A) site, 
termination proteins pause RNAPII, 
the RNA transcript is released and 
transcription is terminated.
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process is also known as promoter escape or promoter clearance and is characterized by the release of 
the Mediator and GTFs75. At that stage, RNA PolII Ser5P is also known as “initiating complex”. The ini-
tiation complex can be paused after promoter escape72, 76, especially by two factors, DSIF77 and NELF78. 
Forty percent of the genes are estimated to undergo transcriptional pausing79, 80 which may provide in 
these cases the time necessary to recruit additional regulatory proteins to the PIC81. CDK9 and CyclinT1 
phosphorylate NELF, DSIF and RNAPII at Ser2 (RNA PolII Ser2P) and the pause is released82, resulting in 
transcription elongation. The RNA PolII Ser2 complex is also known as the “elongating complex”. CDK7 
and CDK9 are obviously two important kinases in transcription by RNAPII73, 74,. Genome-wide analysis 
of RNAPII Ser5P and Ser2P occupancy shows that RNAPII Ser5P diminishes from the promoter whereas 
RNAPII Ser2P is present throughout the transcribing gene. Transcription is complete near the end of 
the gene when the RNAPII transcribes through a poly(A) addition site. Termination proteins recognize 
that site, pause RNAPII and cleave the RNA transcript as part of 3’ maturation process83 exerted by the 
so-called CPSF complexes84, 85. In fact, CPSF is also able to couple to TFIID at transcription initiation and 
subsequently associates with the elongating polymerase86.
Gene transcription and TFs: a relationship of love and hate
Apart from the GTFs, the PIC and the Mediator, gene transcription requires another specialized class 
or TFs, which direct the transcription machinery to the promoters87. Every TF binds a specific sequence 
motif or is part of a complex binding a specific motif that is distant from the TSS. They can bind at the 
promoter or at sequences distant from the promoter to activate/inhibit or increase/decrease tran-
scription from the promoter87. The operon model of Francois Jacob and Jacques Monod in 1961, de-
fined in the bacterial E. coli disaccharide lactose metabolism negative control system, was the stepping 
stone to the era of transcription regulation by introducing the idea that gene transcription can be 
repressed by a protein upon its binding to its target gene88. 
The specific DNA sequence motif, which the TFs recognize in order to bind to the DNA, is often between 
6-12 bp. Such specific short motifs are distributed throughout the genome and offer a huge variety of 
possibilities to the TFs to occupy different positions. As a consequence, they can be located in exons, 
introns, promoters or intergenic/“gene desert” areas. Usually 200-300 bp contain multiple different 
motifs for different TFs, suggesting that TFs can cooperate in a combinatorial fashion89 with other TFs 
(and their co-factors) recruited to the same vicinity, or alternatively that they compete/antagonize 
each other87. The spacing between motifs is often very important but can vary; the hematopoietic TFs, 
GATA1 and TAL1 have a spacing between them of about 8-11 nucleotides90, 91 when they are present in 
the same complex. As mentioned above such motifs can be located in the vicinity of promoters26 or in 
regulatory elements distant from promoters such as enhancers, silencers or even insulators92.
One of the most challenging conundrums is the relationship between TF motifs; the underlying mech-
anism of recruitment of a specific TF (complex) to a specific motif/position while it is not recruited 
to other identical or similar motifs/positions throughout the genome. A proposed mechanism is that 
“pioneering TFs” promote the recruitment of specific TFs to specific genomic locations (discussed in 
Chapter 6). For example, it has been proposed that GATA2 can function as a “pioneer” TF to promote 
the binding of GATA1 to a subset of specific putative genomic locations93, 94.
According to a recent study, humans have 1391 TF encoding genes95, however this number will likely 
change in the foreseeable future through new studies. As explained above, the spatiotemporal ex-
pression of the genes35 requires the activation of genes in specific tissues or at specific developmental 
stages, which is driven by tissue or stage specific expression of TFs and their localization to their target 
genes87 (Figure 3A). That different expression of different TFs in different cells separates the cells into 
different categories or lineages and endows them with their unique characteristics96 (Figure 3A). 
In summary, TFs have many different properties (Figure 3B); they can interact with the Mediator or 
GTFs97, 98, promote the recruitment of other TFs95, synergize or compete and/or antagonize other TFs99, 
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promote specific cell lineages96, interact with the transcription machinery87, activate or repress their 
target gene(s)92, 100 and also promote chromatin looping (discussed in Chapter 3 and 5)92.
An example of those TFs, whose expression might contribute to different cell types, are the GATA 
factors which recognize the WGATAR nucleotide sequence (wherein W=A or T, R= A or G). Gata1 is 
expressed in testis, megakaryocytes, eosinophils and erythroid precursors101-108 whereas Gata2 is ex-
pressed in hematopoietic stem cells (HSCs) and hematopoietic progenitors99, 101, 106-108.  An interesting 
phenomenon is the “GATA switch”99, 109, 110 (discussed in Chapter 7). Gata2 expression activates Gata1, 
with GATA1 to subsequently replace GATA2 and repress Gata299. Another TF, Friend-of-GATA (FOG1), 
can sometimes facilitate GATA1 occupancy and the GATA switch111, 112 via its N-terminal sequence, 
which binds the NuRD chromatin remodelling complex113. This implies that the GATA switch requires 
chromatin remodelers such as the NuRD complex.
An important TF complex is the “LDB1 complex”. Absence of LDB1 results in embryonic death of mouse 
embryos between E9.5 and E10.5 with hematopoietic and other defects114-116.  The hematopoietic LDB1 
complex consists of LDB1, GATA1/2, TAL1, E2A and LMO2116, 117 plus a number of other proteins, includ-
ing CDK997. The LDB1 complex typically recognizes the E-box/GATA motifs whereby GATA1/2 dock at 
the GATA motifs. TAL1 recognizes the E-box motif100 with E2A, which heterodimerizes with TAL1118. 
LMO2 forms a bridge between GATA1/2 and TAL1/E2A90, 118 with LDB1 acting as a scaffold for attracting 
more TFs (like ETO2, MTGR1, RUNX1, LMO4)119 to either suppress or activate their target genes100. The 
LDB1 complex is mainly localized in distal regulatory elements. The most prominent and well-studied 
example is the Locus Control Region (LCR) of the β-globin locus120, which binds the LDB1 complex; this 
promotes the close proximity of the LCR to the β-globin gene121-123. 
As mentioned above, NFκB is a protein dimer consisting of subunits of a TF family that play a critical 
role in cell survival, inflammation, cell proliferation and differentiation124. They were first identified in 
1986 as TFs whose specific DNA binding activity121, 122 is promoted by an extracellular signal to provide 
an immediate early reaction of the genome to the signal125. NFκ-type TFs are important for activation 
and regulation of important genes upon response to developmental cues or extracellular stimuli40, 125. 
NFκB consists of a combination of five proteins: p65, cREL, RELB, p50 and p52, with the interaction 
between p65 and Mediator being important for activation of NFκB-dependent genes126. A structurally 
conserved REL homology region is shared between all the subunits; it is responsible for dimerization, 
nuclear entry, interaction with inhibitory IκB proteins and binding to their DNA target sequences (also 
known as κB sites)126. Prior to its activation, inhibitory proteins such as p100 or IκB members restrict 
NFκB to the cytoplasm, but upon activation, NFκB is quickly released from these and enters the nucle-
us to either repress127 or activate42 particular genes.
Gene A Gene B
Gene A Gene B
Gene A Gene B
Gene A
Gene B
Gene A
Gene B
Gene A
Gene B
TFs
GTFs
Mediator
RNAPII 
TFsGene A
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A B
Figure 3: Properties of TFs. (A) TFs provide different gene expression in specific tissues or developmental stages. Gene A is ac-
tive in one cell type and silenced in another where Gene B is active due to the effect of binding of different TF. (B) TFs can have 
different properties and generate specific cell lineages; they can promote chromatin looping, recruit and/or compete with other 
TFs, interact with the PIC and activate or repress their target gene(s).
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Chromatin compaction: more than meets the eye
Completely unfolded, linear DNA has a length of approximately 2 meters and is packed in a nucleus 
of 2-10μm diameter12. Hence, the DNA must be compacted in higher order structures, with electron 
microscopy (EM) analysis revealing several potential layers of packaging128 (Figure 4A). The basic struc-
tural element of the packed DNA is the nucleosome; it consists of 146bp of DNA wrapped around an 
octameric protein complex composed of two copies of the H2A, H2B, H3 and H4 histones 129-131. H1, 
the linker histone, is present in most nuclei and provides partial nuclease protection for approximately 
20bp of DNA129. The compacted DNA with its histones is called “chromatin”. When observed in EM,  it 
resembles as “beads on a string” (beads are the nucleosomes and the string is the relaxed DNA). The 
nucleosome fibre has a diameter of 10nm. 
The nucleosomes are connected by short DNA segments termed “linker DNA”132. A higher order of 
structure/compaction is formed by nucleosome-to-nucleosome interactions resulting in the 30nm fi-
ber132, a model proposed by Finch and Klug in 1976129. The nucleosomes are arranged in a zig-zag man-
ner in order for a nucleosome to be close to the second neighboring nucleosome and not the immedi-
ate first neighbour128. Despite this often being regarded as a very regular structure mainly arising from 
a popular artistic representation, this is not the actual representation in the original publication129.  A 
perpetual question in the field of chromatin biology is how the chromatin is folded into structures be-
yond the 30nm fiber. In the late 1970s, Laemmli and colleagues showed that chromosomes consist of 
90Kb-sized loops; they also postulated that these are in contact with the nuclear matrix during mitosis, 
forming rosettes composed of approximately 18 loops, with 100 rosettes per mitotic chromosome131. 
In the 1990s, a new chromatin state named the “chromonema” fiber was postulated, which is com-
posed by a 60-130 nm fiber interspersed by loosely folded 30nm segments133. 
The compactness of the genome, the respective ability of TFs and the assembled RNAPII machinery to 
access the chromatin are the main contributing factors for gene transcription and its regulation (Figure 
4B). This can potentially be achieved in a direct or indirect way; nucleosome repositioning results in 
genome accessibility, which is orchestrated by chromatin organisation. It also harbours specific histone 
modifying proteins (histone readers) that target specific histones, yielding subsequently regulation of 
transcription134-136. Nucleosome remodelers and histone-modifying proteins promote the change of 
the chromatin from a highly compact (with no transcription state) to a relaxed state, enabling tran-
scription, and vice versa.
Nucleosome repositioning can be achieved by specific chromatin remodelers via ATP hydrolysis, re-
sulting in a nucleosome-free or dense genomic region with an impact to transcription regulation136. 
DNA can be wrapped around the nucleosomes and the histones in a relaxed or a tight manner, with or 
without gene expression, respectively. The first state is often termed as “open chromatin” or “euchro-
matin” and the latter as “closed chromatin” or “heterochromatin”12, 134 (Figure 4B). In the first direct 
mechanism, TFs cannot access the heterochromatic DNA to promote their functions. However, in the 
euchromatin, pioneering TFs can attract and/or stabilize those TFs to the nucleosome-free positions 
and they subsequently can promote their functions (Figure 3B, 4B). 
The “euchromatin” state can be easily determined by four different methods. The enzyme DNaseI 
(when applied in partial digestion conditions) can recognize “open chromatin” genomic positions, 
which are also called DNaseI-hypersensitivity sites. Digestion with Micrococcal nuclease (MNase) pref-
erentially recognizes linker DNA and nucleosome-free genomic regions, resulting in nucleosomal “lad-
ders” visible after gel electrophoretic separation. DNA methylation footprinting exploits the ability of 
DNA methyltransferases to add methyl-groups to specific nucleosome-free nucleotide sequences (i.e. 
to CG) more efficiently than to DNA wrapped around nucleosomes. With formaldehyde-assisted isola-
tion of regulatory elements (FAIRE), chromatin is fixed by crosslinking, and the nucleosome-free DNA 
released from the interface in a phenol-based extraction selects for DNaseI-hypersensitivity sites and 
active promoters. All these methods can be coupled to high-throughput next generation sequencing 
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(DNaseI-seq, MNase-seq, DNAme-seq, FAIRE-seq) in order to access the “open chromatin” areas in a 
genome-wide manner137 (Figure 4B). Prediction of the “open chromatin” genomic regions can be an 
efficient tool to predict the positions where TFs and/or the transcription machinery are bound to the 
genome thereby providing information as to which genes are transcribed or poised.
Histone-modifying proteins bind to a specific segment of histones, usually the “histone tail”, resulting 
in specific post-translational modifications (PTMs) of these histones138. PTMs were first described by 
Vincent Allfrey in the early 1960139 and meanwhile have yielded a great variety of PTMs: acetylation, 
phosphorylation, methylation, ubiquitylation, sumoylation, neddylation, and others have been de-
scribed138. Such modifications can have either a direct or an indirect effect. The direct effect influences 
the structure of the genome by changing the charge of histones, resulting in relaxed versus condensed 
chromatin. The first state can be achieved by acetylation and/or phosphorylation which can reduce the 
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“open” chromatin, is achieved by nucleo-
some repositioning in a reversible manner. 
HATs (histone acetyltransferases) endorse 
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positive charge of histones thereby diminishing the interactions with the negatively charged DNA138. 
Enzymes such as the histone acetyltransferases (HATs) which add certain modifications to the “histone 
tails” are often called “histone writers”, while the “histone erasers” (HDACs; histone deacetylases) 
remove the histone modifications140 (Figure 4B). The indirect mechanisms underlying gene expression 
modulation involve the recruitment of specific effector molecules, the “readers”, which are separated 
into three categories, i.e. chromatin architectural proteins, chromatin remodelers, recruiters of other 
TFs, respectively, depending on their function. These “readers” determine the functional outcome of 
specific PTMs135.
The full repertoire of the PTMs make up the epigenome (from the Greek επί-γονιδίωμα, on top of the 
genome). Histone modification signatures can be used to predict the position, the role and function 
of regulatory elements such as enhancers (discussed below) and promoters (Figure 5B). Promoters of 
actively transcribed genes are usually marked by H3K4me3, whereas silent promoters are enriched 
for H3K9me3 and H3K27me3141. Interestingly, the intermediate state between “active” and “silenced” 
promoters referred to as the “poised” promoters, are marked by H3K4me3 and H3K27me3141. Those 
promoters are also called “bivalent” since they have both activating and repressing histone modifi-
cation signatures141. The “silenced” and “bivalent” promoters often contain the Polycomb repressive 
complexes (PRC1, PRC2) with PCR2 containing EZH2, which catalyzes H3K27 tri-methylation142. A large 
proportion of the “bivalent” PRC2 targeted promoters (inactive at pluripotent cell stage and rapidly in-
duced or inactivated depending the developmental decision) corresponds to important developmental 
genes, which encode important TFs for successive developmental stages143. In addition, H3K36me3 
and H3K79me2 correlate with transcription elongation144. Large regions of “heterochromatin” are 
characterized by H3K9me2 and H3K27me3 and are in contact with nuclear lamina associated domains 
(LADs)141, 145, 146.
Gene transcription and regulatory elements
The complex linear organisation of metazoan genomes encodes regulatory sequences that can be cate-
gorised into two major groups: enhancers and silencers92 (Figure 5A). TFs can bind regulatory elements 
and regulate their target gene(s) by either activating or repressing them. Even though those elements 
have been studied125, 147, 148 and reviewed extensively35, 87, 92, 149-152, they still pose a challenge for gene 
regulation studies. 
Enhancers are short motifs (200-300 bp) that contain binding sites for TFs; they activate their tar-
get genes independent of enhancer orientation and often over great distance in cis (up to 1Mb) or 
can achieve this also in trans150. Silencers suppress/downregulate gene expression152 and/or confine it 
within specific chromatin boundaries (and thus are sometimes also called ‘insulators’)151 (Figure 5A). 
The interplay between these two types of contrasting regulatory element, their target promoters and 
epigenetic modifications at all levels of 3D organisation (that is, nucleosomes, chromatin fibres, loops, 
rosettes, chromosomes and chromosome location)153, 154 leads to fine-tuning of expression during de-
velopment and differentiation. Although enhancers and silencers have apparently opposite effects, 
accumulating evidence suggests they share more properties than intuition would have suggested155. 
The latest studies estimated that 40% of the genome has some regulatory potential156.
Enhancers
Enhancers were characterised almost 35 years ago157, 158, especially in DNA tumor viruses at that time, 
but their current functional definitions vary because of their flexibility of action (whether in cis or 
in trans)159, position (relative orientation and/or distance)61 and genomic location (in “gene deserts”, 
introns and/or untranslated regions)150 (Figure 5A). Although sequence conservation between species 
can be an efficient predictor of enhancer identity, there are examples where genes with identical ex-
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pression patterns in different species rely on enhancers that bear no similarities whatsoever160. Within 
a single genome, sensitivity to DNaseI and characteristic modifications of histone tails provide a more 
reliable means of identification of enhancers. “Active” enhancers typically occupy approximately 200bp 
of “open” chromatin (making them DNaseI-sensitive)161, are flanked by regions rich in mono- and/or di-
methylated lysine 4 of histone H3 (H3K4me1/H3K4me2), acetylated lysine 27 of histone H3 (H3K27ac) 
and, generally, bind p300162.  Furthermore, the enhancers display low levels of trimethylated lysine 4 
of histone H3 (H3K4me3) and low levels of nucleosome occupancy. Decreasing levels of H3K27ac and 
H3K36me3 can distinguish active enhancers in different subclasses with decreased activity162. Thus, 
those signatures can be used to profile enhancers in a genome-wide manner141 (Figure 5B). 
Genome-wide studies of genomic regions harboring histone modification markers have revealed that 
the regulatory elements of the genome have specific signatures, with every class of them having a dis-
tinct histone modification profile. Attempts have been made to classify enhancers into subclasses that 
are differentially used during development. Comparison between mouse embryonic stem (ES) cells, 
their differentiated derivatives and terminally differentiated murine cells allows distinctions between 
“active”, “intermediate” and “poised” enhancers (here, additional marks are used, e.g. H3K27me3 and/
or H3K36me3)147, 162. “Intermediate” enhancers, are characterized by the presence of H3K4me1, DNa-
seI-hypersensitivity and the absence of H3K27Ac, with their target genes expressed at intermediate 
level, i.e. between “active” and “poised” enhancer target genes147, 162. However, “poised” enhancers 
have typically replaced H3K27Ac with H3K27me3, H3K9me2 and H3K9me3147, 162 (Figure 5B). These 
accessible DNA stretches are often bound (and can thus be identified) by p300, Mediator subunits, 
chromodomain helicase DNA-binding protein 7 (Chd7), cohesin and/or CCCTC-binding factor (CTCF)162, 
163. Most importantly, canonical enhancers are characterised by the presence of bound RNAPII164.
A collection of enhancers can give rise to a Locus Control Region (recently also re-termed super-en-
hancers), firstly described by the Grosveld laboratory for the β-globin locus120; this LCR is located 15 
to 60 kb upstream from the promoter of the different globin genes it regulates. The β-globin LCR is a 
collection of five regulatory elements marked by DNaseI-hypersensitivity (referred to as HS1-5)120, 165-
167. HS1-4 are formed only in erythroid cells, whereas HS5 can be found in many different lineages166, 
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168. Interestingly, HS2-4 but not HS1 and HS5 have an enhancing activity165. The hallmark of LCRs is that 
they consist of a group of regulatory elements, regulating a specific target gene and have the ability to 
maintain a chromatin in an “open” (nucleosome-free) state even when integrated into ectopic genomic 
sites. Since the identification of the β-globin LCR example, many other LCRs have been subsequently 
determined in other loci166. 
Lately, the Young lab and the Collins lab have characterized what they consider a new category of 
enhancers termed “super or stretched enhancers”169, 170. These consist of a cluster of enhancers span-
ning 12.5kb or above 3kb, respectively. They contain TF binding sites and control the transcription of 
important developmental/differentiation genes170-172. Genome-wide identification studies of “super or 
stretched enhancers” revealed that they have a significant overlap with LCRs, including the β-globin 
LCR170. Hence, it is debatable whether “super or stretched enhancers” are a new distinct category of 
enhancers or they simply represent the previously identified LCRs.
Enhancers are transcribed into RNAs (eRNAs) that do not encode proteins, run the length of the en-
hancer sequence, and appear to stabilise enhancer-promoter interactions155, 173-175. eRNAs derived from 
elements upstream of the Arc promoter depend on the activity of that promoter, as removing the 
promoter abolishes eRNA production174. β-globin associated ncRNAs are still produced in the absence 
of the β-globin promoter174, 176, 177. However, the rate at which eRNAs are turned over, the exact mech-
anism by which they function and their abundance (relative to the mRNAs they regulate) all remain to 
be determined.
The non-coding subset of the genome, the “gene desert”, is gradually become regarded as important 
for the precise regulation by enhancers, silencers and insulators61. An additional class of ncRNAs longer 
than 200 nucleotides (long intergenic ncRNAs (lincRNAs)) were found in a survey of human transcripts, 
and some exhibited enhancer function173. More than 3000 lincRNAs have now been determined178. 
Some seem essential for the activation of particular promoters e.g. the promoter of the thymidine 
kinase gene, as well as for the expression of neighbouring protein-coding genes (although not all act as 
bona fide enhancers)35. For example, HOTTIP (a lincRNA transcribed from the 5’ end of the HOXA locus) 
coordinates the activation of several HOXA genes; chromatin looping brings HOTTIP close to its targets, 
and this drives H3K4 trimethylation and transcription179.
Silencers
At the opposite end lie silencers (Figure 5A). They prevent gene expression during differentiation 
and progression through the cell cycle180. This again correlates with RNA production (in some cases, 
through the generation of RNA duplexes that underlie the methylation of DNA at the promoter)181, 182.
Accumulating documentation supports a broad and general role of both long and short RNA mole-
cules in transcriptional inhibition. Antigene RNAs (agRNAs) are small RNAs that target promoters and 
downstream regions181. The expression of genes encoding progesterone, low-density lipoprotein, the 
androgen receptor, cyclooxygenase-2, the major vault protein and huntingtin is inhibited by agRNAs181, 
183. Similarly, microRNAs (miRNAs), which are 20 to 22 nucleotides long, regulate gene expression 
post-transcriptionally184, and they may also act at the level of transcriptional initiation or elongation. 
This is now supported by deep sequencing of nuclear and cytoplasmic small RNA libraries, where the 
majority of mature miRNAs localise in the nucleus (and not only in the cytoplasm)184. For instance, in-
troduction of miRNA mimics that target the progesterone gene promoter decreases RNAPII occupancy. 
It also increases H3K9me2 levels in an Argonaute 2 (Ago2) dependent manner and leads to gene silenc-
ing185. Of note is that mature miRNAs in the nucleus can also act as “enhancers”186.
PRC1 and PRC2 complexes rely on non-coding transcripts from silencing elements for recruitment to 
target sites. A range of examples are available: for instance, repression in cis in CD4+ T-cells and ES 
cells, where PRC2-catalysed H3K27me3 recruits PRC1 to prevent chromatin remodelling of targeted 
loci187 and the PRC2-HOTAIR interaction, where transcripts produced from the XOXC locus establish 
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repression of XOXD178. In human breast cancer cells, overexpression of HOTAIR results in the promiscu-
ous association of PRC2 with more than 850 targets, which are in turn silenced188. Furthermore, in the 
well-studied cascade of X chromosome inactivation, the ncRNA Xist binds PRC2, which in turn drives 
H3K27me3189, 190 and propagation of PRC1’s binding to multiple sites along the silenced allele191. Here 
the 3D conformation is also critical for efficient silencing and results in chromatin compaction and/or 
rearrangement192. Such equilibrium may, however, be shifted by the eviction of Polycomb proteins to 
restore an active state190.
Insulators
Functionally autonomous domains are strung along the chromatin fibre, and these need to be insu-
lated from their neighbours to prevent the action of irrelevant enhancers and silencers (Figure 5A). 
Insulator or boundary elements perform this task. These can be further categorised as enhancer block-
ers (when the insulator is located between a promoter and a cognate enhancer) and barriers (when 
located between a promoter and a silencer)193. Mutating or deleting insulators alters the pattern of 
gene expression and leads to developmental defects194. 
It has been suggested that insulators evolved from a class of promoters binding a specific subset of 
TFs that drive chromatin remodelling and long range interactions155. Many are marked by DNaseI-hy-
persensitivity195 and/or the presence of bound RNAPII. Specifically, in the Drosophila Hox gene cluster, 
stalled polymerases, in conjunction with elongation factors DISF and NELF, insulate four of eight pro-
moters from Hox enhancers, and this correlates with the rearrangement and/or de novo formation of 
chromatin loops196. It has also been known for a long time that the insertion of a gene (i.e. promoter) 
between an enhancer and its target gene can silence its target gene due to competition for the en-
hancer197.
Perhaps the most abundant protein associated with insulator activity is CTCF. In the well-studied ex-
ample of the IGF2-H19 imprinted locus, CTCF prevents activation of the maternal Igf2 allele by a distal 
enhancer. When its cognate binding site is lost, the gene is reactivated198. Nonetheless, in this locus, 
CTCF is a positive regulator of the H19 gene188. Moreover, CTCF mediates enhancer-promoter, insu-
lator-insulator and insulator-promoter interactions155. The insulator function of CTCF is regulated by 
cohesins199-201 with their respective binding sites to coincide in various cell types and loci. 
However, the CTCF-cohesin duplet is characteristic of only one type of insulator or boundary. In a 
comprehensive mapping of such Drosophila elements, additional factors, such as boundary element 
associated factor, GAGA and CP190, were used to pinpoint and classify domain boundaries202. Again, 
DNaseI-hypersensitivity characterises many of these elements, and examples exist where their func-
tion is Ago2 dependent (and so transcription-dependent, but RNAi-independent)203.
 
Unveiling the 3D structure of the genome; cutting the Gordian knot   
Tethering together the regulatory elements; the core of a complex structure
In order for enhancers, silencers or insulators to have their function in gene expression regulation, 
they have to be in fairly close proximity with their target gene(s). The last decade, growing evidence 
supports the theory112, 123, 159, 200, 204-207 that TFs, even ncRNA208, and more recently also the Mediator and 
Cohesin complexes, stabilize that proximity201, 209.  
Four models were proposed to describe how those elements may regulate a gene; the tracking, link-
ing, relocation and looping model92 (Figure 6) with the looping model being the only one that suggests 
that proximity is important. 
According to the tracking model (Figure 6A), a protein loads onto the enhancer and tracks along the 
chromatin fibre towards the promoter, where it stimulates transcription210. This model is based on 
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investigation of the activator gp45, which is loaded on the DNA and tracks its target gene promoter 
by sliding on the DNA210. The linking model is similar (Figure 6B), but here the loaded protein drives 
polymerisation of proteins in the direction of the promoter211. One example is the Drosophila Chip 
protein which interacts with other TFs to promote enhancer-promoter proximity212. In the relocation 
model (Figure 6C), a given gene relocates to compartments in the nucleus where enhancer-promoter 
interactions (and so transcription) are favoured213, 214.  An evidence for that model is that active RNAPII 
can be identified in specific focal sites215 inside the nucleus and that transcriptionally active genes are 
associated with those sites216 (the “transcription factories”)146, 217, 218. The looping model (which shares 
features with the relocation model, Figure 6D) predicts a direct contact between an enhancer and a 
relevant promoter that loops out the intervening DNA121 and thus is closely linked to the 3D architec-
ture of the genome214, 219. 
Next, activators that are bound to the enhancer interact with the Mediator complex, which recruits 
RNAPII and GTFs to the promoter35, 63. Recently, TFs123, 207, Cohesin201 and the Mediator209 complex have 
been implicated in tethering the enhancer to its target promoter in close proximity in the 3D nuclear 
space thereby also promoting transcription regulation. This last model is now favoured, as it readily 
explains enhancer-promoter interactions in trans220. Furthermore, it is supported by a wealth of ex-
perimental data derived from chromatin conformation capture technology112, 121-123, 159, 204-207, 221, 222 and 
modelling146, 154, 219. 
Similarly, among the three major models proposed for insulator function (roadblock associated with 
the tracking model, sink/decoy associated with the looping model, and the topological loop models, 
which are a combination of the tracking/looping models), the topological loop model is best supported 
by experimental data. For example, rearrangement and/or de novo formation of appropriately orient-
ed loops efficiently insulates promoters from enhancer elements223. Note also that recent data show 
how gene repression dependent on gypsy insulators in Drosophila propagates between distant loci to 
be repressed via the organisation of local loops224.  
Gene regulation from distal regulatory elements via local looping or via broader rearrangements in 
3D organisation is now a widely accepted concept. The best studied example is the regulation of the 
β-globin gene by its LCR. The two key elements, the LCR and the β-globin promoter, are located in close 
proximity in the 3D nuclear space forming new chromatin loops112, 121-123, 159, 204-206, 221, 222. This β-globin-
LCR relationship is also a well-studied example of tissue and developmentally specific regulation165-167. 
All cis-regulatory elements in this locus are in close proximity, where they form an “active chromatin 
hub”. This hub is present in mouse primary erythroblasts (mouse fetal liver; mFL) where the β-globin 
gene is actively transcribed, but not in mouse fetal brain (mFB; where the β-globin gene is not ex-
pressed)123, 159, 205, 221, 222,.  An active chromatin hub, as defined in the β-globin locus paradigm, arises 
from the 3D clustering of DNA-hypersensitive sites, depends on specific DNA-protein interactions and 
tethers together all essential components for transcriptional activation159, 205, 222. Other examples are 
GATA1, which represses Kit via specific loop formation, while its exchange with GATA2 reforms the 
enhancer-promoter loop and reactivates Kit expression225. The IgH locus is yet another example;  a 
2.7Mb region is reorganised spatially during IgH locus activation154.  Similarly, various TFs have been 
implicated in the formation of regulatory chromatin loops, including EKLF123; CTCF200, 201, 206; cohesin201, 
226 and LDB1100, 207. Knocking them out or down individually results in loss of looping and changes in 
transcriptional state112, 123.
Transcription Factories; a plausible explanation for genome organization and gene regulation
On a broader scale, the genome is organised non-randomly in 3D space146, 154, 219 as a result of a variety 
of chromatin loops and rosettes146, 213, 227 (unpublished data), and knowledge is emerging that tran-
scription is also architecturally organised146, 228. The traditional model of transcription requires that the 
polymerase tracks along the DNA template, somewhat like a locomotive, resulting in the synthesis of 
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a transcript12. However, lately and increasing evidence suggests an alternative model. It proposes that 
transcription occurs in nucleoplasmic hot spots (called “transcription factories”, see above) where a 
high local concentration of the required molecular machinery renders the whole process more effi-
cient146. This term was first applied in 1968229 by Cook and colleagues, who have contributed signifi-
cantly to this concept41, 42, 146, 214, 215, 217, 230-234. In the 1990s the “transcription factory” term was used for 
the nuclear foci where DNA repair, DNA replication and gene transcription take place215, 235, 236. HeLa 
nuclei contain approximately 1μΜ of RNAPII but the concentration is estimated 1000-fold higher in 
such factories237. The underlying principle is that the polymerase is fixed to the “transcription facto-
ries”, while the promoter of the gene diffuses to the factories and the DNA template moves through 
it by using the energy emanating from nucleotide triphosphate hydrolysis146. Possibly “transcription 
factories” are a collection of several “active chromatin hubs”. 
By definition, “transcription factories” harbour at least two RNA polymerases, each transcribing a dif-
ferent template. RNAPII genes themselves are also transcribed in separate factories from RNAPIII-de-
pendent genes234. Actively transcribed genes tend to co-localise in the nucleus216, 238, but different types 
of genes seem to cluster in “specialised” transcription factories, where they are co-regulated and 
co-expressed. The β-globin “transcription factory” contains at least two polymerases; one transcribes 
the enhancer and another transcribes a protein-coding gene. Interestingly, Eraf is located 25Mb away 
from the β-globin locus, appears to be in close proximity with the LCR and the β-globin locus in a foci 
rich with the required TFs and RNAPII100, 216, 239.  Furthermore there is evidence that TNFα responsive 
genes, such as SAMD4A and TNFAIP2 which are 50Mb apart, are located at the same “NFκB transcrip-
tion factory”42, 232. Although factories can now be isolated and their proteins characterised using mass 
spectrometry240, the mechanism by which factories are “marked” by specific TFs, and the relative rep-
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Figure 6: Existing models for the function of enhancers. The four existing models describing gene regulation by enhancers are 
depicted. (A) The tracking model, where a TF (purple hexagon) loads onto the enhancer and tracks along the chromatin fibre 
towards the promoter, where it stimulates transcription by association with the polymerase (B) The linking model, where the 
loaded TF drives polymerization of proteins in the direction of the promoter. (C) The relocation model, where a gene relocates 
to nuclear subcompartments (pink halo) favouring enhancer-promoter interactions, and so transcription. (D) The looping mod-
el, where the enhancer comes into proximity with the relevant promoter due to protein-protein interactions and stabilized by 
cohesin. This loops out the intervening chromatin and triggers transcriptional activation.
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resentation of different subtypes of factories, remain undetermined. 
How can these ideas be extended to explain the function of enhancers and silencers and/or insula-
tors? All share common features; for example, DNaseI- hypersensitivity, active chromatin marks and 
interaction with TFs and RNAPII. Therefore, I propose that canonical regulatory elements are primarily 
transcription units and that, in order for them to be functional, they need to be transcribed (and so 
associated with a transcription factory). This hypothesis defines two key aspects of chromatin struc-
ture: (i) proximity between distant DNA sequences due to looping, and (ii) tethering of active genes to 
a factory.
Does the number of factories in a given cell suffice to accommodate all transcription units, includ-
ing enhancers and/or silencers? To date, the lower estimate of 200 factories concerns murine prima-
ry cells and comes from RNAPII immunostaining ex vivo216. This suggests that about 80 transcription 
units would share a factory (assuming 16000 active transcription units, the estimated number in HeLa 
cells)231 and that a number of them are transcribed outside a factory as well. Other approaches in HeLa 
cells return a number that is an order of magnitude higher: they propose approximately 2000 factories, 
each hosting an average of 8 transcription units233. Furthermore, the density and diameter of these 
transcriptional hot spots appear to be constant between cell types, suggesting an underlying topology 
accessible to transcription units in different nuclear neighbourhoods231, 241. The difference between 
these numbers may be explained by a difference in the sensitivity of the detection protocols used231. 
Nevertheless, the question whether most transcription occurs in factories has not been answered. It 
seems that most indeed does take place in factories as some estimates indicate that more than 95% 
of nascent nucleoplasmic RNA is found in factories228, 233, 241. Nonetheless, these issues will probably be 
resolved only by direct, live-imaging of such factories in cultured cells. 
Now consider that an enhancer (transcription unit 1) (Figure 7A) tethers its target promoter (located 
in unit 2) close to factory or hub A that contains the necessary machinery. As a result, the target pro-
moter 2 will diffuse through the nucleoplasm and frequently collide with a polymerase in factory A to 
initiate transcription. Although another promoter, i.e. unit 3, is also tethered close to the same factory, 
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Figure 7: A simple model for the function of regulatory elements into transcription factories. Spheres A, B and C represent fac-
tories rich in different sets of TFs and associated halos indicate the probability that promoter 1, 2 or 3 will collide with a factory 
(red indicates high probability). The low-probability zone immediately around the factory arises because the intrinsic stiffness 
of the chromatin fibre restricts the formation of very small loops. Curved black arrow indicates collision between promoter and 
factory that yields a productive initiation. Dashed black arrows indicate the preferred site of initiation (as factory B is rich in 
the relevant TFs). Blocked red arrows indicate unproductive collisions (as the factory contains few of the relevant factors). (A) 
Enhancers and silencers. Transcription unit 1 is being transcribed by a polymerase in factory A. This tethers unit 2 in a ‘hot zone’, 
where it has a high probability of colliding with a polymerase in factory A (which contains high local concentrations of factors 
necessary for initiation by promoters 1 and 2). As a result, unit 1 acts as an enhancer for unit 2. At the same time, unit 3 is teth-
ered far from factory B (which is rich in the factors required for its initiation). Here unit 1 acts as a silencer of unit 3. (B) Insulator. 
At a different stage in development, a different constellation of TFs are expressed. Chromatin domains containing units 2 and 3 
(now be transcribed efficiently only in factory B which is rich in the necessary factors) are separated by unit 1 (now transcribed 
in factory C, which contains low concentrations of the factors required by units 2 and 3), so they rarely bind to factory B and 
interact. Here unit 1 acts as an insulator or barrier.
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it will initiate rarely (because factory A lacks the necessary TFs required by this promoter 3). However, 
promoter 3 can initiate in factory B (which does contain high concentrations of the relevant factors), 
but it will do so rarely, simply because it is tethered close to factory A and is kept far from factory B. 
Next, the transcription unit 1 would then act as an enhancer of unit 2 and as a silencer of unit 3. Then, 
the addition of histone modifications that mark the various units as active or inactive will enforce the 
status quo. After that, once unit 1 has been transcribed, these marks will make it more likely that unit 
1 or unit 2 will reinitiate in factory A, thereby enabling to create a virtual cycle. 
Similarly, at another developmental stage, when a different set of TFs are expressed (Figure 7B), unit 1 
might be transcribed in factory C. It is again flanked by units 2 and 3, but these can now be transcribed 
efficiently only in factory B (which is rich in the necessary factors). As units 2 and 3 cannot stably inter-
act with each other by binding to factory C, unit 1 now acts as an insulator or barrier. As before, histone 
marks will reinforce this different (virtual) cycle.
The model proposed here (Figure 7) illustrates a case where non-genic transcription unit 1, in its nor-
mal genomic location, acts as an enhancer, silencer or insulator or barrier, depending on the target 
and developmental stage. I imagine that most regulatory motifs normally act in only one way; how-
ever, when taken out from their normal context and moved elsewhere (usually the case in most of 
the assays used for testing the action of these motifs), they will act differently, depending on the new 
context (which includes proximity to an appropriate factory). This model encapsulates notions of tran-
scriptional activity, epigenetic marks and 3D architecture, which, in combination, provide the context 
that determines promoter activity.
3D genome organization: important players for a perpetual question
Although the linear composition of the genome is clear, its 3D organization is relatively unknown, 
despite the increasing endeavours to unveil this uncharted territory. Chromosomes occupy distinct 
sub-nuclear volumes, the chromosomal territories (CTs)242 (Figure 8A). A number of recent studies 
have shown that the genome, along the linear chromosomal axis within a CT, is organized in self-asso-
ciating domains that are separated by linker regions243. These so-called “topological domains” or “to-
pologically associated domains” (TADs) generally range from 300Kb to 1Mb and consist of a series of 
different types of chromatin loops, still in agreement with earlier models for the genome153 (Figure 8B). 
Chromatin loops can be categorized into two groups; functional and structural loops221. Structural 
loops enable the folding of the genome creating TADs243 with the base of the loop to define the do-
main boundaries. Functional loops are found within TADs and serve expression of genes112, 123, 159, 204-207, 
221, 222; less frequently there are interactions between TADs192, 221, 243. Thus the “loop-within-loop” model 
proposes one “structural” TAD to contain a lot of “functional” loops (Figure 8B). A conundrum in the 
field of chromatin biology is the common misunderstanding that chromatin looping is conceived and 
perceived wrongly as chromatin interaction. Indeed, a chromatin loop, as detected by any of the chro-
mosome conformation capture (3C) based technologies, only shows that two elements of the genome 
are in close proximity in the 3D nuclear space rather than documenting true interaction. Hence, wheth-
er those elements are actually interacting must be proven by functional experiments.
Within a TAD, the regulatory elements and their target genes are in general located in close proximity 
in the 3D nuclear space to enable the control and regulation of their target genes (Figure 8B). The 
observation that “interactions” within TADs are much more frequent than between TADs suggests a 
modular organization of the genome221, 243. Interestingly, depletion of CTCF results in increased “inter-
actions” between TADs and reduced “interactions” within the same TAD, whereas the depletion of 
cohesin leads only to an overall reduction of “interactions”. Nonetheless, neither CTCF nor cohesin 
depletion alters the boundaries of TADs201. It appears that structure and function of genomes have co-
evolved to maximize the expression of genetic information in a physically limited storage space. Even 
though this relationship seems obvious, the in-depth 3D architecture of genomes, their spatial and 
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temporal dynamics of interactions and 
their relationship to transcription, rep-
lication and cell division, are still far 
from understood.
Towards the effort to unravel the chro-
matin loops and the subsequent 3D 
chromatin organization, the develop-
ment of 3C technology has contribut-
ed significantly. The basic principle of 
various 3C-based methods is to de-
tect which DNA segments are in close 
proximity (interactome) in the nuclear 
space, unravelling of the 3D structure 
of the genome.
Over the last decade a number of dif-
ferent 3C-based technologies have 
been developed. These are 3C-qPCR244, 
3C on a chip (therefore named 4C)238, 
245, 3C combined with high-throughput 
sequencing (4C-seq)246, multiplexed 3C 
sequencing (3C-seq)247, Targeted Lo-
cus Amplification (TLA)248, Chromatin 
Interaction Analysis by Paired-End Tag 
Sequencing (ChIA-PET)249, 3C carbon 
copy (5C)250, Hi-C227, Tethered Confor-
mation Capture (TCC)251, Capture-C252, 
capture Hi-C (cHi-C)253 and Targeted 
Chromatin Capture (T2C)221. Each of 
these methods invariably involves 
the crosslinking of the chromatin (to 
link neighbouring segments of DNA 
together) and fragmentation by en-
zyme digestion followed by ligation of 
the DNA fragments (often termed as 
“3C template” at this step) at very low 
concentration. The latter promotes 
the ligation of linked fragments over li-
gation of non-linked fragments, hence 
promoting mono-molecular reactions. 
This results in the ligation of fragments 
that are close together in space but 
which do not need to be close to each 
other in the linear genome. These new 
ligation joints are subsequently “quan-
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Figure 8: 3D genome organization. (A) Different chromosomes (depicted in 
different colors) are organized into CTs inside the nucleus occupying specific 
space and volume. Within and/or between those chromosomes, DNA seg-
ments are in close proximity in the 3D nuclear space either in cis (i.e. DNA 
segments of the same chromosome being in close proximity) or in trans (i.e. 
DNA segments of different chromosomes located in close proximity. (B) A 
“loop within loops” hypothetical model of how a TAD is formed; a structural 
loop of 1-2Mb forms a TAD with its base to define the domain boundary. 
Inside the structural loop, other smaller loops take place, either structural 
or functional tethering into close proximity regulatory elements with their 
target genes.
tified” with different approaches and basically determine which genome fragments are in close prox-
imity in the 3D nuclear space. As stated already above, all the aforementioned methods provide only 
an estimation of the proximity of the ligated products and not hard evidence of a functional interaction 
between them. Hence, none of them offers “absolute quantifiable” measurement of the true interac-
tome, due to a number of parameters. For example, all the 3C-derived methods involve PCR-based am-
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plification at either higher or lower level, which can be challenging due to limiting amounts of available 
biological material. Two DNA fragments (i.e. an enhancer and a promoter) can be in close proximity 
in the 3D nuclear space, but if there occurs a functional interaction between them (i.e. the enhancer 
promoting the transcription of its target gene), this has to be established by functional experiments. 
All these techniques offer different advantages and limitations (also discussed in Chapter 2 and 3) 
and have provided valuable information on chromosomal interactions and gene transcription mech-
anisms159, 221, 227, 238, 250. 3C-qPCR, 4C, 3C-seq/4C-seq and TLA are based on fragmentation of the 3C 
template and measure the number of ligation events with qPCR, microarray or sequence analysis. 
They require knowledge of the genomic region of interest e.g. the location of at least one enhancer/
silencer/promoter or of another genomic region of interest. With the exemption of 3C-qPCR, they 
all allow a “one to all” approach i.e. the interaction of one specific region (the viewpoint) with all 
other candidate regions. However, 5C is a “many to many” approach and requires the design of oli-
gonucleotides for the DNA segments of interest for which the interaction network is retrieved. Hi-C 
and TCC are genome-wide “many to many” methods which provide the proximity network between 
many individual DNA fragments and the compartmentalization/TADs of the genome. Although these 
offer a genome-wide proximity map (interactome), they lack resolution as they usually offer a 40Kb 
resolution on average, which the latest algorithms have improved to 10Kb. However, the latter reso-
lution requires a large sequencing effort (e.g. 3.4 billion mapped paired-end reads from six biological 
replicates)254. The latest improved Hi-C with 1Kb resolution, required an extreme deep-sequencing 
effort (approximately 6.6 billion paired-end reads) resulting in very high costs255. Capture-C252 describes 
the interactome of specific DNA fragments of the genome (e.g. 455 promoters) selected with a ded-
icated oligonucleotide design for the mechanically sheared library and results in an output similar to 
3C-seq/4C-seq. cHi-C applies a selection process like Capture-C for 22225 promoter regions of mouse 
ES cells, providing the “promoter only” interactome256. However, it also required massive sequencing 
(approximately 800 million mapped paired reads for six biological replicates) and binning of the reads 
covering the digested fragments253, 256.
3C-seq247 employs a restriction enzyme fragmentation and ligation at the 3C template that allows a 
“one to all” approach which can be changed to a “many to all” when multiplexed (multiplexed 3C-seq). 
Multiplexing offers the possibility of using different baits/viewpoints in the same sequencing lane; 
they can subsequently be separated based on their different indexes. This provides the simultaneous 
interactome of different regions of interest. 
T2C221 provides the genome-wide interactome for a selected region of (usually) up to 5Mb, which will 
comprise several TADs. T2C requires low sequencing efforts (up to 1/10 of a sequencing lane; less than 
4 million mapped reads per sample) when compared to Hi-C (or cHi-C).  Due to the high coverage and 
enrichment of the selected regions with mapped reads, T2C yields a much higher signal-to-noise ratio 
and does not require the binning of the reads (like in Hi-C, cHi-C or Capture-C), resulting in absolute re-
striction fragment resolution. Furthermore, every DNA fragment in the selected region of interest can 
be used as a single 3C-seq viewpoint. At the same time T2C offers the possibility to define TADs, their 
interactions and their boundaries, at a higher resolution when compared to Hi-C. Importantly T2C can 
easily be multiplexed as well. Hence, T2C is an affordable, cost-effective “two in one” method with sin-
gle restriction fragment resolution that enables the exploration of the local spatial organization of the 
genome and chromatin interactions, without requiring massive sequencing efforts. Furthermore, due 
to the low number of PCR cycles used when compared to all the other methods, it offers more “quanti-
fiable” conclusions, even though it requires a hybridisation step, which itself will introduce some bias. 
In this thesis I discuss the development and application of two of the 3C derived techniques; 3C-seq 
(discussed in Chapter 2, 4 and 5) and T2C (discussed in Chapter 3 and 5).
The next step in the chromatin biology field is to apply 3C technology without crosslinking, which was 
successful recently. This offers the advantage of a native, unbiased view of the compartmentalization 
of the genome and of the interaction network, without the interference of chemicals such as formal-
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dehyde, which primarily targets lysines for crosslinking and hence introduces a bias in the “observed” 
interactions; this means that a short DNA fragment will have fewer bound proteins and hence fewer 
lysines than a larger fragment. 
3D chromatin architecture
The chromatin fiber is in continuous motion and goes through subsequent rounds of condensation and 
de-condensation. Increasing efforts have been dedicated to unveil the shape and the structure of the 
variety of conformations that the chromatin fiber can adopt. The fiber is often perceived as a polymer. 
Thus, its physical properties can be explained in terms of so-called “random walk models”130 (Figure 
9). The basic principle of each of these models is that the chromatin consists of a series of rigid and 
non-flexible segments connected by flexible hinges. Several random walk models have been proposed 
to describe the dynamic shape and structure of the polymer chain130. These models are the freely 
jointed chain, self-avoiding chain, worm-like chain, random walk/giant loop (RW/GL) model, multiloop 
subcompartment (MLS) model, fractal globule and random loop (RL) model, each one having its own 
unique properties (Figure 9). 
In the freely jointed model (Figure 9A), flexible and free to rotate hinges connect a series of rigid seg-
ments, also known as Kuhn segments, which can overlap and intersect another chain. The basic differ-
ence between the freely jointed model and the self-avoiding model is that the Kuhn segments cannot 
cross themselves or other segments257 (Figure 9B). The worm like chain model (Figure 9C), also known 
as the Kratky and Porod chain, proposes that the polymer chain is continuously flexible (rather than 
flexible only within the hinges that separate the Kuhn segments like in the freely jointed chain). The 
chromatin structure of yeast was proposed to resemble to the worm like chain model130, 258.  
The RW/GL model (Figure 9D) proposes that the chromatin fiber is in random motion and consists 
of large loops of 2-5Mb tethered to loop attachment points with the DNA within the loops to follow 
a random walk130, 259. However measurements of genomic regions within those 2-5Mb loops did not 
agree with the RW/GL model260. High resolution microscopy and experimental procedures like FISH, re-
vealed the MLS model (Figure 9E) in the late 1990s to describe long range chromatin folding260-262. The 
basic principle of the rosette like MLS model is that the chromatin is folded into 1-2Mb large loops and 
contain 60-120Kb sized loops attached to a common loop base and connected with a linker130, 260-262. 
In 2009, Lieberman-Aiden, Mirny and Dekker using Hi-C postulated that the genome folds into a shape 
called “fractal globule”227, 263 (Figure 9F). The basic principle is that due to polymer condensation, a 
compact polymer emerges as a result of polymer condensation which prevents one region of the chain 
to pass across another one. This model has been first proposed theoretically by Grosberg264 stating that 
interphase DNA can self-organize into a long-lived, non-equilibrium conformation. The “non-equilibri-
um globule” resembles to a pack of noodles at the moment they are starting to get boiled; dense but 
un-entangled. However, the “equilibrium globule” resembles to a pack of noodles after cooking where 
a single noodle is difficult to extract in contrast to the non-equilibrium model.
Evidence in the last years like the measurement of nucleosome distribution265 as well as in silico sim-
ulations and Monte Carlo simulations (unpublished data) based on real experimental data make the 
rosette like MLS model most likely. As a result of the high resolution and coverage, T2C data from in 
vitro and in vivo biological material suggest that the loops of the rosettes are in the range of 30-100Kb 
with ~5±1 nucleosomes/11nm. Thus, it is rather tempting to speculate that the 1-2Mb loops are of 
a “structural” type and form the TADs, with the small 30-100 Kb sized loops to be “functional” to 
promote gene regulation (Figure 8B). Another more “flexible” model has also been proposed, the RL 
model (Figure 9G), where the loops have a dynamic size at random chromosomal intervals266. However, 
such a model contradicts with current data indicating that TADs remain the same between cell types 
and species221, 243. In order to resolve these different models, new computational methods as well as 
experimental techniques needed to be developed, which deliver genomic interaction output with high 
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resolution and coverage (like T2C) in order to elucidate the structure and the shape of the genome.
Unravelling a complex developmental procedure
Hematopoiesis
Hematopoietic development, or hematopoiesis (from the Greek αίμα “blood” and ποιείν “to make”) is 
the process for the formation of the blood lineages from the hematopoietic stem cells (HSCs)267. HSCs 
were first identified in 1961 by Till and McCulloch; a population of stem cells in the bone marrow of 
adult mice responsible for the generation of all mature blood cells268. The first example of the proper-
Freely jointed chain Self avoiding chain Worm like chain
Random walk/giant loop model
Giant loops 2-5 Mb
30 nm
30 nm
Multiloop subcompartment model
Rosettes/ 1-2 Mb size
Random loop model
30 nm
Various sizes loops
A B C
ED
F G
Fractal globule model
Figure 9: Polymer chain models of the chromatin fiber can be explained in terms of random walk models130. (A) The freely joint 
model contain flexible and rotate-free hinges connecting rigid segments (Kuhn Segments) which can overlap themselves on the 
contrary to the (B) self avoiding model. (C) The worm like chain model postulates that the polymer chain is continuously flexible 
comparing to the freely joint model. (D) The RW/GL model describes a randomly in motion chromatin fiber with large 2-5Mb 
loops whereas the (E) rosette like MLS model contain 1-2Mb giant loops with 60-120Kb loops inside them (Figure 8B) connected 
to the next rosette with a linker. The fractal globule (F) resembles a cauliflower when cut through the middle, everything is 
symmetrical at increasing levels of architectural organisation. The RL model (G) hypothesizes that the loops have a dynamic size 
at random chromosomal intervals. 
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ties of HSCs was deduced by HSC transplantation into an irradiated recipient with a depleted endog-
enous hematopoietic system and thereby rescuing the recipient’s blood system268. Even though HCSs 
have been extensively studied with important breakthroughs for the field267, 269, their true properties 
and characteristics still remain unknown. Today, HSCs can be quite highly purified based on specific 
cell surface markers270 and can be truly characterized by their retrospective property of production of 
mature blood cells in vivo for prolonged periods271.
The hematopoietic development is characterized by two “waves”; the primitive and the definitive 
wave267. The primitive wave in the mouse takes place in the yolk sac (YS) at approximately E7.5 (days of 
gestation) and produces sufficient primitive erythrocytes (red blood cells; RBCs), megakaryocytes and 
macrophages to sustain the growing embryo with the necessary oxygen267, 272. A second hematopoietic 
induction takes place in the dorsal aorta, at approximately E10.5 with the emergence of the first cells 
that will become definitive HSC273. Robin and colleagues were the first to “capture” this birth live274. 
However, HSCs can be also identified in placenta and the yolk sack at E11267. Subsequently, these defin-
itive pre-HSCs migrate to the FL (E12) where they mature to HSC and expand significantly (more than 
100 fold from E11 to E14) with a mechanism that is poorly understood since the identified numbers of 
HSCs exceed the expected rates based on the average cell division275, 276. This conundrum could be ex-
plained by the maturation of an intermediate pre-HSC into a mature HSC rather than the proliferation 
of the original HSC276. Finally, HSCs migrate to spleen, thymus and the bone marrow (E14.5-E17), the 
latter becoming the main hematopoietic source for the entire lifespan277-279. 
In vitro differentiation models (described below, Figure 10A) indicated that both waves are dependent 
on cell signaling stimuli. High Activin/Nodal and low Wnt-β-catenin favors the primitive wave, whereas 
the opposite support the development of the definitive wave280.
 
Hemangioblast and hemogenic endothelium
Mesodermal cells from the primitive streak migrate to the YS around E7, aggregate and form blood is-
lands. The central part of the blood islands generates primitive blood cells whereas the peripheral cells 
differentiate into endothelial cells. This parallel development of the hematopoietic and endothelial 
cells in these  blood islands is in agreement with the hypothesis that they share a common ancestor/
progenitor; the hemangioblast281, which already was proposed at the early 1900s282, 283.  
In vitro differentiation of mouse embryonic stem (mES) cells provides relatively easy access to early de-
velopmentally stages which are difficult to study in vivo (Figure 10A). This property has been exploited 
to study the early stages of hematopoietic development. ES cell differentiation can recapitulate early 
embryonic events and generate three-dimensional, differentiated cell masses called embryonic bodies 
(EBs)284, 285. EBs are subjected to stimuli which direct embryonic development and can differentiate into 
all three germ layers; endoderm, ectoderm and mesoderm284, 286. The mES differentiation system to EBs 
produces a progenitor cell with the properties of the hemangioblast287, 288. Carefully timed EB differ-
entiation (approximately 3.65-4 days) assays led to the characterization of a progenitor termed “blast 
colony-forming cells” (BL-CFCs). These can give rise to both endothelial and hematopoietic cells287, 288 
leading to the conclusion that BL-CFCs represents the in vitro equivalent of hemangioblasts. BL-CFCs 
express both the mesodermal marker Brachyury (Bry) and the receptor tyrosine-kinase FLK1 provid-
ing corroboration that these are mesodermal cells, which undergo specification towards the hemato-
poietic and vascular lineages289. In gastrulating mice and zebrafish embryos, BL-CFCs were identified 
providing evidence for the in vivo existence of hemangioblasts and that BL-CFC is not an artifact of the 
ES cell differentiation process285, 290, 291. This in vivo progenitor arises in the posterior primitive streak 
of the embryo, expresses Bry and Flk1 and displays the same properties like the BL-CFC derived from 
the EBs285.
It has recently been demonstrated that in vivo hematopoietic cells are derived from the hemangioblast 
through an intermediate state, i.e. a phenotypically differentiated endothelial cell with haematopoietic 
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Figure 10: Different aspects 
of hematopoiesis. (A) In 
vitro model of mES cells dif-
ferentiation through well-de-
fined stages. Four days of 
mES differentiation produce 
EBs containing the in vitro 
equivalent hemangioblast 
(FLK1+, PDFRa-) and cardio-
vascular progenitors (CVP; 
FLK1+, PDFRa+). Subsequent-
ly the hemangioblast via 
the hemogenic endothelium 
gives rise to primitive or de-
finitive hematopoiesis. This 
process is under the control 
of cell signalling stimulus 
such as the Bmp4, Wnt and 
the Activin/Nodal pathway. 
(B) Schematic model of he-
matopoietic development 
from HSCs towards different 
lineages and committed cells 
via a tree like branching pro-
cess278. Each branching re-
sults in the cells losing their 
potency, from initial multi-
potent progenitors to more 
committed and mature cells 
for each lineage. The model 
is proposed by Irving Weiss-
man269 and updated by Sten 
Jacobsen305 (dashed lines). 
Part of the hematopoietic 
development is  erythropoi-
esis (C), which is a well char-
acterized process from MEPs 
towards enucleated RBCs via 
different well defined cell 
types278. (D) Hemoglobin lev-
els in different developmen-
tal stages and tissues278. Two 
switches take place; from ε 
to γ in embryonic develop-
ment and from γ to β/δ after 
birth.
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potential; this hemogenic endothelium is transiently generated during BL-CFC development292.  Inter-
estingly, HSCs apart from the AGM, can be detected in the extra-embyonic vitelline artery and in the 
umbilical artery273, 293. In those arteries, HSCs resides into distinct intra-aortic hematopoietic clusters 
(IAHCs)274.  Multiple studies in chicken294 and mouse embryos292, 295 have confirmed that IAHCs derive 
from the aortic hemogenic endothelium. However, recent evidence speculate that hemogenic endo-
thelial cells do not form fully potent HSCs but rather establish first an intermediate cell population 
referred to as pre-HSCs (organized in IAHCs in the aorta) which will progressively develop to mature 
HSC in E12 FL296.  It is important to note that although the hematopoietic and endothelial cells in YS ap-
pear simultaneously, the aorta and associated endothelium is formed one day before the emergence 
of IAHCs297. 
Interestingly, TFs such as Tal1298 and Runx1299 are important for the establishment of the hemogenic 
endothelium and the generation of the definitive hematopoietic cells from the hemogenic endotheli-
um respectively292. Runx1 expression in the dorsal aorta, umbilical and vitelline arteries, proceeds the 
emergence of hematopoietic cells suggesting that RUNX1 is a candidate TF to mark the hemogenic 
endothelium300. Its absence still leads to formation of the hemogenic endothelium but no definitive 
hematopoietic cells are formed299-301. The in vitro model contains the hemangioblast, which produces 
two types of endothelial cells; fully differentiated endothelial cells and hemogenic endothelial cells 
which can engender blood cells through the endothelial to hematopoietic transition292, 302.
The hemangioblast (FLK1+/BRY+) via the hemogenic endothelium generates the primitive hematopoiet-
ic cells290, 292. In contrast, hemogenic endothelium located at different sites throughout the embryonic 
vasculature later gives rise to definitive hematopoietic cells303, 304. Lately, the Keller group has postulat-
ed the existence of “two types” of hemogenic endothelium (although still not possibly to be separated 
with the current cell surface markers) which can generate either primitive or definitive cells respective-
ly. They are derived from two different types of mesodermal cells; primitive or definitive (depending 
the stimulus from either the Activin/Nodal or the Wnt signalling pathway), with the first one to have 
higher hemangioblast potential than the latter280. Hence, it is rather tempting to speculate that the 
hemogenic endothelium is a mix of primitive and definitive hematopoietic cells. It may imply, that the 
hemogenic endothelium is located at both YS (E7.5) and AGM (E10) and as a result of developmental 
cues or extracellular stimuli can give rise to either primitive or definitive hematopoietic cells. 
Hematopoietic differentiation
Definitive hematopoiesis takes place in FL and adult bone marrow where HSCs give rise to three differ-
ent lineages; the myeloid, the lymphoid and the erythroid269, 278 (Figure 10B). That complex branched 
differentiation process includes several distinct stages; from HSCs to distinct multipotent progenitors 
for every lineage, which progressively differentiate through tightly controlled steps and by losing their 
multipotency to fully mature cells for each lineage. The laboratories of Irving Weissman269 and Sten 
Jacobsen305 have proposed the currently most accepted model of hematopoietic differentiation. Brief-
ly, the HSCs form the multipotent progenitors (MPPs), which gradually loose their self-renewal ability 
and create the first branching point by differentiating into three distinct progenitors269, 305; the common 
lymphoid progenitor (CLP)306 giving rise to all lymphoid cells, the common myeloid progenitor (CMP)307 
which engender the myeloid and erythroid lineage and the lymphoid-primed multipotent progenitor 
(LMPP) which develops to both CLP and granulocyte-macrophage progenitors (GMP)305.
CLPs differentiate into different lymphoid cells such as B/T-lymphocytes, natural killer cells and the 
lymphoid derived dendritic cells306. The latter can be also derived from CMPs308. Furthermore, CMPs 
differentiate into either the megakaryocyte-erythrocyte progenitors (MEPs; can also derived directly 
from MPPs)305 which give rise to the erythroid lineage or to the GMPs (also produced from LMPPs)305 
which generate the myeloid lineage (macrophage, granulocytes and mast cells)307. MEPs can further 
differentiate and branch into two lineages; megakaryopoiesis which generates megakaryocytes and 
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platelets and erythropoiesis which engenders red blood cells278. 
Erythropoiesis 
During my thesis studies, the erythropoietic differentiation was mainly used to study chromatin dy-
namics and combinatorial TF networks. Erythropoiesis takes mainly place in erythroblastic islands in 
fetal liver and adult bone marrow and refers to the differentiation of MEPs towards the erythroid 
lineage with the subsequent production of mature RBCs278, 309 (Figure 10C). RBCs can be distinguished 
into two categories; primitive and definitive. Briefly, YS produces and releases primitive RBCs in the 
circulation at E7.5278, 310 whereas, FL produces the first definitive RBCs267, 271, 278, 310, 311. Finally, HSCs from 
the FL migrate to bone marrow to sustain the production of definitive RBCs for the entire lifetime277-279. 
The erythropoietic differentiation process is well defined and characterized with distinct cell types 
easily characterized based on cell surface markers and expression of specific genes. Erythropoiesis is 
discriminated into three defined and separated compartments; the progenitor, the precursor and the 
definitive RBC compartment. The first two are located in extravascular spaces and the third within the 
vascular network309.
The progenitor compartment contains the first lineage-committed, definitive erythroid progenitor de-
rived from MEPs, which is the burst-forming unit erythroid cells (BFU-E) followed by the colony-form-
ing unit erythroid cells (CFU-E)309. Both BFU-E and CFU-E have the ability to form colonies of mature 
erythroid cells in semisolid media, with the first to require 7 and 14 days to grow and the latter 2 and 
7 days for mouse and human respectively309. 
The second precursor compartment contains four different nucleated precursors, which are produced 
one after the other in a well-defined order:  the proerythroblasts (ProE), the basophilic cells (BasoE), 
the polychromatophilic cells (PolyE) and the orthochromatic cells (OrthoE). This differentiation process 
has some well described properties: (i) erythroblast expansion through a limited set of symmetric 
cell divisions, (ii) accumulation of hemoglobin, (iii) decrease in cell size, (iv) nuclear pyknosis and (v) 
decrease in RNA content309. These different cell types are well characterized and discriminated both 
morphologically and with distinct cell surface markers providing the necessary tools to isolate and 
study them309, 312.
The final step of maturation is enucleation resulting in two populations; the reticulocytes primarily 
containing hemoglobin313 and the pyrenocytes consisting of the extruded nuclei314 which are quickly 
ingested by the macrophages315. Reticulocytes maturation towards RBC is associated with an approx-
imately 20% shrinkage, reduced cell volume and loss of organelles such as mitochondria and ribo-
somes309, 316.
The third compartment, consists of the circulation of reticulocytes and RBCs in the vascular network 
and their perpetual production and release in the bloodstream to compensate the engulfment of se-
nescent RBCs by macrophages in the spleen317. Adult human contain approximately 5 × 106 RBCs per 
microliter of blood with an average life span of 120 days. That results for a 70kg man with 5 litres of 
blood into 2.5 × 1013 total RBCs. Due to the continuous loss of RBCs we replace on average 1/115th of 
RBCs per day resulting in the incredible number of 2.5 × 106 RBCs that have to be produced per sec-
ond278, 309, 318.
Hemoglobin
The main objective of erythropoiesis is the generation of erythrocytes to transfer oxygen from the 
lungs to the whole body and carbon dioxide in the opposite direction. Hemoglobin, the main protein 
produced in erythrocytes, binds oxygen and carbon dioxide. It is consists of two α-like and two β-like 
globin proteins forming a hetero-tetramer, which bind the oxygen via iron ion containing heme groups 
located in each one of the globin αβ dimers319.  The α-like globins can be the α and ζ for either human 
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or mice. The β-like globin proteins for mice are εy, βh1, βmajor and βminor and for humans ε, γG, γA, δ and 
β12, 278. The genes are expressed in different developmental stages forming different types of hemoglo-
bin during primitive or definitive hematopoiesis320 (Figure 10D). 
The first is characterized by the human ε, γ and ζ and the mouse εy, βh1 and ζ forming the following 
tetramers ζ2ε2 ζ2γ2 ζ2β2 and α2ε2. During definitive hematopoiesis in fetal liver, α2γ2 (also known HbF) 
is expressed which allows the embryo to extract oxygen efficiently from the maternal blood. Interest-
ingly, around birth the production of γ is replaced by β which is also expressed in fetal liver. In adults, 
HbF is usually around 1% of the total hemoglobin (although it varies in different humans) with the 
main hemoglobin to be α2β2 (HbA1; 97% of the total hemoglobin) and α2δ2 (HbA2; 2% of the total 
hemoglobin)278. Intriguingly, some adults contain higher than expected HbF, a condition also known as 
hereditary persistence of fetal hemoglobin (HPFH)321. That provides an advantage when in the case of 
either sickle cell disease or β-thalassemia in adult patients. The high HbF ameliorates the severity of 
the symptoms of the diseases278. Hence, reactivation of the fetal γ globin in the adults has been one of 
the “holy grails” for the therapeutic approaches to treat those diseases.
The “labyrinth” of the genome; following Ariadne’s Thread
In this biology era, we have been able to understand a good deal of different biological processes. 
However, it seems that we clearly still have a rather steep hill to climb before we will really be able to 
understand all the functions and properties of the genome. The studies in Chapters 2-7 aim to con-
tribute and place another brick in the wall towards deciphering the complicated questions of genome 
structure and organization in addition to complex mechanisms controlling developmental procedures.
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Abstract
Chromosome conformation capture (3C) technology is a powerful and increasingly popular tool for 
analyzing the spatial organization of genomes. Several 3C variants have been developed (e.g., 4C, 5C, 
ChIA-PET, Hi-C), allowing large-scale mapping of long-range genomic interactions. Here we describe 
multiplexed 3C sequencing (3C-seq), a 4C variant coupled to next-generation sequencing, allowing 
genome-scale detection of long-range interactions with candidate regions. Compared with several 
other available techniques, 3C-seq offers a superior resolution (typically single restriction fragment 
resolution; approximately 1–8 kb on average) and can be applied in a semi-high-throughput fashion. It 
allows the assessment of long-range interactions of up to 192 genes or regions of interest in parallel by 
multiplexing library sequencing. This renders multiplexed 3C-seq an inexpensive, quick (total hands-on 
time of 2 weeks) and efficient method that is ideal for the in-depth analysis of complex genetic loci. 
The preparation of multiplexed 3C-seq libraries can be performed by any investigator with basic skills 
in molecular biology techniques. Data analysis requires basic expertise in bioinformatics and in Linux 
and Python environments. The protocol describes all materials, critical steps and bioinformatics tools 
required for successful application of 3C-seq technology.
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Introduction
In recent years, it has become evident that the 3D organization of genomes is not random. Numerous 
studies have implicated long-range chromosomal interactions in several crucial cellular processes, 
including the regulation of gene expression1-4. Indeed, chromatin coassociations mediated by chromatin 
looping provide a means by which distal enhancers communicate with their target genes and stimulate 
transcription5-7. Accordingly, methods providing efficient and sensitive detection of chromatin looping 
events with high resolution are becoming increasingly popular. The development of 3C technology 
has revolutionized the analysis of spatial genomic organization by allowing the detection of chromatin 
coassociations with a resolution far beyond that provided by light microscopy–based studies8. 3C relies 
on the ability of distal DNA fragments to be ligated together when positioned in close proximity in the 
nuclear space. Over the past decade, several 3C variants have been developed, offering the possibility 
of analyzing chromatin looping events on a genome-wide scale (e.g., 4C9-12, 5C13, ChIA-PET14, Hi-C15). 
We describe here in detail multiplexed 3C-seq, a 3C variant coupled to high-throughput sequencing 
that we recently developed16, 17. Multiplexed 3C-seq allows genome-scale simultaneous detection of 
long-range chromatin interactions of numerous genomic elements in parallel and can be applied to 
low numbers of cells (from 1 × 106 cells18 to as low as 300,000 cells (P.K. and E.S., unpublished data)). 
We recently used this technique to analyze the spatial organization of several loci, including the mouse 
β-globin (Hbb), myeloblastosis oncogene (Myb) and IgK loci (Igk), revealing crucial enhancer-gene 
communications16-18.
Cell cross-linking and nuclei/chromatin isolation Chromatin fragmentation by
primary restriction enzyme 
digestion
Proximity ligation
DNA puriﬁcation and secondary
restriction enzyme digestion
DNA circularization by
ligation
Library ampliﬁcation using
bait-speciﬁc PCR primers
coupled to Illumina adapters
Multiplexed library 
sequencing
Figure 1: Overview of the multiplexed 3C-seq procedure. Nuclei from cross-linked cells are digested (primary restriction enzyme) 
and ligated under dilute conditions to physically link in vivo interacting DNA fragments. After a secondary digestion (secondary 
restriction enzyme) and ligation, inverse PCR is performed using bait-specific primers containing Illumina sequencing adapters 
to amplify unknown fragments interacting with the bait. PCR samples generated with different primer sets are then pooled and 
subjected to multiplexed library sequencing.
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Overview of the procedure
All 3C-based procedures use formaldehyde fixation of living cells or fresh tissues to preserve genomic 
architecture in its native state before fragmentation by restriction enzyme digestion. The digested cross-
linked chromatin is subjected to a ligation reaction under dilute conditions, favoring intramolecular 
ligation events over intermolecular ligation events (proximity ligation). This step yields a 3C library 
composed of chimeric DNA molecules resulting from the ligation of (distal) chromatin fragments that 
were in physical proximity in the nuclear space (Figure 1). The subsequent steps differ depending on 
the type of assay used. The 3C library can be directly analyzed by probing for specific interactions 
by PCR19, 20 or further processed for more global analyses using bait-specific primers (e.g., promoter-
specific primer pair9-12, 16-18) or whole-genome looping assays as in Hi-C15. In the 3C-seq procedure, the 
3C library is subjected to a second restriction enzyme digestion using a frequent cutter, and fragments 
are circularized before an inverse PCR step using bait-specific primers (Figure 1), similar to the original 
microarray-based 4C protocol11. This second restriction digest is necessary to decrease the size of the 
DNA circles, resulting in fragments that can be PCR-amplified efficiently. The inverse PCR products 
contain the DNA elements that were captured (i.e., ligated) by the bait sequence and thereby represent 
its native chromatin environment in the nucleus. The 3C-seq library is then directly sequenced on an 
Illumina HiSeq2000 platform, with the possibility of multiplexing sample sequencing by pooling up to 
12 different bait-specific 3C-seq libraries in a single lane of a HiSeq2000 flow cell, providing marked 
cost reduction and increased throughput. Other sequencing platforms are, in principle, compatible 
with multiplexed 3C-seq, but the multiplexing/de-multiplexing steps and associated informatics tools 
described here may need further optimization and adjustments.
Comparison of 3C-seq with other 3C-based methods
The choice between 3C and the different derivatives strongly depends on the biological question 
under consideration (Table 1). Although 3C-qPCR is particularly suited to quantitatively probe for 
specific interactions and interrogate a restricted number of chosen chromatin coassociations, it rapidly 
becomes technically demanding when large chromosomal domains are under investigation or when 
numerous interactions need to be analyzed in parallel for de novo detection of chromatin looping 
events. In the latter cases, high-throughput 3C derivatives such as 4C, 5C, 3C-seq or Hi-C technologies 
will be preferred. The 4C approach10, 11 consists of a large-scale analysis of chromatin interactions 
with a chosen bait sequence by probing the 4C library on DNA microarrays. It produces chromatin 
interaction maps of a single bait, with the coverage depending on the array used. 4C has the advantage 
of allowing unbiased detection of unknown bait-specific interactions, but is limited by the number of 
TABLE 1 |  Comparison between diﬀerent 3C variants.
3C-based method Applications Advantages Limitations
3C-(q)PCR19,20 One-to-one Relatively simple analysis  
(no bioinformatics required)
Laborious, knowledge of locus required, 
proper controls are essential
3C-on-chip (4C)9-11 One-to-all Relatively simple data analysis Poor signal-to-noise ratio, diﬃcult to 
obtain genome-wide coverage
3C sequencing  
(3C-seq or 4C-seq)12,16
One-to-all Genome-wide coverage, high  
resolution, good signal-to-noise  
ratio, allows multiplexing for  
high-throughput
Restricted to a single view point per 
experiment (except when multiplexing), 
analysis requires some bioinformatics 
expertiseMultiplexed 3C-seq17,18 Many-to-all
3C carbon copy (5C)13 Many-to-many Explores interactions between many  
individual fragments simultaneously 
(instead of using a single viewpoint)
No genome-wide coverage, primer 
design can be challenging
Hi-C15 All-to-all Explores the genome-wide nteractions 
between all individual fragments  
simultaneously
Obtaining high resolution requires a 
massive sequencing eﬀort; expensive, 
complicated analysis
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arrays needed to achieve genome-
wide coverage and by the saturation 
of signals around the bait sequence, 
preventing the detection of medium- 
to close-range interactions (up 
to 200 kb away). The 5C variant13 
overcomes this limitation and offers 
the possibility of exploring every 
potential chromatin coassociation 
in large subchromosomal domains 
by using primer sets covering all 
possible interactions. It is, however, 
difficult to reach genome-wide 
coverage using 5C, as it requires 
extremely large numbers of primers 
for all possible intrachromosomal 
and interchromosomal interactions. 
HiC, in contrast, provides a global 
genome-wide analysis of all possible 
chromatin associations by coupling 
a modified 3C procedure to high-
throughput sequencing15. Although it 
is extremely powerful, Hi-C requires 
substantial computational resources, 
and the number of sequence reads 
needed to obtain high coverage of 
mammalian genomes renders it very 
expensive and, as a consequence, 
unaffordable for a large number of 
academic laboratories.
3C-seq provides a fast and affordable 
genome-scale 3C alternative (Figure 
2). The use of high-throughput 
sequencing eliminates the problems 
of limited coverage and saturating 
signals associated with microarray 
- Single-cell suspension preparation
- Cross-linking and nuclei preperation
- Restriction enzyme digestion I 
Ligation I and de-cross-linking
DNA puriﬁcation Pause point
Restriction enzyme digestion II
Ligation II and DNA puriﬁcation
Bait-speciﬁc 3C-seq library
ampliﬁcation using Illumina
adapter-containing primers
Quality check I 
Quality check II
Pause point
Quality check IV
Multiplexed 3C-seq
library sequencing
- De-multiplexing
- Data processing
- Visualization
Days 1–3
Days 4–5
Day 6
Days 7–11
Days 11–13
Pause point
Quality check III
Step 16
Step 33
Step 44
Steps 57–60
Box 2
Step 32
Step 45
Step 50
Steps 17–23
Steps 1–16
Steps 34 and 35
Steps 36–56
Steps 57–60
Steps 61–64
Steps 24–32
Step 50
Steps 65–84
Figure 2: Flowchart of multiplexed 3C-seq data generation and processing. 
Steps involved in the multiplexed 3C-seq procedure are shown in blue 
rectangles. Time needed to complete these steps is depicted on the left. 
Pause points are indicated together with the timing of the different quality 
checkpoints: I, primary digestion efficiency (Step 16); II, ligation efficiency 
(Step 33); III, secondary digestion efficiency (Step 44); IV, 3C-seq PCR 
performance (Steps 57–60 and Box 2).
technology and markedly increases resolution and signal-to-noise ratios. A disadvantage of 3C-seq 
is that, as in 4C, the analysis is restricted to a single bait sequence and does not provide deep 
characterization of chromatin coassociations of several regulatory elements in parallel. The multiplexed 
3C-seq protocol presented here (Figure 1 and 2) addresses this limitation and shows that, by efficiently 
multiplexing bait-specific library sequencing, genome-scale interactions of up to 192 different genomic 
elements can be assessed in parallel on an Illumina HiSeq2000 platform, thereby markedly increasing 
the throughput of the technique and decreasing sequencing costs. Moreover, 3C-seq data analysis is 
facilitated by the availability of bioinformatics tools. We provide here a dedicated analysis pipeline 
facilitating the entire data handling process, including de-multiplexing, alignment and visualization. 
Together, this renders multiplexed 3C-seq an inexpensive and efficient method for in-depth analysis of 
complex genetic loci and genomic regulatory regions.
Applications of the method
3C-seq can be applied to any nonrepetitive region of a genome. It is generally used to unravel medium- 
to long-range interactions (i.e., few kb to hundreds of kb) of a genomic element of interest. It is usually 
48
Chapter 2
applied to detect interactions between promoter elements and the surrounding regions, or to connect 
distal enhancers to their target gene(s). With the recent developments in high-throughput chromatin 
occupancy profiling21, large numbers of transcription factor binding and chromatin modification 
data sets are becoming available. Combined with this knowledge, 3C-seq can be used to analyze 
the functional relationships existing between regulatory elements, sites of active transcription, gene 
deserts or boundary elements where transitions in chromatin structure or transcription are observed 
(e.g., insulator elements or initiation sites for productive transcription elongation).
Limitations of 3C-seq
Similar to all 3C-based procedures, 3C-seq only provides topological information. The control 
experiments discussed in Experimental design will help validate and ensure the specificity of the 
observed interactions. Even so, it is recommended to combine 3C-seq data with results from 
complementary experiments (e.g., fluorescence in situ hybridization (FISH), gene expression analysis, 
chromatin immunoprecipitation (ChIP)7, 17, 22 or, even better, with functional experiments, before 
drawing conclusions on the functional impact of chromatin coassociations.
Experimental design
Fixing cells. Cell fixation, which represents the starting point of the procedure, provides the template 
for the essential proximity ligation step used to capture DNA-DNA interactions. Fixation conditions 
need to be standardized for increased reproducibility and efficient comparison between samples. In 
our hands, formaldehyde fixation conditions used in ChIP experiments (1–2% (vol/vol) formaldehyde, 
10 min at room temperature (18–22 °C)) work well for 3C-seq16-18. More extensive fixation protocols 
have been reported to improve signal-to-noise ratios in the distance range of a few kb23, although 
this protocol utilizes more frequently cutting restriction enzymes to obtain such resolution and might 
therefore be difficult to compare with our protocol.
Starting material. We have used many human and mouse cell or tissue types in 3C-seq experiments 
(Table 2), although certain cell or tissue types (e.g., fibroblasts) can be more difficult to handle. The 
use of single-cell suspensions is essential when performing 3C-seq (and other 3C-based protocols, 
TABLE 2 | Performance of diﬀerent cell types and tissues successfully used for 3C-seq.
Cell or tissue type Performance in 3C-seq Special requirements
Hematopoietic cell types: mouse and human erythroid 
cells (FACS sorted and cultured), mouse B and  
T lymphocytes (FACS sorted and cultured), mouse  
erythroleukemia cell lines (MEL, I11) 
Hematopoietic tissue (mouse fetal liver E12.5-15.5, 
human fetal liver) 
Mouse ES cells (IB10), ES-derived Flk1 +   cells  
(magnetic-activated cell sorting (MACS)-sorted)
HeLa cells
Excellent None
Other mouse tissues (Mouse fetal brain E12.5-15.5) 
Rat tissues (liver, heart and lung)
Good Use a collagenase treatment (PROCEDURE 
Step 1) to obtain a single-cell suspension 
for eﬃcient cross-linking
Human primary melanocytes 33
Fibroblast cells: cell lines (NIH3T3) and primary cells 
(mouse dermal ﬁbroblasts, mouse and human lung 
ﬁbroblasts)
HEK/293T cells
K562 cells
HUVEC cells
Human ES cells (H9)
Poor: extensive nuclei 
 aggregation resulting in poor 
digestion eﬃciencies
Ensure gentle handling of the cells and 
nuclei. Preferentially collect adherent cells 
with a scraper instead of trypsin. In case 
of aggregation, see Table 3 for additional 
troubleshooting. Melanin produced by 
melanocytes is a potent PCR inhibitor and 
can be removed using a suitable column 
puriﬁcation step 33
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for that matter). When working with tissues that are difficult to dissociate (e.g., brain, heart, lung), 
consider treating them with collagenase before formaldehyde fixation (see PROCEDURE Step 1 and 
TROUBLESHOOTING section). Previously published 3C (and derivate) protocols describe using 106 cells 
or more per experiment. We, however, have successfully applied 3C-seq on much smaller numbers of 
cells (i.e., FACS-sorted cell populations, using < 106 cells), further extending its applicability (P.K. and 
E.S., unpublished data, and 18).
Restriction enzyme choice. The resolution of a 3C-seq experiment depends on the first restriction 
enzyme used. Ideally, the restriction pattern given by the enzyme should provide evenly distributed 
fragments, separating the different regulatory elements of interest (e.g., promoter, enhancers). When 
possible, check for the presence of regulatory elements, transcription factor binding sites and histone 
modification patterns relevant for the tissue to be analyzed using publicly accessible databases such as 
ENCODE (http://genome.ucsc.edu/ENCODE/) in order to determine the most appropriate enzyme for 
the region of interest. We suggest using 6-base-recognizing enzymes (referred to as a ‘six-cutter’) such 
as EcoRI, HindIII, BglII, BamHI and XhoI, which perform well on cross-linked chromatin. The enzymes 
should be insensitive to mammalian DNA methylation in order to prevent introducing digestion biases. 
We observed that the use of a six-cutter yields better reproducibility at the single restriction fragment 
level than enzymes that cut more frequently (e.g., 4-base-recognizing enzymes, referred to as a ‘four-
cutter’). The latter generate many more fragments per kb, which may lead to a poorer signal-to-noise 
ratio owing to more frequent intermolecular ligations. This could result in interaction signals being 
spread over several restriction fragments, thereby yielding interaction profiles that are sometimes 
more difficult to interpret. For instance, enhancer-promoter communication might be difficult to 
analyze using a small four-cutter bait fragment encompassing the transcription start site, as in some 
cases enhancers tend to associate with slightly more downstream or upstream sequences, which may 
not be encompassed by the four-cutter fragment used in the analysis7, 17, 24. We suggest using a four-
cutter as the primary restriction enzyme only when you are refining interactions initially detected by a 
six-cutter or if interactions have to be investigated within a narrow genomic region. For the secondary 
restriction enzyme, any four-cutter insensitive to mammalian DNA methylation and with good re-
ligation efficiencies can, in principle, be used. We have performed successful 3C-seq experiments using 
NlaIII, DpnII, HaeIII and MseI. The final combination of primary and secondary restriction enzymes 
will ultimately depend on their compatibility in terms of generating a suitable bait fragment for the 
inverse PCR primer design (see below and Box 1). To maximize efficient circularization in the second 
ligation step, the final bait fragment should be at least ~250 bp (ref. 25), although we have succeeded 
in obtaining good interaction profiles with bait fragments as small as 120–180 bp (ref. 18; P.K. and E.S., 
unpublished data). Please note that for some potential interacting fragments both restriction enzyme 
sites will be very close (< 50 bp). When such a fragment ligates to the bait, the resulting sequencing 
 Box 1 | 3C-seq primer design
 
 
 
-
Two primers, a P5 primer and a P7 primer, need to be designed for each bait fragment of interest:
The P5 primer must be located as close as possible to the primary restriction enzyme site (usually the six-cutter). As only the sequence 
located after the restriction site is informative for identifying interacting fragments, the distance between the primary restriction 
enzyme primer and the restriction site itself should be minimized to ensure unambiguous alignment and identiﬁcation of the interacting 
fragments (Fig. 3). This primer contains the P5 Illumina adapter sequence (5ʹ-AATGATACGGCGACCACCGAACACTCTTTCCCTACAC
GACGCTCTTCCGATCT-3ʹ to be placed upstream of the annealing sequence; Fig. 3) from which library sequencing will be initiated. The
sequencing reaction starts from the bait fragment, reads through the annealing primer sequence and extends into the unknown
captured fragment. To allow more ﬂexibility for primer design and to ensure optimal alignment of the sequences, we use a 76-bp 
sequencing read length (Step 64).
The second primer, located near the secondary restriction enzyme site (the four-cutter), contains the P7 Illumina adapter sequence
(5ʹ-CAAGCAGAAGACGGCATACGA-3ʹ, Fig. 3), and although it is required for the inverse PCR and the Illumina sequencing chemistry it is 
not sequenced (in contrast to paired-end sequencing, for which a diﬀerent adapter is required). Therefore, the location of the P7 primer 
with regard to the secondary restriction site is more ﬂexible (within 100 bp of the restriction site).
Actual primer requirements are similar to those used in standard PCR reactions. Oligo length is kept between 17 and 24 nt to facilitate 
eﬃcient ampliﬁcation and annealing temperatures are generally chosen between 54 and 59 °C. We regularly use primer design software 
(DNAMAN 5.0) to check these parameters and to ensure that primers are not prone to form dimers.
Note: Oligonucleotide sequences are copyright 2007–2012 Illumina. All rights reserved. Derivative works created by Illumina customers 
are authorized for use with Illumina instruments and products only. All other uses are strictly prohibited.
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reads might be problematic to align 
(see TROUBLESHOOTING section). 
Such a read is not a combination 
of the bait sequence and a single 
interacting fragment, as it will 
also contain sequences from the 
other side of the bait fragment. By 
trimming the 3′ end of the reads 
(PROCEDURE Step 75), a large 
portion of these fragments can be 
rehabilitated.
Primer design. The 3C-seq 
library is amplified using primers 
annealing to the bait sequence, 
facing outward. Proper design of 
both primers for the inverse PCR 
is crucial in the 3C-seq procedure 
(Box 1 and Figure 3). Efficiency 
and reproducibility of the PCR 
primers are first tested without 
the addition of the Illumina 
adapters (Box 2). If performing 
well, oligonucleotides containing 
appropriate Illumina adapters 
As 3C-seq library fragments diﬀer in length and abundance, we use the Expand long template system to minimize any biases resulting 
from these diﬀerences11. Bait-speciﬁc primers (without adapters) are ﬁrst tested for proper linearity and eﬃciency.
1. Test the increasing amounts of 3C-seq library DNA (up to 200 ng) using a 50-μl PCR. Reaction components and conditions are
described in PROCEDURE Step 57.
2. Analyze PCR products on a 1.5% (wt/vol) agarose gel, where they should appear as a reproducible smear of DNA fragments, usually 
showing two prominent bands11. These prominent bands are the result of recircularization of the bait fragment in the ﬁrst ligation step, 
and of detection of the neighboring fragment owing to incomplete digestion of the primary restriction site on the bait fragment11.
3. Assess the linear range of the individual primer pairs by quantifying prominent bands in each reaction of the dilution range.
4. Order versions of the primer pairs that perform well, including the P5 and P7 Illumina adapter sequences (Box 1). Test these new 
primers as described in steps 1–3 of Box 2.
5. Use successful P5 and P7 primers to prepare 3C-seq samples for sequencing (PROCEDURE Steps 57–60).
Box 2 | 3C-seq PCR setup and optimization 
The Illumina sequencers use the ﬁrst four sequenced bases to locate the DNA clusters on the ﬂow cell. When too little variation is 
present in these ﬁrst bases, the DNA clusters will not be correctly recognized and base calling will be compromised. The following 
pooling guidelines are used to ensure that the sequencing process proceeds correctly.
1. Pool at least six samples together in a single lane for multiplexing. As one sample can be sequenced in multiple lanes, there is no 
physical limit as to how many samples can be pooled. We have regularly pooled up to 12 samples in one lane.
2. Ensure that at least one adenine and one thymine base are present in each of the ﬁrst four cycles of a sample pool. The cycles with 
the highest intensity of the adenine and thymine bases are used for cluster recognition by the sequencer. Without these speciﬁc 
nucleotides in the ﬁrst four bases, base calling will be compromised and the sequencing run will fail.
3. Do not pool samples generated with the same bait-speciﬁc PCR primer, as sequences derived from these samples cannot be
discriminated in the downstream analysis. If pooling of such samples is desired, short bar-code sequences (2–6 nt) will have to be added 
to the adapter-containing bait-speciﬁc primers in the ﬁnal PCRs (Step 57).
Box 3 | 3C-seq pooling guidelines 
Optimal primer location Suboptimal primer location
Known bait sequence 
(noninformative)
Unknown captured sequence 
(informative)
Sequencing
read (76 bp)
Known bait sequence 
(noninformative)
Unknown captured sequence 
(informative)
>25 bp; accurate
alignment 
<25 bp; inaccurate
alignment 
Illumina adapter
Informative sequence
Sequencing
read (76 bp)
P5
P7
P5
P7
Figure 3: 3C-seq primer design and positioning. Schematic drawing of the 
location of the inverse PCR primers used to amplify a 3C-seq library. The ring 
represents a circular DNA molecule composed of the bait fragment (blue) ligated 
to an unknown captured fragment (red). The two PCR primers are located on 
the bait fragment next to the restriction sites, with adapters shown as gray 
overhangs. The P5 primer is located next to the primary restriction site (black 
dash), and the P7 primer is located next to the secondary restriction site (yellow 
dash). Illumina sequencing is initiated from the P5 primer and extends into the 
unknown fragment (dashed arrow). If the P5 primer is located right next to the 
primary restriction site (within 50 bp), sequence reads generated will be long 
enough for highly accurate alignment (>25 bp, left). If the distance between the 
P5 primer and the primary restriction site becomes too large (>50 bp, right), 
accurate alignment might be compromised.
are then tested again before being used in the final library amplification PCR before sequencing. For 
multiplexing purposes, the bait-specific primer sequence itself is used as a bar code to identify reads 
originating from each individual 3C-seq library. If identical bait-specific libraries need to be sequenced 
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in parallel (e.g., the same promoter for different biological conditions), small bar codes (2–6 nt) may be 
added to the primers (PROCEDURE Step 62; Box 3).
Controls. 3C-seq data need to be interpreted carefully, as high interaction signals are not necessarily 
indicators of functionally relevant chromatin coassociations (also see the ‘Limitations’ section). 
Furthermore, the PCR amplification step may introduce biases owing to differences in fragment length 
and GC content, which can affect amplification efficiencies. To ensure proper data interpretation, 
consider including several control experiments26. Whether an interaction is specific for a certain tissue/
cell type or whether it correlates with the activity of a specific gene can be tested by analyzing different 
tissues/cell types or non-expressing cells, respectively. For example, we generally use embryonic stem 
(ES) cells, cell lines, tissues or FACS-sorted cells that do not express the gene under investigation as 
controls when investigating promoter-enhancer interactions of an active gene. In addition, using a 
captured interaction site of interest as bait in a ‘reverse experiment’ can provide excellent validation 
of the interaction.
Materials
•	 Freshly collected tissues, sorted populations of cells and/or cell lines
Caution: Approved governmental and institutional regulations must be followed and adhered to.
•	 FCS (Sigma-Aldrich, cat. no. A4781)
•	 DMEM (Gibco, cat. no. 41966)
•	 Glycine (1 M in PBS; Sigma-Aldrich, cat. no. G7126)
Critical: Glycine stocks should be stored at 4 °C and used cold. They can be stored for a maximum of 6 
months.
•	 PBS (Sigma-Aldrich, cat. no. P4417)
•	 FCS/PBS (10% (vol/vol))
•	 Lysis buffer (see Reagent Setup)
•	 Sodium chloride (NaCl; Sigma-Aldrich, cat. no. S7653)
•	 Nonidet P-40 substitute (NP-40, Sigma-Aldrich, cat. no. 74385)
•	 Complete protease inhibitor, EDTA free (Roche, cat. no. 11873580001, see Reagent Setup)
•	 Milli-Q H2O
•	 Collagenase, 2.5% (wt/vol) (Sigma-Aldrich, cat. no. C1639), in PBS
•	 Formaldehyde, 37% (vol/vol) (Merck, cat. no 1039992500)
Caution: Formaldehyde is toxic.
•	 Restriction enzymes with 6-bp and 4-bp recognition sites and their corresponding buffers (see 
INTRODUCTION; Roche or New England Biolabs)
•	 SDS (20% (wt/vol); Sigma-Aldrich, cat. no. 05030)
•	 Triton X-100 (20% (vol/vol); Sigma-Aldrich, cat. no. T8787)
•	 T4 DNA ligation buffer (Roche, cat. no. 10799009001)
•	 T4 DNA ligase, high concentration (Roche, cat. no. 10799009001)
•	 Proteinase K (10 mg ml−1, Sigma-Aldrich, cat. no. P2308)
•	 RNase (10 mg ml−1, Sigma-Aldrich, cat. no. R6513)
•	 Phenol/chloroform/isoamyl alcohol (25:24:1 (vol/vol/vol); pH 8; Sigma-Aldrich, cat. no. 
77617)
•	
Caution: Phenol/chloroform is toxic.
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•	 Glycogen (20 mg ml−1, Roche, cat. no. 10901393001)
•	 Ethanol (100% (vol/vol) or 70% (vol/vol); Sigma-Aldrich, cat. no. 459844)
•	 Sodium acetate (2 M, pH 5.6; Sigma-Aldrich, cat. no. S2889)
•	 Tris-HCl (10 mM, pH 7.5, or 1 M, pH 8.0)
•	 Liquid N2
•	 Agarose electrophoresis gels (0.6% and 1.5% (wt/vol))
•	 Expand long template system 10× buffer 1 (Roche, cat. no. 11759060001)
•	 dNTPs (10 mM each)
•	 Expand long template system DNA polymerase (Roche, cat. no. 11759060001)
•	 PCR primers (see INTRODUCTION)
•	 QIAquick gel extraction kit (Qiagen, cat. no. 28706)
•	 TruSeq SR cluster kit v3-cBot-HS (Illumina, cat. no. GD-401-3001)
•	 TruSeq SBS kit v3-HS (50 cycles) (Illumina, cat. no. FC-401-3002)
•	 Python 2.6 (http://www.python.org/)
•	 Illumina offline base calling software (http://support.illumina.com/sequencing/sequencing_
software/offline_basecaller_olb.ilmn)
•	 NARWHAL (https://trac.nbic.nl/narwhal/)
•	 Pysam (http://code.google.com/p/pysam/)
•	 Supplementary analysis scripts (see Supplementary Data; the scripts findSequence.py, 
regionsBetween.py, alignCounter.py and libutil.py should be extracted to the same directory)
EQUIPMENT
•	 Cell strainer, 40 μm (BD Falcon, cat. no. 352340)
•	 Polypropylene centrifugation tubes (Greiner bio-one, cat. no. 188271)
•	 Safe-Lock 1.5-ml centrifugation tubes (Eppendorf, cat. no. 0030120.086)
•	 Thermomixer (Eppendorf, cat. no. EF4283)
•	 Water bath
•	 Microcentrifuge (Eppendorf, cat. no. 5417R)
•	 PCR thermocycler (MJ Research, cat. no. PTC-200)
•	 Spectrophotometer (NanoDrop 2000c, Thermo Scientific)
•	 Agilent 2100 Bioanalyzer (Aligent Technologies, cat. no. G2938C) with the 7500 DNA chip (cat. 
no. 5067-1506)
•	 Illumina HiSeq2000 high-throughput sequencing machine (Illumina)
•	 Excel spreadsheet software (Microsoft)
•	 Computer with a minimum of 8 Gb RAM and 1.5 Tb attached storage running a Linux 
distribution and the software listed above
REAGENT SETUP
•	 Complete protease inhibitor, EDTA free
Dissolve one tablet in 1 ml of PBS to create a 50× working solution. Store the solution at −20 °C for up 
to 2–3 months; avoid repeated freeze-thaw cycles.
•	 Lysis buffer
Prepare the following solution in Milli-Q H2O: 10 mM Tris-HCl (pH 8.0), 10 mM NaCl, 0.2% (vol/vol) NP-
40 and 1× protease inhibitor solution.
Critical: Because protease inhibitors degrade quickly in solution, use freshly prepared lysis buffer for 
each new experiment.
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PROCEDURE
Steps 1 - 3: Single-cell preparation and cross-linking
Timing: 1–2 h
1. Obtain single-cell preparations from fresh tissue, FACS-sorted cells or cell lines in 10% (vol/vol) 
FCS/PBS (see Table 2 for cell types successfully used by us in 3C-seq experiments). Tissues rich in 
extracellular matrix (e.g., brain) can be treated with collagenase (0.125% (wt/vol) in PBS; incubate 
the tissues for 30–60 min at 37 °C) first. Filter tissue-harvested cell preparations through a 40-
μM cell strainer to obtain single-cell suspensions (see ref. 19). Determine cell concentrations and 
dilute 0.3 × 106 to 10 × 106 cells (10 × 106 is preferred but substantially fewer starting cells can be 
used) in 12 ml of culture medium (e.g., DMEM) or 10% (vol/vol) FCS/PBS (15-ml polypropylene 
tube).
Critical step: Cell preparations need to be single-cell suspensions in order for proper formaldehyde 
cross-linking to be achieved.
2. Add 649 μl of 37% (vol/vol) formaldehyde to each 15 ml tube (2% (vol/vol) final formaldehyde 
concentration), and incubate it for 10 min at room temperature while tumbling.
Critical step: 1% (vol/vol) formaldehyde can also be used, especially if digestion efficiencies are 
suboptimal.
3. Transfer the tubes to ice and add 1.6 ml of cold 1 M glycine (0.125 M final concentration). 
Immediately proceed with Step 4.
Steps 4 - 16: Cell lysis, nuclei preparation and first restriction enzyme digestion
Timing: 18–20 h
4. Centrifuge the mixture for 8 min at 340g (4 °C) and remove all of the supernatant.
5. Carefully add ice-cold PBS to a volume of 14 ml and resuspend the pellet.
6. Pellet the cells again as in Step 4. Remove all of the supernatant.
7. Carefully resuspend the pellet in 1 ml of cold lysis buffer and add another 4 ml of lysis buffer to 
obtain a total volume of 5 ml for each tube. Incubate the mixture for 10 min on ice.
8. Centrifuge the mixture for 5 min at 650g (4 °C) to pellet the nuclei.
Pause point: The pelleted nuclei can be washed with PBS, snap-frozen in liquid N2 and stored at −80 °C 
for several months.
9. Resuspend the nuclei in 0.5 ml of 1.2× restriction buffer and transfer them to a 1.5 ml Safe-Lock 
microcentrifuge tube.
10. Place the tubes at 37 °C in a thermomixer and add 7.5 μl of 20% (wt/vol) SDS (final: 0.3% SDS).
	Troubleshooting
11. Incubate the mixture at 37 °C for 1 h while shaking (900 r.p.m.).
12. Add 50 μl of 20% (vol/vol) Triton X-100 (final: 2% Triton X-100).
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13. Incubate the mixture at 37 °C for 1 h while shaking (900 r.p.m.).
14. Take a 5 μl aliquot (undigested control sample) of each sample and store it at −20 °C until analysis 
of digestion efficiency is required (see Step 16).
15. Add 400 U of the selected six-cutter restriction enzyme to the remaining samples and incubate 
them overnight at 37 °C while shaking (900 r.p.m.).
Critical step: More unconventional primary restriction enzymes with optimal temperatures of 38–50 °C 
(e.g., ApoI) are also used at 37 °C to avoid partial de-cross-linking of the sample. Prolonged incubation 
times and/or addition of more enzyme might be required in these cases.
16. Take a 5 μl aliquot (digested control sample) of each sample. At this point, digestion efficiencies 
can be analyzed by purifying the genomic DNA from the control samples using a standard phenol/
chloroform extraction and running it on a 0.6% (wt/vol) agarose gel (see ref. 19). A successful six-
cutter restriction enzyme digestion results in a DNA smear with the majority of fragments located 
between 5 and 10 kb (Figure 4a).
Steps 17 - 23: Preparation of the 3C library: first ligation and de-cross-linking
Timing: 20–22 h
17. Add 40 μl of 20% (wt/vol) SDS (final: 1.6% SDS) to the remaining sample from Step 15.
18. Incubate the mixture for 20–25 min at 65 °C while shaking (900 r.p.m.).
19. Transfer the digested nuclei to 50-ml centrifugation tubes and add 6.125 ml of 1.15× ligation buffer.
20. Add 375 μl of 20% (vol/vol) Triton X-100 (final: 1% Triton X-100).
21. Incubate the mixture for 1 h at 37 °C in a water bath while shaking gently.
22. Add 100 U of T4 DNA ligase (20 μl of a high-concentration stock) and incubate it at 16 °C for 4 h.
Pause point: The samples can be kept overnight at 16 °C if necessary.
23. Add 30 μl of 10 mg ml−1 proteinase K (300 μg in total) and incubate it overnight at 65 °C to de-
cross-link the samples.
Steps 24 - 33: Preparation of the 3C library (DNA purification)
Timing: 7–8 h
24. Add 30 μl of 10 mg ml−1 RNase (300 μg in total) and incubate the mixture for 30–45 min at 37 °C.
25. Briefly cool the samples to room temperature and add 7 ml of phenol/chloroform/isoamyl alcohol 
(25:24:1) and shake the samples vigorously.
26. Centrifuge the samples for 15 min at 3,200g (room temperature).
27. Transfer the upper aqueous phase into a new tube and add 7 ml of Milli-Q H2O. Add 1.5 ml of 2 M 
sodium acetate (pH 5.6), and then add 35 ml of 100% ethanol.
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28. Mix the tubes thoroughly and place them at −80 °C for 2–3 h until the liquid is frozen solid.
29. Directly centrifuge the frozen samples for 45 min at 3,200g (4 °C).
30. Remove the supernatant and add 10 ml of 70% ethanol.
31. Centrifuge the mixture for 15 min at 3,200g (4 °C).
32. Remove the supernatant, air-dry the pellet for ∼20 min at room temperature and dissolve the 
pellet in 150 μl of 10 mM Tris-HCI (pH 7.5) by incubating it for 30 min at 37 °C.
Pause point: This material is referred to as the ‘3C library’ and can be stored at −20 °C for several 
months.
33. To determine ligation efficiency, run 0.5–1.0 μl of 3C material on a 0.6% (wt/vol) agarose gel. A 
successful ligation of six-cutter–digested 3C material should result in a single band, running at a 
similar height as the undigested control sample from Step 14 (Figure 4b).
Steps 34 - 35: Preparation of the 3C-seq library (determination of DNA concentration and secondary 
digestion of 3C material)
Timing: 16–18 h
34. If primary digestion and ligation were successful, the 3C library (Step 32) can either be used for 
3C-qPCR experiments (see Hagege et al.19 for a detailed protocol) or be used to prepare the 3C-seq 
library as described here. First, run an aliquot (e.g., 1 μl) of 3C library DNA alongside a reference 
sample of species-matched genomic DNA to estimate DNA concentrations. To obtain sharp bands 
suitable for accurate gel densitometry quantification, a 1.5–2% (wt/vol) agarose gel is used. Optical 
density (OD) measurements do not provide an accurate estimation of DNA concentrations in 3C 
library samples.
35. Digest a preferred amount of the 3C library overnight (generally 25–50 μg) with a 4-base 
recognition restriction enzyme of choice (the four-cutter), at a DNA concentration of 100 ng μl−1, 
using 1 U of enzyme per μg of DNA. Use buffers and incubation temperatures as recommended in 
the manufacturer’s instructions.
Steps 36 - 56: Preparation of the 3C-seq library (Second ligation and DNA purification)
Timing: 12–13 h
36. Transfer the sample to a 1.5-ml Safe-Lock tube. Add an equal amount of phenol/chloroform/
isoamyl alcohol (25:24:1) and mix it vigorously.
37. Centrifuge the mixture for 15 min at 15,800g (room temperature).
38. Transfer the upper phase to a new tube and add 2 μl of 20 mg ml−1 glycogen. Add a one-tenth 
volume of 2 M sodium acetate (pH 5.6), mix the contents and add 850 μl of 100% ethanol.
39. Mix the tubes thoroughly and snap-freeze them in liquid N2.
40. Directly centrifuge the frozen tubes for 20 min at 15,800g (4 °C).
41. Remove the supernatant carefully and add 1 ml of 70% (vol/vol) ethanol.
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42. Centrifuge the mixture for 5 min at 15,800g (4 °C).
43. Remove the supernatant carefully, air-dry the pellet for ∼15 min and dissolve the pellet in 100 μl 
of Milli-Q H2O by incubating it for 15 min at 37 °C.
44. Analyze 5 μl of the digested DNA on a 1.5% (wt/vol) agarose gel to check digestion efficiency. The 
resulting type of smear depends on the enzyme used, but the majority of fragments should be <1 
kb and are usually between 300 and 500 bp (Figure 4b).
A B
12,000
200
2,000
1,650
1,000
650
500
400
300
100
Ladder
0.6% ge l
Dig
est
ed
(si
x-c
utt
er
)
Un
dig
est
ed
11,490
1,700
1,159
805
339
264
514
Ladder
1.5% gel
Dig
est
ed
(fo
ur
-cu
tte
r)
Lig
ati
on
Figure 4: (a) Agarose gel (0.6%, wt/vol) on which 
an aliquot of undigested (left lane) and digested 
(right lane) sample (primary restriction digestion, 
Step 16) was run. A six-cutter was used, showing a 
typical smear of DNA fragments (a majority of DNA 
fragments residing between the 12 kb and 4 kb 
marker bands). (b) After ligation (left lane, Step 33), 
the DNA smear has returned to a sharp band (~12 
kb). Secondary enzyme digestion (four-cutter) of the 
ligated 3C library typically results in a DNA smear of 
2–0.1-kb fragments (1.5% (wt/vol) agarose gel).
45. Transfer the remaining sample to a 50-ml centrifugation tube. Add the components tabulated 
below and incubate the mixture at 16 °C for 4 h.
                Component   Amount per reaction  Final
 10× ligation buffer  1.4 ml    1×
 T4 DNA ligase (5 U μl−1)                 40 μl    200 U
 Milli-Q H2O   Up to 14 ml  
Pause point: The samples can be kept overnight at 16 °C if necessary.
46. Add 14 ml of phenol/chloroform/isoamyl alcohol (25:24:1) and shake the mixture vigorously.
47. Centrifuge the mixture for 10 min at 3,200g (room temperature).
48. Split the upper phase into two new 50-ml tubes. Add an equal amount of Milli-Q H2O to each tube 
and add 1 μl of 20 mg ml−1 glycogen per ml.
Critical step: Increasing the volume before precipitation will greatly reduce the amount of coprecipitating 
DTT.
49. Add a one-tenth volume of 2 M sodium acetate (pH 5.6), mix the contents and add two volumes 
of 100% ethanol.
50. Place the tubes at −80 °C for 2–3 h until the liquid is frozen solid.
Pause point: The samples can be kept at −80 °C for several days.
51. Directly centrifuge the frozen tubes for 45 min at 3,200g (4 °C).
52. Remove the supernatant and add 15 ml of 70% (vol/vol) ethanol.
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53. Centrifuge the mixture for 15 min at 3,200g (4 °C).
54. Remove the supernatant, air-dry the pellet for ∼20 min and dissolve it in 75 μl of 10 mM Tris-HCI 
(pH 7.5 (per pellet)) by incubating it for 30 min at 37 °C. Thereafter, samples divided over two 
tubes can be recombined into a single tube.
55. Purify the DNA using the QIAquick gel purification kit according to the manufacturer’s 
recommendations for direct cleanup from enzymatic reactions. Other DNA purification kits can be 
used, but we have obtained excellent purities with the QIAquick kit.
Critical step: One column can bind a maximum of 10 μg of DNA: use enough columns to avoid 
overloading and a subsequent loss of material.
56. Determine the DNA concentration of the resulting 3C-seq library using NanoDrop OD measurements.
Steps 57 - 60: 3C-seq inverse PCR (preparing the sample for Illumina sequencing)
Timing: 5–6 h
57. Perform several PCR reactions (we generally amplify the equivalent of 500–1,000 ng input DNA 
per bait fragment) using the primers containing the P5/P7 Illumina adapters as overhang using the 
PCR reaction setup and program tabulated below. The amount of input 3C-seq library DNA used 
should be the maximum amount for which the PCR reaction is still linear and reproducible (see 
tables below and Step 58), not exceeding 200 ng per reaction.
Component   Amount per reaction    Final
10× buffer I   5 μl     1×
10 mM dNTPs   1 μl     0.2 mM
25 pmol μl−1  forward primer 1 μl     25 pmol
25 pmol μl−1 reverse primer 1 μl     25 pmol
Polymerase mix (5 U μl−1)                 0.75 μl     3.75 U
3C-seq library DNA  Depends on concentration                 25–200 ng
Milli-Q H2O   Add up to 50 μl  
Cycle number    Denature     Anneal   Extend
1     94 °C, 2 min    
2–31     94 °C, 15 s     Primer-specific,1 min                 68 °C, 3 min
32            68 °C, 7 min
Critical step: Inverse PCR primers first have to be tested for linearity and reproducibility as described 
in Box 2 (also see ref. 11), first without and then with the P5/P7 Illumina sequencing adapters attached.
	Troubleshooting
58. Verify PCR success by running small aliquots (10 μl) of each reaction on a 1.5% (wt/vol) agarose 
gel.
59. Pool all successful reactions from the same bait fragment and purify the DNA using 2 QIAquick gel 
purification columns. Elute the columns with 40 μl of Milli-Q H2O and combine the samples.
60. Verify the purification procedure success by running an aliquot (5–10 μl) on a 1.5% (wt/vol) 
agarose gel. The sample is now ready to be used for Illumina high-throughput sequencing.
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Pause point: The samples can be kept at −20 °C for several months.
Steps 61 - 64: 3C-seq sample pooling and Illumina high-throughput sequencing
Timing: 4 d
61. Quantify the DNA molarity of the individual samples on an Agilent Bioanalyzer with the DNA 
7500 chip cartridge according to the manufacturer’s instructions. Perform a ‘smear analysis’ 
quantification using the Bioanalyzer software.
Critical step: Make sure to use the DNA 7500 chip cartridge, as 3C material contains large (1–5 kb) DNA 
fragments that will influence DNA molarity and may not be detected using other DNA chip cartridges.
62. Design a pool of 3C-seq samples to be sequenced together in a single lane on the flow cell using 
the guidelines described in Box 3.
63. Pool the selected samples in equal molarities in a single tube.
64. Proceed with the sequencing procedure as described by the manufacturer in the Illumina TruSeq 
SR cluster kit and TruSeq SBS manuals. The sequencing procedure can be outsourced to a sequence 
service provider. We generally use 76-bp single-read sequencing; paired-end sequencing is not 
required for 3C-seq.
Critical step: When loading the flow cell, aim for a cluster density of 750,000–850,000 clusters per 
mm2. In our case, this is usually achieved with a final template DNA concentration of 9 pM.
Critical step: Ensure that the total number of sequencing cycles exceeds the sum of the bait-specific 
sequence length and a minimum of 36 bases for optimal alignment of the unknown interacting 
fragments.
Steps 65 - 79: Initial data processing
Timing: 1–2 d
65. Copy the whole run folder generated by the Illumina sequencer to the storage on the Linux 
computer.
66. Open a terminal on the Linux computer and enter the commands described after the > signs.
67. Convert the binary output from the sequencer to text files in the Qseq format by using the 
BclToQseq scripts included in the Illumina Offline Basecaller (available at the Illumina website 
http://www.illumina.com/):
> cd Illumina_Run_Folder/Data/Intensities/BaseCalls
> /path_to_OLB/bin/setupBclToQseq.py --in-place –b.
> make –j 6
68. Determine the bait-specific sequences for de-multiplexing. Note that this also includes the primer, 
the primary restriction site and any sequence in between. To obtain the highest yield while still 
retaining high specificity, de-multiplexing is performed using only 6 bases instead of the entire 
bait-specific sequence. The first set of 6 bases that differ for 2 or more bases from the other bait 
sequences are used for de-multiplexing.
Critical step: Record the unique 6-bp bait-specific sequences (6-bp-bait) and their positions (6 bp-bait-
pos) in the bait for each sample.
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69. Determine the number of bases to trim from the 5’ and the 3’ ends of the reads as described in 
Steps 70–75. This procedure is performed in Microsoft Excel.
Critical step: The 5’ trimming is crucial, as the remaining bait-specific sequences will prevent the 
read from aligning to the reference sequence (Figure 3). The 3’ trimming prevents the loss of short 
interacting fragments (see Experimental design).
70. First, extend the bait-specific primer sequence with the genomic sequence up to and including the 
primary restriction site.
71. Extend the bait-specific primer sequence with the genomic sequence up to and including the 
primary restriction site.
72. Subtract the forward Illumina P5 adapter sequence from the 5’ end of this sequence (Box 1).
73. Count the number of bases in the resulting sequence using the len() function to obtain the number 
of bases to trim from the 5’ end of the read (n5trim).
74. Subtract n5trim from the read length.
75. Subtract 36 bases from the result of Step 74 to obtain the number of bases to trim from the 3’ 
end (n3trim).
76. Create a NARWHAL27 sample sheet (Supplementary Table 1) for the lanes that contain the 3C-seq 
samples. In this sample sheet, use any profile that runs BOWTIE28 with the --best option. To de-
multiplex, several options need to be set in the sample sheet: the bar code-read field is set to 
1; the bar code-start field is set to the 6-bp-bait-pos; the bar code field is set to the 6-bp-bait 
sequence. For the trimming, the following options are added to the options field of the sample 
sheet to trim the sequences: 
   --trim5=n5trim,--trim3=n3trim.
77. Copy the NARWHAL sample sheet to the Linux computer.     
 
78. (Optional) When the flow cell does not exclusively contain 3C-seq samples, it might be necessary 
to analyze only specific lanes. This can be achieved by setting up a directory with only the Qseq 
files for the specific lanes to be analyzed. This can be performed as follows, with i as the lanes to 
be analyzed:
> mkdir MyLanes/
> ln –s /full_path_to_qseq_folder/s_[i]_1_*_qseq.txt MyLanes/
79. Run NARWHAL using the following command:
> narwhal.sh –s samplesheet.txt Qseq_folder output_folder
After the alignment, NARWAL will generate a PDF reporting the total number of reads generated, the 
percentage successfully aligned reads, the read distribution across the chromosomes, edit rates and 
duplication rates27. Successful 3C-seq experiments should have high duplication rates (>95%), with a 
majority of reads (>50%) mapped to the chromosome on which the bait is located.
	Troubleshooting
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Steps 80 - 84: Bioinformatics and initial data visualization
Timing: 2 h
80. After the initial data processing, a restriction map of the genome needs to be generated as 
described in Steps 80–82. First, Search the genome for restriction sites using the findSequence.py 
script (Supplementary Data). This script will generate a BED file containing all the occurrences of 
a given sequence in the genome.
> python findSequence.py –f genome.fasta –s primary_restriction_sequence –b occurrences.bed
81. Create a BED file containing the regions between the restriction sites by using the regionsBetween.
py script (Supplementary Data):
> python regionsBetween.py –i occurrences.bed –s chromsizes.txt –o regions.bed
82. Sort the regions with the BEDtools29 sort command:
> bedtools sort –i regions.bed > sorted_regions.bed
83. Count the reads per target fragment using the alignCounter.py tool (Supplementary Data). The 
count result is a table that can be loaded into other tools such as R.
> python alignCounter.py –b aln.srt.bam –r sorted_regions.bed –o output_table.txt
84. Convert the read count tables to BED files using the command below. These BED files can be 
loaded into a variety of genome browsers including the UCSC Genome Browser (http://genome.
ucsc.edu/).
> gawk ′/^[#]/{ if($4 > 0){print $1 ″\t″ $2 ″\t″ $3 ″\t″ $4 ;}; }′ output_table.txt > output_table.bed
	Troubleshooting
Troubleshooting
Multiplexed 3C-seq success primarily depends on digestion efficiencies, 3C-seq PCR setup (Boxes 1 
and 2) and Illumina sequencing. Table 3 contains 3C-seq troubleshooting advice, mainly concerning 
these steps. Digestion efficiencies are also highly dependent on the cell or tissue type used. Table 2 
provides additional cell type–specific troubleshooting information. Other published protocols have 
also provided detailed troubleshooting for the 3C procedure19, 30.
Timing
Steps 1–3, single-cell preparation and cross-linking: 1–2 h
Steps 4–16, cell lysis, nuclei preparation and first restriction enzyme digestion: 18–20 h
Steps 17–23, preparation of the 3C library: first ligation and de-cross-linking: 20–22 h
Steps 24–33, preparation of the 3C library: DNA purification: 7–8 h
Steps 34 and 35, preparation of the 3C-seq library: determination of DNA concentration and secondary 
digestion of 3C material: 16–18 h
Steps 36–56, Preparation of the 3C-seq library: second ligation and DNA purification: 12–13 h
Steps 57–60, 3C-seq inverse PCR: preparing the sample for Illumina sequencing: 5–6 h
Steps 61–64, 3C-seq sample pooling and Illumina high-throughput sequencing: 4 d
Steps 65–79, initial data processing: 1–2 d
Steps 80–84, bioinformatics and initial data visualization: 2 h
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TABLE 3 | Troubleshooting table.
Step Problem Possible reason Solution
10 Formation of aggregates 
after addition of SDS to 
the restriction buﬀer
Too many nuclei are used or the 
nuclei are of poor quality
Dilute the material 2–4 times in 1.2× restriction buﬀer  
containing 0.3% (wt/vol) SDS. For future experiments, 
ensure gentle handling of the cells and nuclei. A more 
stringent lysis buﬀer and/or Douncing step can also be 
beneﬁcial. If persistent, consider starting with fewer cells 
in future experiments
16 Poor primary digestion 
eﬃciency
Formaldehyde concentrations used 
are too high for the enzyme; the 
enzyme is not compatible with the 
3C protocol and/or extensive nuclei 
aggregation
Lower formaldehyde concentrations (e.g., 1% instead of 2% 
(vol/vol)) or increase Triton X-100 concentration in Step 12. 
Alternatively, consider changing to a diﬀerent enzyme. 
If nuclei are forming large aggregates, see Step 10 trouble-
shooting for advice
57 Poor PCR linearity, 
 reproducibility or PCR 
failure
PCR conditions or design are 
 suboptimal
Primer dimer formation PCR conditions or design are 
 suboptimal
79 Fewer than expected 
sequence yield for a  
particular sample
Unanticipated bait-speciﬁc sequence
Low mapping percentage 
after sequencing
Primer dimers present in 3C-seq 
sample or the secondary restriction 
site occurs directly after the primary 
restriction site in the most abundant 
target fragments
 
84 Complete absence of 
reads at expected sites of 
 interaction
The fragment expected to interact 
with the bait is  <36 bp
The genome assembly has changed 
(updated)
Weak 3C-seq interaction 
signals
Poor signal-to-noise ratio
Ensure that the correct primer Tm is used. Further 
optimizing the Tm using a gradient can be beneﬁcial. 
Often, simply redesigning the 3C-seq primers will greatly 
improve PCR success
See above. If primer dimer formation speciﬁcally occurs 
after addition of the P5/P7 adaptors, DNA puriﬁcation kits 
with a > 100-bp cutoﬀ can be used to remove dimers 
before sequencing
Compare the list of expected barcodes to the most 
abundant sequences. To generate a list with the most 
abundant barcode sequences from a FastQ ﬁle, the 
following Linux command-line code can be used:
> grep '^[ACTGN]\ + $' in.fastq | sed 's/^\(.\{6\}\).*/\1/g' |
sort | uniq –c | sort –nr | head –n 30
Cross-reference unexpected highly abundant sequences 
with the expected primers and if possible assign these 
reads to a sample.
Re-do de-multiplexing with the updated barcodes
Obtain all the non-aligning sequences from the BAM ﬁle:
> samtools view aln.srt.bam |
grep -P '^\S + \t\d + \t\*.*$' >
not_aligned.aln
Check these sequences for subsequences of the primers 
used in the ampliﬁcation.
Determine whether these sequences contain the 
restriction site for the secondary restriction enzyme. This 
issue occurs more frequently with increasing read-length. 
For this reason, we strongly recommend using the 3ʹ 
trimming procedure from Steps 70–75. If after trimming 
the target sequence is shorter than 25 bp, the secondary 
restriction enzyme needs to be changed in order for the 
read to be aligned properly
Further extend the 3ʹ trimming procedure or use a 
diﬀerent six-cutter/four-cutter combination
Reanalyze older data sets using the proper version of the 
genome assembly. This may be crucial when recent data 
sets need to be compared with older ones
Consider using a double cross-linking procedure by using 
ethylene glycol bis-succinimidylsuccinate treatment 
before formaldehyde as described in Lin et al.34
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Anticipated results
After sequencing and data processing, the resulting BED files (Step 84) can be visualized in a genome 
browser (e.g., UCSC genome browser, http://genome.ucsc.edu/). Careful attention should be given to 
the particular version of the genome that is used for analysis, especially when different experiments 
are compared. Several simple but important checks can provide information on whether the 3C-seq 
experiment was successful, which are automatically provided during initial data processing (Steps 
65–79) by the NARWAL software27. The PDF file provided contains statistics on the chromosomal 
location of the aligned reads and the duplication percentage. These are important metrics for the 
initial validation of a 3C-seq experiment: the vast majority ( > 50%) of reads are usually found in 
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Figure 6: Comparison of interactions detected for the same 3C-seq sample after single or multiplexed library sequencing. (a) 
Interaction profiles around the bait fragment for a 3C-seq sample after multiplexed (top) or nonmultiplexed (bottom) library 
sequencing, showing highly similar profiles. (b) Scatter plot comparing read counts for 146 fragments around the bait fragment 
between nonmultiplexed and multiplexed data sets.
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Figure 5: Typical interaction profiles obtained from a multiplexed 3C-seq experiment. (a) 3C-seq interaction profiles in mouse 
fetal liver cells shown for three bait fragments in the Myb locus17 (1.2-Mb region shown). Bait signals are depicted by an arrow. 
(b) 3C-seq interaction profiles generated from both mouse fetal liver and brain using the Myb promoter as bait (shown is an 
∼250-kb region encompassing the Hbs1-like (Hbs1l) neighboring gene). Myb is highly expressed in fetal liver cells, but expression 
is much lower in fetal brain cells. Several fetal liver–specific interactions are located within an intergenic region containing 
several regulatory (Reg.) elements (green lines and blue shading)17. Bait signals are depicted by an arrow. Data were visualized 
using the UCSC genome browser. All animal work was approved by the Netherlands Animal Experimental Committee (DEC) and 
the Institutional Ethical Review Board of Erasmus Medical Center, and was carried out according to institutional and national 
guidelines.
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cis (i.e., on the same chromosome), and as 3C-seq profiles consist of stacked reads the duplication 
percentage should be > 95%. Typical alignment percentages are above 70%, although this can vary 
considerably between different primer sets. Lower percentages are often caused by the sequencing of 
primer dimers present in the PCR samples or failure to align reads coming from the (in general) most 
abundant interactions (the bait fragment itself and the neighboring fragment, see Box 2 and Table 3). 
However, low alignment percentages can still provide informative data, as long as the total number 
of aligned reads is high enough (>1 million reads30) and read distribution is as expected (see below 
and Figure 5). After uploading the BED output file (Step 84) in a genome browser, interactions with 
the chosen bait fragments can be observed. Signals are represented as bars (Figure 5), the width of 
which is determined by the size of the actual restriction fragment. The height of the bars represents 
the number of reads found on the fragment and is a measurement of the frequency of interaction with 
the bait fragment. The highest signal density is always found around the viewpoint (typically ~40% of 
all reads are located within 1 Mb of the bait), with the two most abundant interactions being the bait 
and its neighboring fragment (Box 2). Signal intensity tends to rapidly decline with increasing genomic 
distance from the bait (a classic characteristic of 3C and its derivatives, see refs. 11,26), resembling 
a bell-shaped distribution around the bait (Figure 5a). The majority (>75%) of cis interactions are 
normally found within a 1-Mb window around the bait, although bait fragments within highly complex 
genomic structures (e.g., immunoglobulin loci) can produce profiles that deviate from this general 
picture18. Interactions found in trans (generally about 40–50% of the reads) often show low interaction 
frequencies and appear to be randomly scattered around the genome. Trans-interaction signals 
therefore need to be interpreted with caution, as their reproducibility may appear questionable in a 
number of cases. However, several studies have begun to probe their functional relevance in specific 
cases, in particular in light of chromosomal translocations, and showed correlation between physical 
proximity and sites of recombination, indicating that physical proximity in trans may be relevant31, 32.
Multiplexing 3C-seq samples greatly increases the technique’s throughput and results in a substantial 
cost reduction. Even though the total number of reads is lower in a multiplexed sample compared with 
a nonmultiplexed sample, interaction patterns remain almost identical (Figure 6). Thus, multiplexing 
3C samples seems to have little effect on the resulting interaction profiles (Figure 6).
Further validation of detected interactions can be obtained by complementary experiments (e.g., 
3C-qPCR, FISH) or by performing new 3C-seq experiments with these interactions as bait (a ‘reverse 
experiment’, see ‘Controls’ section of INTRODUCTION). Functional interpretation of 3C-seq profiles is 
often desired and requires correlation with other data sets, usually transcription factor binding and/
or histone modification patterns for the locus of interest. When using 3C-seq to explore the regulatory 
elements in close proximity to a gene, strong interaction signals can often be positively correlated to 
the binding of transcription factors and the presence of specific histone modifications17. Performing 
3C-seq experiments in different cell or tissue types can further provide valuable information on 
the tissue specificity of interactions and whether their presence can be correlated to differences in 
gene expression or protein binding (Figure 5b). The 3C-seq data can also be further processed using 
dedicated tools and scripts (S.Thongjuea, R.S., F.G., E.S. and B. Lenhard, unpublished data, and ref. 12) 
for more in-depth analysis.
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Abstract
Background
Significant efforts have recently been put into the investigation of the spatial organization and the 
chromatin-interaction networks of genomes. Chromosome conformation capture (3C) technology and 
its derivatives are important tools used in this effort. However, many of these have limitations, such 
as being limited to one viewpoint, expensive with moderate to low resolution, and/or requiring a 
large sequencing effort. Techniques like Hi-C provide a genome- wide analysis. However, it requires 
massive sequencing effort with considerable costs. Here we describe a new technique termed 
Targeted Chromatin Capture (T2C), to interrogate large selected regions of the genome. T2C provides 
an unbiased view of the spatial organization of selected loci at superior resolution (single restriction 
fragment resolution, from 2 to 6 kbp) at much lower costs than Hi-C due to the lower sequencing effort.
Results
We applied T2C on well-known model regions, the mouse β-globin locus and the human H19/IGF2 
locus. In both cases we identified all known chromatin interactions. Furthermore, we compared the 
human H19/IGF2 locus data obtained from different chromatin conformation capturing methods with 
T2C data. We observed the same compartmentalization of the locus, but at a much higher resolution 
(single restriction fragments vs. the common 40 kbp bins) and higher coverage. Moreover, we compared 
the β-globin locus in two different biological samples (mouse primary erythroid cells and mouse fetal 
brain), where it is either actively transcribed or not, to identify possible transcriptional dependent 
interactions. We identified the known interactions in the β-globin locus and the same topological 
domains in both mouse primary erythroid cells and in mouse fetal brain with the latter having fewer 
interactions probably due to the inactivity of the locus. Furthermore, we show that interactions due to 
the important chromatin proteins, LDB1 and CTCF, in both tissues can be analyzed easily to reveal their 
role on transcriptional interactions and genome folding
Conclusions
T2C is an efficient, easy, and affordable with high (restriction fragment) resolution tool to address 
both genome compartmentalization and chromatin-interaction networks for specific genomic regions 
at high resolution for both clinical and non-clinical research.
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Background
A number of recent studies have shown that the genome is organized in self-associating domains1 
that are separated by linker regions. These so-called “topological domains” or “topological associated 
domains” generally range from 300 kilobasepairs (kbp) to 1 megabasepairs (1Mb) and consist of a 
series of different types of chromatin loops in agreement with earlier models of the genome (2 and 
references therein).
One loop is defined as two distant chromatin regions coming, spatially, into close proximity (interact 
with each other), thereby creating DNA loops. Such “long-range interactions” have been first observed 
between promoters and distant enhancers (3, 4 and references therein) and can bring DNA-elements 
together that are separated by a large distance on the linear DNA strand (5, 6 and references therein). 
These regulatory elements (enhancers or silencers) are short sequences containing several binding 
sites for transcription factors, which regulate the activation (reviewed in 7) repression (reviewed in 8) 
genes and their subsequent transcription (reviewed in 9). In the linear genome the distance between 
enhancer(s) and gene can be quite large, for example, the sonic hedgehog (shh) enhancer is located 
about 1 Mb away from its target gene Shh10. Changes or differences within these elements and their 
interaction with genes can be responsible for changes in gene expression11, causing intrinsic differences 
between individuals, disease susceptibility and disease progression. 
A number of chromatin loops are thought to be purely structural, that is to enable the folding of the 
genome creating distinct topological domains, while other loops have a function in the expression of 
genes. Loops of the latter type are frequently found within topological domains, but are less frequently 
observed between different topological domains1, 12. These regulatory chromatin loops change 
and depend on a large number of proteins including CTCF13, cohesin14 and a series of transcription 
factors15-18, which are mostly involved in the transcriptional regulation of genes within the domain. 
The recent refinements of the genome structure were largely due to the Chromosome Conformation 
Capture (3C) technique which allowed the rapid identification of chromatin regions residing in close 
proximity19, 20. The basic principle of the 3C technique is that segments, which are spatially in close 
proximity within the cell nucleus, can be tethered together by cross-linking. After cross-linking and 
restriction enzyme digestion of the genome, the proximal segments remain covalently linked and 
segment-ends can be, subsequently, ligated in dilute conditions. The ligation products can be analyzed 
using PCR-based methods19. A number of different 3C-type techniques have been developed to answer 
different biological questions including: 3C/3C-qPCR19, 21, 22, 3C-seq/4C-seq23, 24, 4C (3C-on-a chip)25-27, 
Chromatin Interaction Analysis by Paired-End Tag Sequencing (ChIA-PET)28, 5C (3C carbon copy)29 and 
Table 1 Comparison between diﬀerent chromatin conformation capturing techniques (adopted and modiﬁed from23)
snoitatimiLsegatnavdAsnoitacilppAdohteM
3C-qPCR sucolehtfoegdelwonkseriuqer,suoirobaLsisylanaelpmiSeno-ot-enO
and proper controls
3C-seq/4C-seq One-to-all              Good resolution,
good signal-to-noise ratio
Restricted to single viewpoint per experiment
when multiplexing several viewpoints, analysis
requires extra bioinformatics expertise, not an
all-to-all genome-wide method
3C-on-chip (4C)
5C Many-to-many     Identiﬁes interactions between
many individual fragments
Very laborious, no genome-wide coverage,
primer design can be challenging. Analysis
requires advanced bioinformatics expertise
Hi-C All-to-all Very expensive, requires a large sequence eﬀort
to obtain suﬃcient coverage, approximately 10 to
40 kbp resolution, requires advanced bioinformatics
expertise
T2C Many-to-all Is restricted to the selected regions ofthe
genome,
requires advanced bioinformatics expertise
Explores the genome-wide interactions
between all individual fragments
Explores the interactome of a selected region
in cis but also in trans, high (restriction fragment)
resolution, cheaper than Hi-C and 5C, requiring 
only half a lane of Illumina HiSeq2000
Relatively simple data analysisOne-to-all Poor signal-to-noise ratio, diﬃcult to obtain
genome-wide coverage
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Hi-C30. All these techniques have their own advantages and limitations (Table 1) and have provided 
very valuable information on chromosomal interactions and gene transcription mechanisms20, 25, 30, 31. 
3C and 4C are quite work and cost intensive, given that they are only one-to-one fragment and one-
to-all fragment techniques respectively. Prior knowledge of the locus is necessary to define the region 
of interest. 
The analysis of the interactions of several viewpoints with the aforementioned techniques in 3C and 
4C is possible, but the choice for several viewpoints will increase the costs and work effort linearly. 
However, the number of viewpoints can also be limited due to the (often) limiting amount of available 
cell material. 5C is demanding in primer design and allows the analysis of interactions only among 
the primer designed fragments. Furthermore, genome-wide coverage is not possible. Hi-C is very 
expensive as it requires extremely deep sequencing in order to cover the whole genome, even at 
a relatively low resolution of 40 kbp. The most recent Hi-C data analysis has used a new algorithm 
and provided a genome-wide interaction map of 10 kbp resolution. However, an enormous amount 
of sequencing is required (3.4 billion mapped paired-end reads from six biological replicates)32. Such 
effort is not affordable for most research groups and, in addition, the scientific interest is most of the 
time focused on a specific question involving a limited set of specific loci or domains. Hence, there is a 
need for a technique which eliminates most of the aforementioned limitations. 
Here we present Targeted Chromatin Capture (T2C), a new 3C method, which does not involve a 
massive sequencing effort, but which results in a high resolution map of interactions for particular 
loci of interest. We used the well-studied human H19/IGF2 locus and compared the results of our 
new method with data from other chromatin conformation capturing techniques. Using the mouse 
β-globin locus we demonstrated that the method can reliably identify chromatin structural changes 
between different tissues and also allows the study of the role of individual transcription factors in the 
chromatin architecture.
Overview of the procedure
To overcome the aforementioned problems of the 5C and Hi-C techniques we have developed the 
novel method T2C. The method has the advantage that it allows the analysis of the structure of the 
genome and all the interactions of selected regions of the genome at high resolution (single restriction 
fragments) without a massive sequencing effort and associated costs. 
T2C employs a selective enrichment of the 3C ligation products in preselected regions of interest in 
order to identify their interactions within a domain as well as the compartmentalization of one or 
several specific regions of the genome. These regions can be continuous Mb sized genomic regions, 
but could also be a collection of smaller regions (a few kbp each). Every captured restriction fragment 
can be used as a single “4C-seq viewpoint” and analyzed accordingly. The results of T2C provide a 
local interaction map at a restriction fragment-level resolution accompanied with a lower sequencing 
effort and less intricate bioinformatics analysis than Hi-C. T2C also overcomes the limits of 5C since 
it identifies not only interactions within the targeted region(s), but also interactions between the 
targeted region(s) and with regions outside of them.
In brief, we have designed sets of unique oligonucleotide probes (ranging from 62 to 90 nucleotides) 
specific for all the restriction fragments and as close as possible to the end of the first restriction site 
(Mm – HindIII + NlaIII digest, Hs – BglII + NlaIII digest) in our regions of interest, the mouse β -globin locus 
and the human H19/IGF2 locus (see Methods). Alternative to continuous regions, separate genomic 
regions within one (or more) chromosomes could be analyzed simultaneously. The oligonucleotides 
are spotted on an array or can alternatively be captured on beads. Some fragment ends cannot be 
captured by a designed oligonucleotide due to the presence of repeat elements or the insufficient size 
of the restriction fragment end. Repetitive sequences are a general problem in all 3C based methods, 
including Hi-C. The size limitation of the fragment end can be circumvented if necessary by a backup 
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Crosslinking, nuclei isolation and lysis Chromatin digestion
Chromatin ligation and 
decrosslinking
Secondary restriction 
enzyme digestion
End repair and 
adapter ligation
Analysis and visualizationPaired-ended Sequence
Adapter Adapter
Adapter Adapter
Adapter Adapter
Elution
HindIII/BglII NlaIIINlaIII
Immobilization of the
oligonucleotide probes
on a microarray or beads
HindIII/BglII
NlaIII
oligonucleotide probes
chromosomeor
beads
AdapterAdapter
Hybridization to 
oligonucleotide probes
Figure 1. Overview of the Targeted Chromosome Capture (T2C) procedure.
Isolated cross-linked chromatin is digested with a restriction enzyme (dark blue lines) and ligated under diluted conditions to 
favour ligations between restriction fragments that are spatially in proximity. After de-cross-linking and a secondary digestion 
(orange lines), the overhangs are repaired followed by adapter ligation. Different address sequences can be used in the 
adapters for different samples to allow multiplexing of different samples (hybridisation of different samples to the same set 
of oligonucleotides). The resulting library is hybridized to a set of unique oligonucleotides on an array or oligonucleotides in 
solution that are captured on beads. The unique oligonucleotides (green, red, black and blue lines) are located as close as 
possible to the first restriction site. The hybridized DNA, which contains the library of all interactions from the selected area of 
the genome, is eluted and is pair-end sequenced on an Illumina HiSeq2000 followed by bioinformatic analysis 
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procedure with different enzymes (changing either the first or the second restriction enzyme or both), 
which generates a new set of end fragments or by mechanically shearing of the chromatin (instead 
of the second restriction enzyme digestion) which can result in fragment sizes of different length (see 
discussion). 
The first steps of the preparation of the chromatin conformation capturing library are carried out as in 
3C-seq23. Basically, chromatin is cross-linked, followed by digestion with a 6 bp recognition restriction 
endonuclease, ligation in diluted conditions and de-cross-linking of the DNA. The library is subsequently 
digested with a frequently-cutting 4 bp recognition restriction endonuclease or mechanically sheared 
to obtain small fragments containing the ligation site, followed by end-repair and ligation of an adapter. 
Within the adapter, different barcodes can be included that would allow multiplexing of different 
samples. The resulting library is hybridized to the specific oligonucleotide probe set representing the 
area(s) of interest (either on an array or in a bead capturing procedure) to enrich specifically for the 
interacting fragments of the region of interest (all fragments positioned at the ends of the original 6 
bp-cut fragments after the second 4bp-cut and eliminate all fragments internal to the 6 bp generated 
fragments). After extensive washing all ligation products including regions covered by the targeting-
array are eluted and their sequence determined by Illumina-sequencing (Figure 1). The capture 
efficiency (the proportion of paired reads of total reads when at least one read of the paired end reads 
is located on a fragment represented by an oligonucleotide) is between 47% and 86% depending the 
cell type and the region (see Table 2). 
Results 
T2C identifies known long-range interactions 
We first have chosen the H19/IGF2 region on human chromosome 11 to test and compare the method 
to other 3C-methods. Previously, we analyzed the 3D-structure of the locus by 3C to study the role of 
cohesin and CTCF for chromosomal long-range interactions33 and also generated 4C-seq data14 (Figure 
2). Hi-C interaction maps were retrieved for IMR90 cells1.
We selected unique oligonucleotides mapping near the ends of 344 BglII generated fragments 
spanning 2.1 Mb around the H19/IGF2 locus (Table 2). This set of 525 oligonucleotides was spotted on 
a capture array. A ligation fragment library was generated from the breast endothelial cell line 1-7HB2 
(abbreviated HB2) after digestion with BglII and NlaIII according to the 3C-seq protocol 23 (see also 
Figure 1). The library was subsequently hybridized to the capture array. After elution from the capture 
array the captured DNA fragments were amplified by a PCR with low cycle number (12 cycles) and 
sequenced by paired-end Illumina sequencing (see Methods).
To demonstrate that T2C reveals a similar overall interaction pattern and compartmentalization of the 
locus as observed by Hi-C in IMR90 cells1 we first binned the paired-reads into 40 kbp bins (Figure 2A, 
B). The interaction patterns  at this level of resolution show that the topological domain is maintained 
between different cell types, HB214 versus IRM901 with a Spearman’s rank correlation coefficient r
s
 
=0.64 (P < 2.2x10-16).
However, with T2C we obtained a chromatin interaction map at restriction fragment resolution (Figure 
2C, each block represents one restriction fragment), revealing significantly more detail with respect 
to the general chromatin organization of the region when visualized by a logarithmic and rainbow-like 
coloured interaction frequency. To first validate T2C in comparison to 3C and 4C-seq we compared 
the interactions of a single restriction fragment (CTCF AD viewpoint33) to interactions detected for 
this fragment by 3C33 and 4C-seq14 (Figure 2D, E, F). Although there are some variations in the read 
coverage of the individual interactions, similar interactions can be observed by both 4C-seq and T2C. 
Moreover, both methods detect interactions which we previously observed with 3C33. It should be 
noted that an important difference between 4C-seq and T2C is the number of PCR amplification cycles. 
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Figure 2. Comparison of interactions detected by T2C for the human chr11p15.5 region with Hi-C and 4C-seq.
(A) Hi-C data generated by Dixon et al., for IMR90 cells covering the H19/IGF2 region of interest, presented at a resolution 40 kbp 
with their respective domain boundaries (DB) depicted as black boxes1. (B) T2C interactions in HB2 cells at a 40 kbp resolution. 
The overall topological domain pattern observed by the two methods is similar (r
s
 =0.65, P < 2.2×10-16). (C) T2C interaction with 
their actual resolution at restriction fragment level. (D) Interactions detected by 3C33. The restriction fragments are indicated 
with yellow triangles. (E) 4C-seq interaction data14, for a viewpoint close to the IGF2 gene. (F) Interactions observed for a 
particular viewpoint by T2C plotted with logarithmic y-axis. The position of the viewpoint is indicated as bold pink line to allow a 
direct comparison between the methods. The thin pink lines indicate a couple of interaction fragments for ease of comparison.
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For T2C this is on average 12 cycles (only after capture) whereas for 4C-seq it is 30 cycles. The lower 
number of cycles will give less PCR bias of the different fragments relative to each other, because 
fragments have different PCR efficiencies.
We conclude that the T2C method yields interaction data at a resolution identical to 4C-seq for 
the individual restriction fragments (median approximately 4 kbp resolution) and that when T2C is 
performed for a continuous region over 2 Mb it can reproduce the overall topological domain structure 
that was observed by Hi-C.
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Figure 3. Comparison of the compartmentalization and interactions for the β-globin locus.
T2C performed in a 2.1 Mb region around the β-globin locus for mouse primary erythroid cells (A) and mouse fetal brain cells (B) 
from E12.5 mice. The topological domain patterns between different biological materials are identical and are independent of 
the number of interactions. Analysis of the interactions obtained with T2C obtained from mouse primary erythroid cells (C) and 
mouse fetal brain cells (D) were plotted at 40 kbp resolution to compare T2C to the regular Hi-C binning. The overall topological 
domain pattern is similar in the two tissues. All the T2C interactions are normalized to the same color code (see color inset). 
The bottom tracks show a linear representation of the β-globin locus, the oligonucleotides probes positions (black lines), HindIII 
recognition sites (red lines) and the ChIP-seq derived binding sites of PolII (red lines), LDB1 (purple lines)38, CTCF (black lines), 
p300 (black lines) and various histone modification markers (light blue, dark blue, green and red)37 in mouse erythroleukemia 
cells. 
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T2C identifies different interaction networks based on different biological materials
Next we used the extensively characterized mouse β-globin locus as a model system to show that 
the T2C method can detect reliably conformational changes due to activation of the genes in vivo at 
high resolution (Figures 3 and 4). We further showed, with an intersection between ChIP-seq derived 
chromatin protein data and T2C, that chromatin proteins may be involved in forming or maintaining 
the 3D structure of the genome (Figure 5).
The mouse β-globin locus undergoes structural changes upon activation in erythroid tissue20, 34, 35, but 
is surrounded by silent olfactory receptor genes, which are only expressed in the olfactory epithelium. 
The major difference between the H19/IGF2 locus and the β-globin locus is that the β-globin locus 
is embedded in a large area of inactive genes. Thus two patterns of interactions may be expected 
in erythroid cells, those important for the globin locus and those present in inactive chromatin.  We 
selected a region of 2.1 Mb around the locus (Table 2) containing 719 restriction fragments of the 
restriction enzyme HindIII (6 bp recognition site). About 800 oligonucleotide probes were designed 
close to the ends of the fragments. To analyze the locus in its active state we used primary erythroid 
cells from fetal liver which were compared to fetal brain cells as a model of inactive loci. Based on 
results from previous 3C studies of the locus20, 35 we expected in primary erythroid cells a higher number 
of interactions around the β-globin gene and between the β-globin gene and its regulatory elements.
The analysis of the hybridised fragments shows that almost the entire 2.1Mb appears to be part of one 
topological domain (with two possible sub-domains, one of which contains the β-globin locus) with 
the next domain starting near the end of the selected sequences (due to the repetitive sequences and 
the borders of the region of interest, that topological domain cannot be depicted clearly, in agreement 
with Dixon et al.,1) both in mouse primary erythroid cells (Figure 3A, right hand side) and mouse 
fetal brain cells (Figure 3B) with many interactions within the topological domain (Figure 3C and 3D). 
Although the topological domain structure between the different biological materials is similar, there 
appear to be less interactions in mouse fetal brain cells relative to mouse primary erythroid cells due 
to the inactivity of the locus in the brain (Figure 3). Focusing on the β-globin region, all the well-known 
interactions in the β-globin locus are detected in the primary erythroid cells. The known interactions, 
such as between the β-globin promoter and Locus Control Region (LCR) (Figure 4B, adapted and 
modified from Drissen et al.16, with blue line depicting the interactions for primary erythroid cells 
and with grey the interactions for mouse fetal brain cells) and between the LCR-3’HS1 are clearly 
visualized16, 20, 35 (Figure 4A). These interactions are absent from the fetal brain sample (Figure 4C). 
Furthermore, the main regulatory region (HS1-6) shows the well-known interaction with the β-globin 
genes and HS1 at the 3’ end of the locus in fetal liver cells but not in brain16, 20. In addition, for the 
β-globin promoter we identify a few additional interactions further away than the ones previously 
reported. These are located even approximately 1Mb far from the β-globin promoter (Figure 3A). It is 
unknown whether these interactions are related to the functioning of the β-globin genes or whether 
these DNA elements are in close proximity due to the folding of the domain, although their absence 
in the fetal brain suggests they have a role in the regulation of the globin β-globin. In addition to the 
interactions in cis, the β-globin (Hbb-b1) gene and the LCR also contact a number of positions on other 
chromosomes.
T2C in combination with ChIP-seq identifies factor specific interactions
We also compared the interactions of the binding sites of an important regulatory transcription factor 
in mouse primary erythroid cells, the LDB1 complex, and the insulator binding protein CTCF (Figure 
5A-D). LDB1 is highly enriched on the β-globin locus and its LCR in mouse primary erythroid cells 
compared to fetal brain cells36. By visualizing only the restriction fragments containing the LDB1 or CTCF 
binding sites as determined by ChIP-seq in fetal liver derived mouse erythroleukemia cells (MEL)37, 38, 
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we can immediately deduce in which interactions the LDB1 complex (Figure 5E, F) or CTCF (Figure 5G, 
H) are involved. In addition, we can identify the restriction fragments that represent gene promoter 
fragments (by Histone 3 Lysine 4 trimethylation (H3K4me3)) or enhancer fragments (marked by 
H3K4me1, that is in the LCR, HS-60 and −62.5) or neither of these, by plotting the histone modifications 
ChIP-seq profiles37. Interestingly the 3’HS1 and HS-85 belong to the latter class and have robust CTCF 
but not LDB1 binding sites. This suggests that they are “structural” elements which would fit with the 
observation that the deletion of the 3’HS1 results in a loss of looping but not in a decrease of β-globin 
mRNA levels13. In contrast the enhancer immediately 3’ of the β-globin enhancer is apparent, but it 
does not appear to interact with any distal elements. It is also clear that in mouse primary erythroid 
cells LDB1 (Figure 6A) and CTCF (Figure 6B) occupy restriction fragments that have more interactions 
with other positions in the locus when compared to mouse brain cells. In addition the median distance 
on the linear chromosome between two fragments in spatial proximity is larger in primary erythroid 
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Figure 4. Comparison of T2C with 3C-qPCR 
for the β-globin promoter
T2C for mouse primary erythroid cells (A) 
and mouse fetal brain cells (C) from E12.5 
mice, revealed the same interactions from 
the β-globin promoter when comparing 
them to 3C-qPCR (B). The 3C-qPCR was 
adapted and modified from Drissen et al.16 
with blue line depicting the interactions for 
primary erythroid cells and with grey the 
interactions for mouse fetal brain cells from 
E12.5 mice. White lines indicate the areas of 
particular interest (such as 3’HS1, β-globin 
promoter, Locus Control Region (LCR) 
and 5’ HS-60/-62) in the β-globin locus. 
Interactions between LCR, the β-globin 
promoter and the 3’HS1 are lost in mouse 
brain cells. The shaded vertical bars indicate 
the comparison between the different 
panels. The red vertical bar indicates the 
β-globin promoter. All the T2C interactions 
are normalized to the same color code (see 
color inset).The bottom tracks show a linear 
representation of the β-globin locus, the 
oligonucleotides probes positions (black 
lines), HindIII recognition sites (red lines) 
and the ChIP-seq derived binding sites 
of PolII (red lines),  LDB1 (purple lines)38, 
CTCF (black lines), p300 (black lines) and 
various histone modification markers (light 
blue, dark blue, green and red)37 in mouse 
erythroleukemia cells. 
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Figure 5: T2C/ChIP-seq intersection plot. 
A comparison of the interactions containing one or two fragments with a LDB1 or CTCF binding site. Interactions are plotted, 
at restriction fragment resolution, over a 2.1 Mb region around the β-globin locus for LDB1 (A, B) or CTCF (C), (D) for mouse 
primary erythroid cells (A, C) and mouse fetal brain cells (B, D) from E12.5 mice. The topological sub-domain around the β-globin 
locus is clearly depicted in the mouse primary erythroid cells when compared to mouse brain cells. Focusing on the β-globin 
locus, T2C-intersection plots, at restriction fragment resolution, of interactions that contain a LDB1 bound fragment (E, F) 
or a CTCF bound fragment (G, H), for mouse primary erythroid cells (E, G) and mouse brain cells (F, H). White lines indicate 
particular areas of interest (like 3’HS1, the β-globin promoter and the Locus Control Region (LCR)) in the β-globin locus. The 
mouse primary erythroid cells interactions between LCR, β-globin promoter and 3’HS1 are lost in mouse brain cells. The shaded 
vertical bars, indicate the comparison between the different panels. All the interactions are normalized to the same color code 
(see color inset). The bottom tracks show a linear representation of the β-globin locus, the oligonucleotides probes positions 
(black lines), HindIII recognition sites (red lines) and the ChIP-seq derived binding sites of PolII (red lines), LDB1 (purple lines)38, 
CTCF (black lines), p300 (black lines) and various histone modification markers (light blue, dark blue, green and red)37 in mouse 
erythroleukemia cells.
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cells for both LDB1 (Figure 6C) and 
CTCF (Figure 6D) binding sites. This 
suggests that this area of the genome 
is less condensed. We conclude from 
these experiments that T2C indeed 
detects topological domains and the 
different interactions between and 
within domains. These interactions 
depend on the expression status of 
the genes such as the active β-globin 
locus in primary erythroid cells versus 
the same silent locus in fetal brain. In 
addition, the high level of resolution 
of the interactions allows novel 
observations such as shown for the 
β-globin locus LDB1 and CTCF binding 
sites and immediately shows which of 
these binding sites interact with each 
other and where they are positioned 
on the linear genome.
Discussion
The importance of the role of 
chromatin interactions in the 
regulation of the gene transcription is 
well established9, 39-42. However, there 
is still an increasing need for a quick, 
easy and affordable technique to 
provide the information on chromatin 
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Figure 6: The mean, median and the number of T2C interactions for the 
LDB1 or CTCF containing fragments.
The number of LDB1 (A) and CTCF (B) interactions is lower in mouse fetal 
brain when compared to primary erythroid cells. Furthermore, the mean and 
the median of the distance between either LDB1 (C) or CTCF (D) interaction 
partners is lower in mouse fetal brain cells when compared to mouse primary 
erythroid cells. P -values were calculated using the Mann-Whitney U test.
interactions and the compartmentalization of the genome. T2C is affordable to most scientific groups 
and will meet in a satisfactory manner their needs for detecting high resolution chromatin organization 
of selected loci. Every restriction fragment can serve as a ‘viewpoint’ and all their interactions, either 
short or long or to other chromosomes (data not shown), can be identified. Thus multiple 3C-seq, 
4C-seq or 5C experiments do not have to be performed. Moreover, with T2C the compartmentalization 
of the genome can be identified in the regions of interest without requiring the large sequencing 
effort of Hi-C, which would increase the costs tremendously. Furthermore, due to the T2C design, 
a better coverage and resolution of the locus is obtained when compared to other genome wide 
techniques (like Hi-C and 3C with its derivatives) using a 6 bp cutter as first restriction enzyme. Here 
we multiplexed two samples, but by multiplexing more than two samples the costs are likely to be 
reduced significantly without sacrificing the quality of the output. We have recently successfully used 
13 samples per sequencing lane, including the β-globin locus which showed the same interactions 
(data not shown).
The resolution of T2C is based on the restriction enzyme used. Digesting cross-linked chromatin from 
primary erythroid cells and HB2 cells with HindIII or BglII, resulted in a median resolution of 2 kbp and 
4.1 kbp respectively (Table 2). That provides a significantly better resolution than the usual 40 kbp 
bins obtained with Hi-C. Furthermore, comparing T2C with 4C-seq14 and Hi-C1 for the H19/IGF2 locus 
(Figure 2) and with already published 3C-qPCR data for the β-globin locus16, 20, 35, the same topological 
domains and chromatin interaction networks were identified. Taken together, all these results, reveal 
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the strengths of the T2C as a tool to identify all the interactions and the compartmentalization of 
specific regions of the genome. 
In addition, the T2C interactions are easily connected to the factors that play a role in these 
interactions or the type of elements (promoters/enhancers) involved in the interactions. LDB1 and 
CTCF are important proteins which mediate chromatin interactions. LDB1 is an important transcription 
factor necessary for primitive mouse hematopoiesis and for the development of megakaryocytes43, 
44 and controls essential hematopoietic pathways in mouse early development45. Depletion of Ldb1 
is lethal for mouse embryos after E9.5 with severe effects such as impairment of hematopoietic and 
vascular development46. It is well established that the LCR has higher interaction frequencies with the 
β-globin locus in mouse primary erythroid cells comparing to mouse brain cells16, 20, 35 and that LDB1 is 
significantly enriched in the LCR region in mouse primary erythroid cells relative to mouse fetal brain 
cells36 (Figure 5E vs. Figure 5F). Furthermore, CTCF is an insulator binding protein known to be involved 
in chromatin conformation33 and is enriched at the boundaries of topological domains1. CTCF mediates 
long range interactions in the β-globin locus13 (Figure 5C vs. Figure 5D and Figure 5G vs. Figure 5H). 
Hence, it is no surprise that for LDB1 and CTCF occupied restriction fragments we observe a higher 
number of interacting fragments at larger linear distances of fragments that interact in mouse primary 
erythroid cells than in mouse brain cells (Figure 6). This effect can be explained by the fact that the 
β-globin locus is active in mouse primary erythroid cells. Furthermore, we observe that the boundaries 
of the topological domain, which contains the β-globin locus, are easily observed in mouse erythroid 
cells (Figure 3A). That is prominent when depicting only the CTCF interacting fragments (Figure 5C vs. 
Figure 5D). Furthermore, the number of interactions within that topological domain, appear higher in 
the erythroid cells comparing to fetal brain cells (Figure 3A vs. Figure 3B, Figure 6A, B). We hypothesize 
that this is due to the fact that the β -globin locus is active with open chromatin in mouse primary 
erythroid cells. Hence, the chromatin has a different conformation by enabling the interaction between 
many different elements necessary for the regulation of the gene34. However, in mouse fetal brain cells, 
where β-globin locus is not active, that is not necessary and there are no important elements that need 
to spatially be in close proximity.
The method may be improved by bringing the cost further down. For example each of the β-globin 
locus experiments was carried out by using one sequencing lane on an Illumina HiSeq machine for 
each different biological sample (mouse primary erythoid cells and mouse fetal brain cells).  That 
yielded after comprehensive data analysis and 271.177 and 557.763 paired-reads within the limits of 
the region of interest excluding self-ligations and uncut fragments for both fetal brain and liver (see 
Methods). These reads represented 2.369 and 4.057 distinct interactions with 114 and 137 reads per 
interaction on average for fetal brain and liver, respectively (Table 2). The read frequency of the highest 
20% of the interactions is from 11858 to 202 in fetal liver and from 29637 to 188 (the top 30% is from 
11858 to 123 and 29637 to 120 for fetal liver and fetal brain, respectively). The bottom 20% account 
for 4 reads in both tissues (while 30% account for 9 and 13 for fetal liver and fetal brain, respectively). 
The question then becomes whether one could do more samples per lane (that is a reduction in cost 
per sample) which would result in fewer reads per interaction point. The decision on this depends to 
some extent on the research question asked. Analysis of functional interactions and/or the “rough” 
overall structure of a locus, can be achieved by using a range between 1/2 and 1/13 of a sequencing 
lane which will dramatically lower the costs without losing much information.
We also considered using mechanical shearing instead of a secondary restriction enzyme. The advantage 
of the secondary restriction enzyme over mechanically shearing is that it is very reproducible and 
provides a better repair step of the ends and hence ligation of the adapters. The possible disadvantage 
of the second cleavage would seem to be a loss of fragment, because a number of fragments would be 
represented by one or no oligonucleotide. However when the oligonucleotides are used in excess, as in 
T2C, there is virtually no statistically significant difference in detecting the reads of fragments represented 
by two, one, or no oligonucleotides (Figure 7). Mechanically shearing would have the advantage that 
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the chance of capturing a fragment 
is improved, because some of the 
secondary restriction sites are too 
close to the primary restriction sites. 
However the disadvantages are that 
mechanically shearing is random, 
which will have the same possible 
loss addressed above, but more 
importantly mechanical shearing 
is difficult to standardize between 
different laboratories. Using two 
different sets of oligonucleotides 
in combination with two different 
restriction enzymes for the first or 
second cleavage would give the 
most advantage because fewer 
fragments would be lost and the 
overall resolution and coverage 
would be further improved. 
The “quantification” could be 
further improved by spiking 
the samples with control cells 
preferably from another species, 
to allow easy recognition of the 
spike when mapping the sequences 
back to the genome during the 
analysis of the ligated fragments. 
This would also require the addition 
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Figure 7: Comparison of capture efficiencies
The efficiency with which each fragment of the selected area is captured was 
derived from counting all of the reads for any particular fragment, that is all its 
interactions, its self-ligation and non-cleaved material and plotting these against 
the presence of two, one or no oligonucleotides (probes) in the fragment (A). 
This shows that the presence of one or two oligonucleotides does not make 
a difference in the capture as would be expected under conditions where the 
oligonucleotides are in saturation. When no oligonucleotides are present for 
a particular fragment, the number of reads will be lower, because the reads 
due to self-ligation cannot be captured. When the reads are corrected for the 
self-ligation and non-cleaved fragments this difference largely disappears (B). 
P-values were calculated using the Mann-Whitney U test   
of a spike specific set of capturing oligonucleotides. Spiking the sample with a DNA sample with a 
different address sequence at the amplification and sequencing stage of the procedure would also 
be an improvement, although it would be less quantitative than the spiking with cells at the start of 
the procedure. The normalization of the signals using the capture efficiency of each of the fragments 
(Figure 7) also increases the “quantification”, although it should be noted these are all relative numbers 
rather than a real quantification because a number of parameters cannot be controlled or assessed 
properly. 
Because T2C is focused on particular regions of interest, it would be easy to design a set of 
oligonucleotides for a number of loci that are known to be associated with a particular disease and 
design a diagnostic kit on that basis that could handle many samples at the same time. Since SNPs are 
often linked to diseases, dedicated oligonucleotides for them can be designed in order to assess their 
effect in long range interactions and the regulation of the gene transcription. For non-clinical research 
purposes the size of the region used in our experiments is sufficient (more than 2 Mb) to extract safe 
conclusions about the local chromatin interactome and the compartmentalization of the genome. 
Conclusions
We conclude that T2C can be used as an affordable, cost-effective diagnostic tool with single restriction 
fragment resolution to explore the local spatial organization of the genome and chromatin interactions 
without requiring laborious procedures or massive sequencing efforts.
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Methods
Oligonucleotide design
A microarray for the β-globin locus was designed containing unique oligonucleotides and physically as 
close as possible to the HindIII restriction sites spanning 2.1 Mb around the gene (chr7: 109876329-
111966581, mm9). For the H19/IGF2 locus unique oligonucleotides were designed close to BglII 
restriction sites (chr11:1100646-3173091, hg18) spanning an area of 2.1 Mb (Table 2). 
The oligonucleotides were designed with the following criteria, they should be: (1) as close as possible 
to the first restriction site; (2) a unique DNA sequence within the area of interest and preferably in the 
entire genome; (3) similar melting temperatures, but with different base composition and the length; 
(4) oligonucleotides which exceed the second restriction site due to very small end fragments, were 
trimmed keeping in mind to stay close to the same melting temperature.
A custom-made NimbleGen Sequence Capture 2.1M capture array is produced separately for the H19/
IGF2 locus and for the β-globin locus containing for each one the oligonucleotides which satisfy the 
aforementioned criteria. The oligonucleotides, 525 for the H19/IGF2 locus and 800 for the β-globin 
locus, were replicated proportionally and equally up to 2.1M in total for each design, i.e. for the 
β-globin locus each of the 800 oligonucleotides was spotted in 2625 spots.
Chromatin isolation and library preparation
Nuclei from approximately 107 mouse primary erythroid cells from mouse fetal liver E12.5, mouse 
fetal brain cells E12.5 and a human breast endothelial cell line (HB2) were isolated, cross-linked (in 2% 
formaldehyde at room temperature) quenched with 1M glycine and were re-suspended in lysis buffer 
(10 mM Tris-HCl (pH 8.0), 10 mM NaCl, 0.2% (vol/vol) NP-40 and 1× protease inhibitor solution). The 
chromatin was digested with a 6-cutter (400 units of HindIII for mouse cells and BglII for the HB2 cells) 
and ligated using 100 units of T4 DNA ligase (Promega) under conditions favouring intramolecular 
ligation events. After reversing the crosslink at 65°C overnight, 50 μg of the resulting DNA chromatin 
library were digested with a frequent 4-cutter (DpnII or NlaIII for the mouse cells, NlaIII for the HB2 
cells, at a DNA concentration of 100 ng/μL, using 1 unit of enzyme per μg of DNA). All these steps were 
performed according to the initial steps of 3C-seq protocol, as described previously23. 
The final library is prepared for analysis on the Illumina Cluster Station and HiSeq 2000 Sequencer 
according to the Illumina TruSeq DNA protocol with modifications (www.illumina.com). In short, the 
digested library is purified using AMPure XP beads (Beckman Coulter), end-repaired and cleaned using 
AMPure XP beads. The now blunt-ended fragments were A-tailed using the Klenow exo enzyme in 
the presence of ATP and purified again using AMPure XP beads. Then indexed adapters provided by 
Illumina were ligated to the A-tailed DNA fragments with subsequent purification using AMPure XP 
beads.
Array capturing
The resulting adapter-modified DNA library (300-500 ng) was hybridized in 35 μL for 64 hours at 42°C on 
a custom-made NimbleGen Sequence Capture 2.1M capture array according to NimbleGen Sequence 
Capture array protocol (www.nimblegen.com/seqcapez) on the NimbleGen Hybridization System. 
The captured DNA fragments are eluted from the capture array and purified using MinElute columns 
(Qiagen). The yield for a positive region (a fragment inside the region of interest) and a negative region 
(a fragment outside the region of interest) differ by >30 fold on average. The captured DNA fragments 
are amplified by 12 PCR cycles. PCR products are purified using AMPure XP beads and eluted in 30 μL 
of re-suspension buffer. One microliter is loaded on an Agilent Technologies 2100 Bioanalyzer using a 
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DNA 1000 assay to determine the library concentration and to check for quality. 
Cluster generation and high throughput sequencing
Cluster generation is performed according to the Illumina Cluster Reagents preparation protocol (www.
illumina.com). Briefly, 1 μL of a 10 nM TruSeq DNA library stock DNA is denatured with NaOH, diluted 
to 9-10 pM and hybridized onto the flowcell. The hybridized fragments are sequentially amplified, 
linearized and end-blocked according to the Illumina Paired-end Sequencing user guide protocol. 
After hybridization of the sequencing primer, sequencing by synthesis is performed using the HiSeq 
2000 sequencer with a 101 cycle protocol according to manufacturer’s instructions. The sequenced 
fragments were denatured with NaOH using the HiSeq 2000 and the index-primer was hybridized onto 
the fragments. The index was sequenced with a seven-cycle protocol. The fragments are denatured 
with NaOH, sequentially amplified, linearized and end-blocked. After hybridization of the sequencing 
primer, sequencing-by-synthesis of the third read is performed using the HiSeq 2000 sequencer with 
a 101-cycle protocol.
Targeted Chromatin Capture data analysis.
The generated HiSeq 2000 sequencing reads were trimmed if the reads contained the first enzyme 
restriction recognition site (HindIII for the mouse derived reads and BglII for the human derived reads) 
For each read with one or more enzyme recognition sites, the DNA sequence after the 3’ end of the 
first site was removed, that is after the trimming procedure the trimmed reads contained and ended 
with a single restriction recognition site. Subsequently, consecutive bases with a quality score lower 
than 10 were cut off from the ends of all the reads and the reads that contained less than 12 bases 
were omitted using Trimmomatic47. We used the Burrows-Wheeler Alignment tool (BWA, version 
0.6.1) to the whole genome NCBI36/hg18 assembly for the human derived reads and to NCBI37/mm9 
assembly for the mouse derived reads, using default settings48. Aligned reads that localized between 
two second enzyme recognition sites that did not contain a first enzyme recognition site, that is all 
NlaIII-NlaIII restriction fragments were removed using BEDtools [51].
In the alignment, paired reads were removed if one of the reads was not uniquely mapped. Furthermore, 
paired reads that were a result of a self-ligation event, non-digestion/re-ligation event or a ligation of 
identical ends were removed from the analysis, since these paired reads introduce a common bias 
in chromosome conformation capture techniques49, 50. The alignments were further processed with 
SAMtools48 to generate paired-end Binary Alignment/Map (BAM) files. BEDtools51 was used to remove 
reads that overlapped more than one restriction fragment. Interaction matrices were generated from 
the alignments at a resolution of the restriction fragments and at 40 kb resolution (using BEDtools on a 
40 kbp binned genome). In addition, the human T2C 40 kb binned data were compared to IMR90 40 kb 
Hi-C data of the combined replicates1. The T2C interaction plots were normalized for capture efficiency 
of the fragments. For each interaction the number reads of each interaction was normalized through 
dividing it by the sum of the reads of both fragments involved in the interaction. Similarly, the T2C 
plots of the 40 kb bins were normalized after all the fragments were divided into 40 kb bins along each 
chromosome. ChIP-seq and T2C interaction-intersection plots were generated from normalized T2C 
interaction plots and intersected with fragments that contained a ChIP-seq peak signal of the protein 
of interest. The statistical software package R (version 3.1.0) was used to generate the interaction plots 
and to conduct the statistical calculations52. 
ChIP-seq analysis
Published ChIP-seq datasets37, 38 were obtained and analyzed. MACS53 was used to identify peaks 
(fdr≤0.01, peak height≥20 overlapping reads) to intersect their positions with the interacting fragments 
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obtained from T2C.
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Abstract
Background
The rearrangement of nucleosomes along the DNA fiber profoundly affects gene expression, but little 
is known about how signalling reshapes the chromatin landscape, in three-dimensional space and over 
time, to allow establishment of new transcriptional programs.
Results
Using micrococcal nuclease treatment and high-throughput sequencing, we map genome-wide chang-
es in nucleosome positioning in primary human endothelial cells stimulated with tumour necrosis fac-
tor alpha (TNFα) - a proinflammatory cytokine that signals through nuclear factor kappa-B (NF-κB). 
Within 10 min, nucleosomes reposition at regions both proximal and distal to NF-κB binding sites, 
before the transcription factor quantitatively binds thereon. Similarly, in long TNFα-responsive genes, 
repositioning precedes transcription by pioneering elongating polymerases and appears to nucleate 
from intragenic enhancer clusters resembling super-enhancers. By 30 min, widespread repositioning 
throughout megabase pair-long chromosomal segments, with consequential effects on three-dimen-
sional structure (detected using chromosome conformation capture), is seen.
Conclusions
Whilst nucleosome repositioning is viewed as a local phenomenon, our results point to effects occur-
ring over multiple scales. Here, we present data in support of a TNFα-induced priming mechanism, 
mostly independent of NF-κB binding and/or elongating RNA polymerases, leading to a plastic network 
of interactions that affects DNA accessibility over large domains.
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Background
The arrangement of nucleosomes along the chromatin fibre profoundly affects genome function1, 2. 
For example, silenced genomic segments and constitutive heterochromatin contain nucleosomes po-
sitioned in high-density arrays1, 3, 4, whereas active and regulatory regions appear more disorganized 
and ‘open’1, 5, 6. Although some data exist on the reorganization of the nucleosomal landscape following 
extra-cellular signalling7, 8 and differentiation9, 10, the temporally resolved dynamics of chromatin archi-
tecture remain poorly characterized.
Nucleosome positioning can be mapped genome-wide at single-nucleosome resolution using micro-
coccal nuclease digestion followed by sequencing (MNase-seq)11, 12. We applied this technique to pri-
mary human umbilical vein endothelial cells (HUVECs) stimulated with tumour necrosis factor alpha 
(TNFα). This potent cytokine drives the inflammatory response by signalling through the transcrip-
tion factor nuclear factor kappa-B (NF-κB)13, 14; on phosphorylation, NF-κB translocates into nuclei, 
where it regulates hundreds of genes15, 16. Therefore, we correlated nucleosomal repositioning with 
genome-wide NF-κB binding (assessed by chromatin immunoprecipitation coupled to high-throughput 
sequencing; ChIP-seq) and gene expression (assessed by sequencing of total RNA; RNA-seq).
We focused on spatial and temporal changes in chromatin architecture during the critical window 
when ‘immediately-early’ proinflammatory genes become active: 0, 10 and 30 min post-stimulation. 
In agreement with the idea that nucleosomes reposition in coincidence with (and/or as a result of) 
transcription factor binding at cognate sites1-6, we did not expect to observe widespread repositioning 
before NF-κB binding was quantitatively detected (that is, 15 min post-stimulation17, 18). However, we 
observed widespread nucleosome repositioning already by 10 min, coinciding with marginal, if any, 
stable binding of the factor (Figure 1A). Similarly, we expected elongation by pioneering RNA poly-
merases along TNFα-responsive genes to initiate a ‘wave’ of repositioning; however, examination of 
long (>100 kilobase pairs (kbp)) genes that are synchronously activated by TNFα showed that nucle-
osomes were already repositioned all the way from 5′ to 3′ ends, despite polymerases having tran-
scribed <50% of their length after 30 min19, 20. We attribute this to changes in positioning that nucleate 
from few selected NF-κB binding clusters embedded in the bodies of such responsive genes. We show 
that these effects are accompanied by changes in the three-dimensional conformation of the chroma-
tin fibre detected using chromosome conformation capture coupled to deep sequencing (3C-seq21).
Results
TNFα induces immediate widespread changes in nucleosome positioning
HUVECs grown to confluence were serum-starved (to promote synchrony), stimulated with TNFα for 
0, 10 or 30 min, and treated with MNase to release mononucleosomes. The purified DNA (Additional 
file 1A) was deep-sequenced to obtain approximately 180 million read-pairs per time point (Figure 1A). 
When mapped to the reference genome (hg19), reads from two 0- and 30-min biological replicates 
gave comparable profiles (Additional file 1B).
First, we identified peaks in the MNase-seq read profiles that marked single-nucleosome positions 
(using findPeaks22) and selected those differentially unmasked at 10 or 30 min post-stimulation (that is, 
those where nucleosomes are repositioned by >10 bp when compared to 0 min). By 10 min, unmasked 
regions were enriched for binding motifs of proinflammatory transcription factors (for example, NF-
κB, AP-1; Additional file 1C), and characterized by Gene Ontology terms associated with cell regulation 
and cytokine signalling (Additional file 1D). Notably, short interspersed nuclear elements23, especially 
AluY, AluSx and AluSg, which all contain NF-κB binding sites24 and confer enhancer-like characteris-
tics25, were amongst the most significantly unmasked regions (Table 1). These findings are perhaps 
surprising, because levels of nuclear NF-κB do not peak before 15 to 17.5 min (Additional file 1E)18,26,27. 
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By 30 min, regulatory regions (for example, CpG islands, promoters, 5′ untranslated regions) and genes 
(for example, coding regions, exons) were all statistically significantly unmasked (Table 1). These data 
point to a progressive transition from the 0- to the 10-min, and finally to the 30-min, state.
TNFα induces repositioning in differentially regulated gene subsets
We next examined genes differentially regulated following a 30-min TNFα pulse. They were selected 
using data obtained after deep sequencing total rRNA-depleted RNA (RNA-seq; approximately 120 
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Figure 1. Nucleosome repositioning in TNFα-responsive genes. 
(A) Strategy: HUVECs were serum-starved and stimulated with ΤΝFα (0, 10, 30 min), treated with MNase, and DNA associated 
with mononucleosomes (highlighted yellow) deep-sequenced. Nucleosomes reposition within 10 min to unmask NF-κB binding 
sites (magenta), before NF-κB enters the nucleus. (B) Browser tracks (vertical axes - reads/million; magnifications of transcription 
start sites shown below) for typical up- or down-regulated genes obtained by MNase-seq (green; reflects nucleosomal profiles; 
0-min levels in grey underlie 10- and 30-min ones to facilitate comparison), p65 ChIP-seq (black; reflects NF-κB binding), and total 
RNA-seq (magenta; reflects RNAPII activity). (C) Nucleosome occupancy (reads/million; MNase-seq) at 0 (grey) or 30 min post-
stimulation (green) along metagenes derived from 109 up-regulated (>0.6 log2 fold-change at 30 compared to 0 min, plus >100 
reads mapping to each), 69 down-regulated (<-0.6 log2 fold-change, plus >100 reads mapping to each), and 509 constitutively 
expressed genes (±0.01 log2 fold-change, plus >100 reads mapping to each). Genes were aligned at transcription start/
termination sites (dotted lines), gene bodies divided into 50-bp windows, lengths scaled proportionately, and MNase-seq reads 
in each window summed; profiles from 5 kbp up- and downstream are also displayed. ChIP-seq, chromatin immunoprecipitation 
coupled to high-throughput sequencing; kbp, kilobase pair; MNase-seq, micrococcal nuclease digestion followed by sequencing; 
NF-κB, nuclear factor kappa-B; RNA-seq, sequencing of total RNA; TNFα, tumour necrosis factor alpha; TSS, transcription start 
site; TTS, transcription termination site.
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million read pairs per time point) and were required to change by at least ±0.6 log2-fold (that is, ±1.5-
fold at 30 min relative to 0 min); constitutively expressed genes (±0.01 log2-fold) provided controls 
(Additional file 2A and Additional file 3). We also monitored NF-κB binding using ChIP-seq data (by 
targeting its p65 subunit) at 10 and 30 min post-stimulation. At 10 min, marginal binding was observed, 
in agreement with data showing that NF-κB translocation into the nucleus and binding to cognate sites 
is not quantitatively detected before 15 or 30 min, respectively (examples in Figure 1B and Additional 
file 1E). At 30 min, more than 80% of up-regulated genes were associated with at least one p65 peak, 
compared to just 10% of down-regulated ones (compared to 6% and 7% for the 10-min data; Addition-
al file 2B).
Comparison of MNase-seq (raw) read profiles along a typical immediate-early up-regulated gene, NFK-
BIA, showed nucleosomes already repositioned by 10 min, and changes in nucleosome occupancy 
became more pronounced at 30 min, when density decreased throughout the locus as NF-κB bind-
ing increased (Figure 1B, left). By contrast, profiles on a typical down-regulated gene, LIN37, became 
heightened and more defined (Figure 1B, right). This held true for other up- or down-regulated genes, 
whilst those of constitutively expressed loci varied little (Additional file 2C).
Global changes in genic nucleosome occupancy were assessed using ‘metagene’ analyses, by aggre-
gating profiles from all up- or down-regulated genes. In up-regulated genes, the first few nucleosomes 
downstream of the promoter became more precisely positioned (most likely as transcription start site 
(TSS)-proximal nucleosomes form well-positioned arrays [1]), and occupancy decreased incremental-
Table 1 Genome Ontology analysis of nucleosome-unmasked regions
10 versus  0 min   TNFα stimulation  30 versus  0 min   TNFα stimulation  
Annotation  GO group  log  P -value  Annotation  GO group  log  P -value  
rRNA  Basic  -132.6  CpG island  Basic  -18 ,894.5  
-  -  -  coding  Basic  -2 ,508.6  
-  -  -  protein -coding  Basic  -2 ,202.6  
-  -  -  exons  Basic  -2 ,175.4  
-  -  -  promoters  Basic  -1 ,637.2  
-  -  -  5 ʹ UTR  Basic  -1 ,573.7  
-  -  -  rRNA  Basic  -90.7  
-  -  -  miscRNA  Basic  -57.6  
-  -  -  TTS  Basic  -30.3  
-  -  -  miRNA  Basic  -2.3  
Alu  SINE  -1 ,010 ,851.5  Alu  SINE  -127 ,523.7  
Satellite  Satellite  -138 ,649.4  AluY  SINE  -254 ,77.1  
AluSx  SINE  -130 ,806.8  AluJb  SINE  -13 ,157.4  
Simple  Repeat  -109 ,102.9  AluSx  SINE  -10 ,162.6  
AluSz  SINE  -95 ,618.8  AluSx1  SINE  -9 ,723.1  
Satellite  Satellite  -84 ,407.6  AluSz  SINE  -7 ,150.9  
TGn  Repeat  -82 ,907.0  AluJr  SINE  -6 ,259.1  
Can  Repeat  -82 ,146.3  AluJo  SINE  -5 ,837.8  
AluSx1  SINE  -81 ,015.6  AluSz6  SINE  -3 ,989.9  
CATTCn  Satellite  -77 ,388.9  AluSg  SINE  -3 ,556.9  
 
A list of the top regions unmasked at 10 and 30 min post-stimulation (looking at nucleosomes identified using findPeaks [23] 
that were repositioned by >10 bp at 10 or 30 compared to 0 min). Top half: regions associated with ‘basic’ genome annotation. 
Bottom half: repeat elements. For each entry, the annotation category, genome ontology group and identification confidence 
levels (log P-value) are shown; Alu repeats known to bind NF-κB [24] are in bold. GO, Gene Ontology; SINE, short interspersed 
nuclear elements; TNFα, tumour necrosis factor alpha.
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ly towards the 3′ end (as nucleosome-rich 
exons tend to be found more 3′28, 29). In 
down-regulated genes, occupancy in-
creased throughout; again, little change 
was observed in constitutively expressed 
loci (Figure 1C).
Nucleosome repositioning precedes tran-
scriptional elongation in long genes
The transcriptional activation of five long 
genes of >100 kbp has been studied in de-
tail in this experimental model17-20. Follow-
ing treatment with TNFα, pioneering RNA 
polymerases (RNAPs) initiate synchro-
nously at the TSSs within 15 min, and then 
elongate at approximately 3 kbp/min. 
Thus, elongating RNAPs have transcribed 
less than the first half of these long genes 
after 30 min (see RNA-seq profiles in Fig-
ure 2 and ChIP-quantitative PCR (qPCR) in 
Additional file 4A). Therefore, one would 
expect nucleosomes only in the first half 
of these genes to have been repositioned.
To simplify analysis, we initially applied the 
PeakPredictor algorithm30 to our MNase-
seq data and ‘called’ single-nucleosome 
positions along three such long genes. As 
expected, TSS-proximal regions appeared 
progressively more depleted of nucleo-
some peaks (for example, in the first 10 
kbp downstream of the TSS of 318-kbp 
EXT1, 41, 38 and 24 peaks were called at 
0, 10 and 30 min, respectively; Additional 
file 4B). Unexpectedly, peak depletion of 
the same scale spread over hundreds of 
kilobase pairs from TSS to transcription 
termination site (TTS) (for example, the 
number of peaks throughout EXT1 fell by 
12% after 30 min; Additional file 4B), and 
‘MNase-on-ChIP’ verified this effect (Addi-
tional file 4C).
Of course the above effect does not ac-
curately describe the phenomenon, as 
there exist no such long nucleosome-de-
void stretches of DNA. Thus, we analysed 
MNase-seq data throughout each long 
gene via a custom bioinformatics pipeline 
to examine whether nucleosome reposi-
HUWE1 (154 kbp)
constitutively-expressed
100_
100_
0_
100_
Repositioning precedes elongation
-0.4
+0.4
0
100_
100_
RN
A
-s
eq
0 min
10 min
30 min
0 min
up-regulated
-0.4
+0.4
010 min
0 min
0_30 min
100_
ALCAM (186 kbp)
RNAPII
RNAPII
SAMD4A  (221 kbp)
+0.3
-0.3
0
+0.3
-0.3
0
RNAPII
RNAPII
ch
an
ge
s 
in
 n
uc
le
os
om
e
oc
cu
pa
nc
y 
(lo
g
) 2
100_
100_
RN
A
-s
eq
0 min
10 min
0_30 min
100_
30 min
0 min
10 min
0 min
-0.4
+0.4
030 min
0 min
-0.4
+0.4
0
10 min
0 min
0 min
10 min
30 minRN
A
-s
eq
ch
an
ge
s 
in
 n
uc
le
os
om
e
oc
cu
pa
nc
y 
(lo
g
) 2
ch
an
ge
s 
in
 n
uc
le
os
om
e
oc
cu
pa
nc
y 
(lo
g
) 2
Figure 2. Nucleosome repositioning at 3ʹ ends of long genes precedes 
transcription by pioneering (elongating) polymerases. 
Browser views show (log2 fold) changes in nucleosome occupancy 10 
or 30 min post-stimulation calculated using 5-kbp non-overlapping 
windows and a running-means average along up-regulated long genes 
ALCAM and SAMD4A. Changes (read enrichment - grey; read depletion 
- orange) are shown normalized to those in transcriptionally inert 
genomic regions. Total RNA-seq tracks (magenta) show elongating 
polymerases generating intronic signal close to the 5′ ends of genes 
after 10 and 30 min, as they have not yet reached termini (dotted 
lines - positions of pioneering RNAPs after 10 and 30 min). The long, 
constitutively expressed HUWE1 locus (bottom) serves as a control. 
Kbp, kilobase pair; RNAP, RNA polymerase; RNA-seq, sequencing of 
total RNA.
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tioning follows RNAP elongation (as might be expected). Genes were divided into 5-kbp non-over-
lapping windows, and changes in each window scored relative to (background) levels of nucleosome 
repositioning occurring in transcriptionally inert genomic segments (see Methods). This revealed a 
decrease in nucleosome occupancy (hereafter termed depletion), which was evident throughout 186-
kbp ALCAM and 221-kbp SAMD4A (Figure 2), as well as in 116-kbp NFKB1 and 458-kbp ZFPM2 (Addi-
tional file 5A), at both 10 and 30 min, when pioneer RNAPs had advanced for <30 and <100 kbp, re-
spectively. This effect was reproducible between biological replicates (Additional file 5B), and profiles 
of down-regulated and constitutively expressed genes served as controls (Figure 2 and Additional File 
5A).
NF-κΒ binding is associated with repositioning over great distances
We next examined whether NF-κB binding was enriched in kilobase pair-long genomic segments dis-
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Figure 3. NF-κB binding in TNFα-regulated nucleosomal domains. 
(A) A minority of p65 peaks are found in depleted domains. The genome was partitioned into 5-kbp non-overlapping windows, 
and those depleted of nucleosomes selected (determined as in Figure 2) and compared to the location of p65 binding sites 
(determined using ChIP-seq data obtained 30 min post-stimulation). By 10 min, 74,486 nucleosome-depleted windows appear, 
after 30 min 288,377 such windows develop (21,788 of which are also seen at 10 min). By 30 min, 8,554 p65 peaks are seen, 
but only 244 and 1,318 overlap (≥25% of sequence) with the 10- and 30-min nucleosome-depleted windows, respectively. 
(B) Nucleosome-depleted p65-containing windows are predominantly intragenic. Bar graphs give the fraction of nucleosome-
depleted windows or p65 peaks (0, 10, 30 min) coinciding with regions lying within or outside annotated genes (blue - intragenic; 
grey - intergenic, or ±1 kbp from the transcription start site (purple - promoter) (C) Browser tracks illustrating changes in 
nucleosome occupancy (log2 fold-changes determined using 5-kbp non-overlapping windows as in Figure 2) in a 1-Mbp locus on 
chromosome 14 (TNFα-responsive genes - red, non-responsive - blue); p65 ChIP-seq tracks (0, 10 and 30 min post-TNFα; vertical 
axes - reads/million) are also shown. ChIP-seq, chromatin immunoprecipitation coupled to high-throughput sequencing; kbp, 
kilobase pair; TNFα, tumour necrosis factor alpha.
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playing reduced MNase-seq signal. ChIP-seq collected 10 min post-stimulation showed sparse binding 
of p65 (approximately 200 peaks genome-wide, most at repeat elements; Additional file 6A), but by 
30 min around 8,600 peaks were detected, most found at sites bearing histone marks characteristic 
of enhancers (high H3K4me1 and H3K27ac, low H3K4me331; Additional file 6A). At the same time, 
>280,000 5-kbp windows appeared depleted of nucleosomes (defined as above). Remarkably, <20% of 
p65 peaks (1,318) were embedded in such depleted windows, and the overlap was even smaller when 
compared to 10-min windows (244 peaks; Figure 3A). This is inconsistent with a simple model where 
NF-κB binding drives genome-wide nucleosome depletion, especially as little NF-κB has quantitatively 
bound in HUVEC chromatin by 10 min (Figure 1B and Additional file 1E). Intriguingly, p65-bearing win-
dows significantly associated with gene bodies (Figure 3B).
As p65 binds both close to and in the body of many up-regulated genes (Additional file 2B), we specu-
lated that the TNFα-driven repositioning seen throughout such genes (Figure 1C) might be nucleated 
from p65 bound at intragenic sites (Figure 3C illustrates one locus). Thus, of all up-regulated genes ex-
amined, 72% encompassed ≥1 p65 peak; by contrast, <10% of down-regulated genes contained a p65 
peak (Additional file 7A). The physical separation between such intragenic peaks in up-regulated genes 
is an order of magnitude greater than those between intergenic ones (despite the small fraction of the 
genome occupied by protein-coding genes); thus, this group of peaks covers a substantial portion of 
the respective gene bodies (Additional file 7A). These results point to a focused binding of NF-κΒ, in 
clusters of ‘primed’ sites, within genes (even though the transcription factor might be bound at low 
titres), followed by nucleosome repositioning over several tens of kilobase pairs (Additional file 6B and 
Additional file 7B).
Multi-scale nucleosome repositioning impacts on higher-order structure
We next used the long arm of chromosome 14 as a model to study how changes in nucleosome density 
might affect structure at increasingly larger scales (as loci on this chromosome have been extensively 
studied before17-20). The chromosome was divided into non-overlapping windows of 25, 50 and 100 
kbp, and nucleosome occupancy examined. By 10 min, alternating enriched and depleted domains 
were seen at all window sizes; by 30 min most of these further evolved (Additional file 8A) and deplet-
ed profiles predominated (also reproducible between replicates; Additional file 8B). In other words, a 
gradual spreading of nucleosome-depleted domains was observed, and this appeared to be nucleated 
by the hotspots seen at 10 min (many also engulfing DNase-hypersensitive sites, especially by 30 min 
post-stimulation; Additional file 8C).
To relate changes in nucleosome occupancy to those in DNA conformation, we performed 3C-seq at 0 
and 30 min post-stimulation21 using the TSSs of TNFα-responsive SAMD4A and constitutively expressed 
ΕDN1 as viewpoints. For the SAMD4A TSS, we showed previously that stimulation induces develop-
ment of new contacts throughout the genome18; here we focus only on the more abundant intra-chro-
mosomal contacts. At 0 min, SAMD4A contacts were scattered throughout the chromosome arm, and 
after 30 min new ones developed (Figure 4A, top). Of the 167 most frequently seen 30-min contacts, 
131 formed de novo upon TNFα treatment. When correlated with changes in nucleosome occupancy 
(in 5-kbp windows, as in Figure 2), we found essentially all 30-min and ‘shared’ contacts embedded in 
nucleosome-depleted windows (significantly more than 0-min contacts; Figure 4A).
By contrast, the EDN1 TSS formed fewer new contacts upon stimulation (of the 496 most frequent 30-
min contacts 42% were also see at 0 min; Figure 4B, top). Moreover, significantly more shared contacts 
correlated with nucleosome-depleted windows (compared to 0- or 30-min specific ones; Figure 4B). 
Closer inspection of the two loci shows that contacts (in accord with obtained chromatin interaction 
analysis by paired-end tag sequencing data18) do not form randomly between ‘nucleosome-free’ re-
gions, but rather share particular features (that is, NF-κB binding, H3K4me1 enrichment and transcrip-
tional activity; Additional file 9).
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Figure 4. Changes in nucleosome positioning affect higher-order structure. 
(A) High-confidence contacts (P <0.05; determined using 3C-seq 0 or 30 min post-stimulation) made by the transcription start 
site (TSS; arrowhead) of TNFα-responsive SAMD4A with parts of the long arm of chromosome 14 (ideogram) are depicted as a 
domainogram (y-axis - contacts visualized in 2- to 200-kbp sliding windows). Most contacts are unique for each time point (Venn 
diagram). The magnified region (red rectangle) compares 3C-seq contacts (y-axis - reads per million) to changes in nucleosome 
occupancy (determined as in Figure 2). The table (bottom right) gives the fraction of 3C contacts embedded in nucleosome-
depleted windows at 0 or 30 min, or shared at both times; a significant increase is seen for 30-min and shared contacts (*P <0.05; 
Fisher’s exact test). (B) Details as in panel (A), for the non-responsive EDN1 TSS (arrowhead) on the long arm of chromosome 6 
(ideogram). Almost 40% of high-confidence contacts persist from 0 to 30 min (Venn diagram), and are significantly associated 
with nucleosome-depleted 5-kbp windows (*P <0.05; Fisher’s exact test). 3C-seq, chromosome conformation capture coupled 
to deep sequencing; TNFα, tumour necrosis factor alpha. 
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Discussion
We addressed the question: how does TNFα stimulation reshape the chromatin landscape as it estab-
lishes the immediate-early proinflammatory transcriptional programme? The cytokine signals through 
NF-κB13, and one might envisage that the factor first binds in the vicinity of regulatory elements to 
induce repositioning of nucleosomes locally. This would then facilitate transcriptional initiation by RNA 
polymerase, and would in turn open up the bodies of TNFα-responsive genes as polymerases elongate 
through them32, 33. However, changes observed here cannot be reconciled with this scenario.
First, we saw hotspots of nucleosome depletion 10 min post-stimulation (Additional file 8Α), before 
detectable NF-κB binding to cognate sites (Additional file 6Α). Although there were approximately 
1,300 NF-κB binding peaks in nucleosome-depleted windows after 30 min, most bound NF-κB was 
not embedded in kilobase pair-long depleted regions (Figure 3A). This also fits with the distribution of 
typical NF-κB motifs (5′-GGRRNNYYCC-3′): out of >550,000 sites found genome-wide, only 60,000 and 
250,000 were embedded in windows depleted of nucleosomes after 10 and 30 min, respectively (with 
28,000 being shared and very few being occupied; Figure 3A). It follows that NF-κB binding is highly 
selective; the first transcription factor complexes to enter nuclei (between 10 and 15 min) must pref-
erentially bind to a small subset of primed domains depleted of nucleosomes, harbouring the highest 
affinity sites - probably within the critical enhancers that regulate the ensuing cascade and/or on par-
ticular Alu repeats24. This is reminiscent of a subset of NF-κB dimers in macrophages selectively binding 
to already-accessible chromatin segments where partner regulators constitutively bind34 - which raises 
the question of what the endothelial-specific NF-κB partners might be.
Second, results cannot be reconciled with the idea that transcription through nucleosomes by pio-
neering elongating RNAPs is solely responsible for changes in chromatin structure. Nucleosomes in 
long TNFα-responsive genes are repositioned throughout, well before elongating polymerases have 
transversed their full length (Figure 2). Then, what molecular mechanism might drive repositioning 
at sites many kilobase pairs away from a bound NF-κB or a pioneering polymerase? We can suggest 
some possibilities that might act singly, or in concert. For example, an effector other than NF-κB might 
be responsible for priming; then, NF-κB (and/or another effector) could induce chromatin remodelling 
enzymes to act throughout the surrounding locale - perhaps a chromatin loop or cluster of loops in 
a topological domain attached to a transcriptional hot spot35. Alternatively, transcription could gen-
erate supercoiling that remodels one such loop (or cluster of loops) within a topological domain36. 
Lastly, polymerases other than pioneers on responsive genes could drive repositioning - perhaps ones 
generating enhancer RNAs (like in Additional file 6B)37. This is supported by the presence of NF-κB 
clusters bound within gene bodies at sites marked by histone marks and transcripts characteristic of 
enhancers; these overlap ‘super-enhancers’ previously mapped in HUVECs38 that also show decreased 
nucleosome density post-stimulation (see examples in Figure 3C and Additional File 6B).
Third, nucleosome repositioning has traditionally been viewed as a local phenomenon, but we detect 
occupancy changes throughout megabase pair-long segments (see chromosomes 4 and 14 in Addi-
tional file 8). (Note that, using semi-quantitative Western blotting with antibodies targeting histones 
H3 and H4, we verified TNFα stimulation does not affect global histone levels; data not shown.) Using 
3C-seq, we confirmed the intuition that changes in nucleosome positioning around two megabase 
pair-long chromosomal loci go hand-in-hand with the development of contacts in three-dimensional 
nuclear space. Interestingly, a subset of recorded 3C contacts - which predominantly form between 
regulatory cis-modules39, 40 marked by NF-κB and characteristic histone modifications (Additional file 9) 
- persist throughout the transition from the unstimulated to the TNFα-stimulated state (Figure 4). This 
is consistent with pre-looped chromatin facilitating responses to extra-cellular cues41, and can now be 
explained also at the level of nucleosomal organization.
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Conclusions
Collectively, our data point to TNFα triggering chromatin priming so that most nucleosomes are repo-
sitioned independently of NF-κB binding and/or polymerases elongating through responsive genes. 
This effect is a prelude to the ensuing proinflammatory programme, and it occurs both locally (at the 
gene level) as well as at considerable distances from, what have hitherto been considered, the major 
nucleating sites to affect large chromosomal segments. Finally, although ‘topological domains’ may 
constitute invariant building blocks within chromatin41-43, an underlying and plastic network of interac-
tions within a domain must affect DNA accessibility to polymerases, ultimately allowing the rapid tran-
sitions that occur as different sets of genes become active and inactive and the inflammatory cascade 
unfolds15, 16. Of course, the molecular machines responsible for priming, their interplay with NF-κB, 
and the potential role of other factors (like histone H1 eviction or activity of topoisomerases) need be 
addressed in light of these findings.
Methods
Cell culture
HUVECs from pooled donors (Lonza,  Cologne, Germany were grown to 80% to 90% confluence in 
endothelial basal medium 2-MV with supplements (EBM; Lonza) and 5% foetal bovine serum (FBS); 
starved for 16 to 18 h in EBM + 0.5% FBS; treated with TNFα (10 ng/ml; Peprotech, Hamburg, Germa-
ny); and harvested 0, 10 or 30 min post-stimulation.
Isolation of mononucleosomes, sequencing and mapping
Approximately 5×106 HUVECs stimulated with TNFα for 0, 10 or 30 min were digested (3 min at 37°C) 
with 750 units of micrococcal nuclease (MNase; Sigma-Aldrich, Seelze, Germany). Mononucleosomal 
DNA was isolated following separation on 1.3% agarose gels using glass beads (Qiagen, Hilden, Ger-
many), and average fragment lengths determined using a 2100 Bioanalyzer (Agilent). Libraries were 
generated using the NEBNext DNA Library Prep Master Mix Kit (New England Biolabs, Ipswich, USA) 
and paired-end (2×50-bp) sequenced on a HiSeq2000 platform (Illumina) to comparable depths (that 
is, 181, 185 and 187 million reads for 0, 10 and 30 min samples, respectively). Obtained reads were 
processed using the toolkits FastQC44 and FASTX45, mapped to hg19 using Bowtie46.
MNase-seq analysis
Different peak-calling algorithms were applied depending on the downstream application. For Addi-
tional file 4 the Peak Predictor/GeneTrack package30 was used. For motif analyses, as well as Gene 
and Genome Ontology profiling (Additional file 1 and Table 1), the HOMER software package47 and 
findPeaks 3.122 were applied (adjusting fragment size to that determined using the Bioanalyzer with 
the following settings: −style factor –size 147 –minDist 1 –F 0 –L 0 –C 0). When comparing two or more 
datasets, the getDifferentialPeaks or mergePeaks scripts were used. For visualization, tag directories of 
mapped reads were generated and .bedGraph files produced using the makeUCSCfile (for raw reads) or 
pos2bed.pl (for peaks and other BED-formatted files) scripts; tracks were then visualized with the UCSC 
Genome browser48. Both known and de novo motif analyses were performed with findMotifsGenome.
pl using standard settings and the repeat-masked hg19 genome build. All peak annotations, including 
histograms, were generated with annotatePeaks.pl, and graphs plotted in R49 with a smoothing spline 
of 0.2.
Differences in nucleosome positioning between any two time-points (0- compared to 10- or 30-min 
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datasets) were elucidated statistically using a novel Neyman-Pearson ‘normalized log-likelihood-ratio’ 
analysis. Chromosomes 1-X were divided in n non-overlapping windows w
1,
 w
2,
 … wn of a constant size 
|wi|. In a pre-processing step, MNase-seq data files containing read positions at t1 and t2 were used 
to compile datasets R = (r1, r2, … rn) and S = (s1, s2, … sn); ri and si are the read counts in each wi ob-
served under treatments t1 and t2, respectively. Then hypotheses H1 and H2 were tested by computing 
a log-likelihood-ratio Q according to:
1 2log ( , .... ); .in i
i
rRQ q q q q
S s
= = =
This set of log-likelihood-ratio values has a mean of 1
1 n
mean i
i
Q q
n =
= ∑
 and a normalized distribution 
||Q|| = Q - Q
mean
. It follows that ||qi|| values are centred on zero. The null hypothesis is then that all 
observed qi-values from regions that were transcriptionally inert (assessed using RNA-seq data) were 
due to random fluctuations and not caused by treatments t1 and t2. The normalized cumulative distri-
bution N
cum
 was used to determine a p-value p(||qi||) for ||qi|| ≥0 according to:
(|| ||) 1 (|| ||)i cum ip q N q= −
Thus, the smaller p(||qi||) is, the lower the probability that the ratio ||qi|| is merely due to a stochas-
tic fluctuation of read counts.
Chromosome conformation capture
Nuclei were harvested after 0 or 30 min of TNFα stimulation, cross-linked in 1% paraformaldehyde 
(PFA; Electron Microscopy Science, Munich, Germany), and processed as described [21] using ApoI as 
the primary restriction endonuclease. Following sequencing on a HiSeq2000 platform (Illumina; ap-
proximately 2×107 reads), data were analysed using the r3Cseq pipeline50. The domainogram in Figure 
4 was generated using the top 167 cis-contacts on chromosome 14 (on which the viewpoint lies) using 
publicly available software51. In brief, 3C-seq reads are made binary and relative enrichments calcu-
lated using sliding windows compared to a randomized background made up of 3,000 fragment ends. 
Data permutation is then used to determine a threshold of <0.01 false discovery rate (FDR); windows 
exceeding this threshold are scored as interacting.
Chromatin immunoprecipitation and ChIP-seq analysis
Approximately 107 HUVECs were cross-linked (using 1% PFA for 10 min, preceded by 25 min in 10 
mM ethyl-glycol-bis-succinimidylsuccinate at room temperature, as described previously18) 0, 10 or 
30 min after TNFα stimulation; chromatin was fragmented by sonication (Bioruptor; Diagenode, Liège, 
Belgium); then immunoprecipitation was carried out using a rat monoclonal against phospho-Ser2 in 
the C-terminal domain of the largest subunit of RNA polymerase II (3E1052; a gift from Dirk Eick, Helm-
holtz Institute, Munich, Germany) or a rabbit polyclonal against the full-length p65 subunit of NF-κB 
(39369, Active motif) on aliquots of approximately 25 μg chromatin. Immunoprecipitated complexes 
were washed and eluted using the ChIP-It-Express kit (Active motif, Rixensart, Belgium).
For qPCR analysis, a Rotor-Gene 3000 cycler (Qiagen) and Platinum SYBR Green qPCR SuperMix-UDG 
(Invitrogen, Darmstadt, Germany) were used. Following incubation at 50°C for 2 min to activate the 
qPCR mix, and 95°C for 5 min to denature templates, reactions were carried out for 40 cycles at 95°C 
for 15 s, and 60°C for 50 s. PCR primers were designed via Primer3Plus53 using qPCR settings with an 
optimal length of 20 to 22 nucleotides, a Tm of 62°C, targeting 100 to 200 bp. The presence of single 
amplimers was confirmed by melting-curve analysis, and data were analysed to obtain enrichments 
relative to input. P values (two-tailed) from unpaired Student’s t-tests54 were considered significant 
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when <0.05.
For deep sequencing, previous (0- and 30-min18) and newly generated (10-min) p65 ChIP-seq data were 
aligned to hg18 and signal peaks detected using MACS55. This allowed 68, 214 and 8,583 high-confi-
dence p65-binding events to be detected for 0, 10 and 30 min respectively (FDR ≤0.01, peak height ≥20 
reads/million). Peaks were correlated to publicly available ENCODE Hidden Markov chromatin models 
and HUVEC ChIP-seq data (H3K27ac: GSM733691; H3K4me1: GSM73369031, 56) and annotated against 
RefSeq genomic features (TSS, exon, intron, intergenic region).
Total RNA sequencing and analysis
Total RNA was isolated from 0.5×106 HUVECs stimulated with TNFα for 0, 10 or 30 min using TRIzol 
(Invitrogen), treated with RQ1 DNase (1 unit/μg RNA, 37°C, 45 min; Promega, Leiden, Netherlands), 
depleted of rRNA (RiboMinus; Epicentre, Madison, USA), chemically fragmented to approximately 350 
nucleotides, and cDNA generated using random hexamers as primers (according to the True-seq pro-
tocol; Illumina). Adapters were then ligated to cDNA molecules, and libraries sequenced (Illumina HiS-
eq2000 platform; 100-bp paired-end reads; around 120×106 read-pairs per sample). Raw reads were 
then mapped to hg18 using TopHat57 and reads aligning to RefSeq gene models were counted using the 
HTseq package58. Statistical analysis of differentially expressed genes was performed with the DESeq 
Bioconductor package59 (asking for >100 reads per gene, and for a >0.6, <-0.6, or ±0.01 log2 fold-change 
for up-regulated, down-regulated or constitutively expressed genes, respectively; Additional file 3).
Immunofluorescence
HUVECs grown on coverslips etched with hydrofluoric acid were fixed with 4% PFA (Electron Micros-
copy Science) in phosphate-buffered saline (PBS; 20 min, 20°C), washed once in PBS (5 min, 20°C), 
permeabilized using 0.5% Triton X-100 in PBS (5 min, 20°C) and blocked with 1% bovine serum albumin 
(BSA) in PBS (Sigma-Aldrich; 45 min, 20°C). Phosphorylated (at Ser536) p65 was detected using a rab-
bit monoclonal antibody (1:500 dilution, 0.5% BSA in PBS; #04-1000, Millipore, Nottingham, UK) and 
Alexa488-conjugated donkey anti-rabbit AffinityPure F(ab’)2 Fragment (1.5 μg/ml; Jackson ImmunoRe-
search, Maine, USA). After DAPI counter-staining, images were collected on a Leica DMI6000 B wide-
field microscope and analysed using ImageJ60; nuclei were encircled, the mean intensity calculated per 
area, and nuclear fluorescence (arbitrary units) calculated by subtracting the background (measured 
as the minimum intensity in the image).
Data availability
MNase-seq raw data are available at the GEO database under accession number [GEO: GSE53343], 
while 3C-seq, p65 ChIP-seq and total (ribo-depleted) RNA-seq data generated here can be accessed at 
the SRA archive under accession number [SRA: SRP044729].
Abbreviations
3C-seq; chromosome conformation capture coupled to deep sequencing; bp, base pair; BSA, bovine 
serum albumin; ChIP-seq, chromatin immunoprecipitation coupled to high-throughput sequencing; 
EBM, endothelial basal medium; FBS, foetal bovine serum; FDR, false discovery rate; kbp, kilobase pair; 
MNase-seq, micrococcal nuclease digestion followed by sequencing; NF-κB, nuclear factor kappa-B; 
PFA, paraformaldehyde; PBS, phosphate-buffered saline; RNAP, RNA polymerase; RNA-seq, sequenc-
ing of total RNA; TNFα, tumour necrosis factor alpha; TSS, transcription start site; TTS, transcription 
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Summary
The genome contains all the necessary information for all developmental processes required for the 
proper survival of every living species. Genes, which are located on the chromatin fiber, have an im-
portant role in those processes. They are regulated by regulatory elements and other genes and the 
genome has to shape in specific conformations to fit inside the nucleus and to tether specific regulato-
ry elements to their target genes. Although the linear composition of many genomes is largely known, 
their three dimensional (3D) organization and dynamics are largely unknown. Although it was known 
that genome conformation was important for the control of all the complex developmental processes, 
our knowledge is far from complete. Hence the main objectives of this thesis were: 1) to study the 
genome conformation/interactome and their effect on gene regulation and 2) to unveil the role of 
transcription factor proteins (TFs) in complex developmental processes.
In order to unveil the interactome of some genomic regions with the rest of the genome in a few hun-
dred Kb radius, a 3C variant was developed, called 3C-seq. It provides information about the interac-
tome of either one (3C-seq) or many (multiplexed 3C-seq) viewpoints with their regulatory elements 
and the rest of the genome. In Chapter 2 we described the development of 3C-seq and in Chapter 4 
and Chapter 5 we provide examples of its application. 
In order to overcome the limitation of the different 3C variant methods, Targeted Conformation Cap-
ture (T2C) was next developed. T2C provides the genome wide interactome network for a selected 
region of (usually) up to 5Mb, which will comprise several Topological Associated Domains (TADs) as 
an alternative to Hi-C. It requires low sequencing depth (up to 1/10 of a sequencing lane) compared to 
other methods and can be multiplexed. Due to the high coverage that T2C offers, it yields high signal 
to noise ratios resulting to absolute restriction fragment without the requirement of binning the reads 
of the fragments. As a result, T2C provides high resolution, high coverage mapping of TADs and their 
interactions and boundaries. Due to the low number of PCR cycles it also provides more “quantifiable” 
conclusions. Hence, T2C is a cost effective tool to study the local spatial organization of the genome 
and its interactome with high resolution. Chapter 3 describes the development of T2C and Chapter 
5 provides examples of its application. The high resolution and coverage of T2C allows an analysis of 
how the genome is shaped (unpublished data). In vivo and in vitro T2C data, suggest that the rosette 
like MLS model is the most likely architecture, with ~5±1 nucleosomes/11nm. Comprehensive analysis 
postulates that the loops of the rosettes of the MLS model are in the range of 30-100Kb and the loops 
of a rosette together form TADs of 1-2Mb. 
Nucleosomes, the basic architectural blocks of the genome, rearrange along chromatin fiber and pro-
foundly affect gene expression. Chapter 4 shows how TNFα signaling reshapes the conformation of 
the genome to allow the establishment of new transcriptional programs. Intriguingly, TNFα triggers 
nucleosome repositioning prior to and independently of NFκB binding. However, approximately half 
of the nucleosome depleted regions contain typical NFκB motifs. Interestingly, we confirmed that nu-
cleosome repositioning is accompanied by changes in the interactome of responsive genes, with new 
contacts appearing in nucleosome depleted regions enriched for NFκB and H3K4me1 binding. Chapter 
5 assesses the effect of TNFα signaling on the spatial conformation of the genome and the interactome 
for both TNFα responsive and non-responsive genes as well as the bimodal function of NFκB based on 
its consensus DNA motif.
Chapter 6, describes the role of the LDB1 complex and its dynamics in hematopoietic development 
(starting from the hemangioblast to pro-erythroblast and erythroblasts) and the dynamics of the 
switch from GATA2 to GATA1. Interestingly, during development the binding of LDB1 complex is redis-
tributed to new genomic regions subsequently affecting its target genes. The first genes bound by the 
LDB1 complex for both the hemangioblast and pro-erythroblast stage are important for hematopoietic 
differentiation. Upon establishment of the hematopoietic lineage, the LDB1 complex is also located 
near genes necessary for erythroid/red blood cell differentiation and maintenance as well as heme 
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synthesis. The redistribution of the LDB1 complex during development is facilitated by “pioneering” 
TFs. We postulate the existence of two types of “pioneering” TFs based on the newly acquired data; 
ones which could attract the LDB1 complex to new genomic regions and others which stabilize it. 
At later developmental stages (between the pro-erythroblasts and erythroblasts), GATA1 forms com-
plexes with different TFs such as FOG1 and GFI1B in addition to the LDB1 complex (Chapter 7). The 
GATA1/FOG1 complex bound to regulatory elements at the pro-erythroblast stage, has repressive 
properties. In contrast GATA1/GFI1B bound regulatory elements at the erythroblast stage regulatory 
have activating properties. Those different properties of GATA1 when complexed with either FOG1 or 
GFI1B, demonstrate the dynamic equilibrium of a combinatorial TF network and we propose candidate 
TFs which may determine the equilibrium.
Finally Chapter 8 has a general discussion of the findings presented in this thesis and highlights the 
important aspects of this work. Furthermore, I discuss the importance of understanding the spatial 
conformation of the genome and the importance of the dynamics of TFs during development and I 
propose future perspectives for the continuation and evolvement of the current findings.
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Samenvatting
Het genoom bevat alle noodzakelijke informatie voor alle ontwikkelingsprocessen die nodig zijn voor 
in alle levende wezens. Genen, die onderdeel zijn van de chromatine vezel, spelen een belangrijke rol 
bij deze processen. Genen worden gereguleerd door regulerende elementen en andere genen en het 
genoom dient specifieke conformaties aan te nemen om in de kern te passen,  en er zo voor te zorgen 
dat specifieke regulerende elementen naar hun doelgenen kunnen vinden. Ook al is de lineaire samen-
stelling van vele genomen grotendeels bekend, hun driedimensionale (3D) organisatie en dynamiek 
is grotendeels onbekend. Het was al enige jaren bekend was dat genoom conformatie belangrijk is 
voor de controle van alle complexe ontwikkelingsprocessen, maar onze kennis hierover is verre van 
volledig. De hoofddoelstellingen van deze scriptie waren daarom: 1) het bestuderen van de genoom 
conformatie/interactoom en het effect daarvan op genregulatie en 2) de rol van bepaalde transcriptie 
factor eiwitten (TF) in complexe ontwikkelingsprocessen op te helderen.
Om het interactoom van enkele gebieden van het genoom met de rest van het genoom binnen een 
afstand van enkele honderden kb’s op te helderen, is een 3C variant ontwikkeld; 3C-seq. Het geeft 
informatie over het interactoom van één (3C-seq) of een groter aantal (multiplex 3C-seq) posities met 
hun regulerende elementen en de rest van het genoom. De ontwikkeling van 3C-seq is beschreven In 
hoofdstuk 2 we en hoofdstuk 4 en hoofdstuk 5 beschrijven voorbeelden van de toepassing hiervan.
Teneinde de beperking van de verschillende 3C varianten te verwijderen, werd hierna Targeted Con-
formation Capture (T2C) ontwikkeld. T2C biedt het genoomwijde interactoom netwerk voor een ge-
selecteerde regio van (meestal) tot 5Mb, die verschillende Topological Associated Domains (TADs) zal 
omvatten, als een alternatief voor hi-C. Het vereist veel minder sequencing diepte (tot 1/10 van een 
sequencing laan) vergeleken met andere methoden en kan worden gemultiplexed. Door het hoog 
aantal sequenties per fragment in T2C levert het een hoge signaal-ruisverhouding per restrictiefrag-
ment zonder de noodzaak van binning de “reads”. T2C heeft daarom een hoge resolutie en een hoge 
dekkingsgraad bij het in kaart brengen van TADs, en hun interacties en grenzen. Door het lage aantal 
PCR-cycli dat nodig is, geeft het bovendien meer “kwantificeerbare” conclusies. T2C is daarom een 
kosteneffectief middel om de lokale ruimtelijke organisatie van het genoom en zijn interactoom met 
hoge resolutie te bestuderen. Hoofdstuk 3 beschrijft de ontwikkeling van T2C en hoofdstuk 5 geeft 
voorbeelden van de toepassing hiervan.
De hoge resolutie en dekking van T2C maakt een analyse van hoe het genoom mogelijk is gevouwen. 
In vivo en in vitro T2C data suggereren dat het rozet-achtige MLS model de meest waarschijnlijke ar-
chitectuur is, met ~ 5 ± 1 nucleosomen / 11nm. Uitgebreide analyse postuleert dat de lussen van een 
rozet in het MLS model ergens tussen de 30-100Kb zijn en de lussen van een rozet samen een TAD 
vormen van tussen 1-2 MB.
Nucleosomen, de fundamentele bouwstenen van het genoom, herschikken zich langs chromatine ve-
zel en hebben een sterke invloed op genexpressie. Hoofdstuk 4 laat zien hoe TNFα signalering de 
conformatie van het genoom verandert om zo nieuwe transcriptie programma’s mogelijk te maken. 
Fascinerend is dat TNFa de nucleosoom herpositionering teweeg brengt  voorafgaande aan en onaf-
hankelijk van NFκB binding. Echter, slechts ongeveer de helft van de nucleosoom vrije gebieden bevat 
een typisch NFκB motief. Interessant genoeg kon bevestigd worden dat nucleosoom herpositionering 
wordt vergezeld door veranderingen in het interactoom van responsieve genen, met nieuwe contacten 
die verschijnen in nucleosoom verarmde gebieden, die  verrijkt zijn met NF-κB en H3K4me1 binding. 
Hoofdstuk 5 stelt het effect van TNFα signalering vast op de ruimtelijke ordening van het genoom en 
het interactoom voor zowel op TNFα reagerende genen als niet op TNFα reagerende genen als ook de 
bimodale functie van NFκB gebaseerd op zijn DNA motief. 
Hoofdstuk 6 beschrijft de rol van het LDB1 complex en de dynamiek van de hematopoietische ontwik-
keling; beginnend vanaf de hemangioblast tot pro-erythroblast en erythroblasten – en de dynamiek 
van de switch van “GATA2 naar GATA1”; een omschakeling van GATA2 naar GATA1. Interessant is dat 
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tijdens de ontwikkeling, de binding van het  LDB1 complex herverdeeld wordt over nieuwe (en oude) 
genomische regio’s, met een effect op de expressie van die nieuwe target genen. De eerste genen die 
het LDB1 complex bindt tijdens de hemangioblast / pro-erythroblast fase zijn belangrijk voor hema-
topoietische differentiatie. Tijdens de geboorte van de hematopoietische lichaamscellen, is het LDB1 
complex ook gelokaliseerd vlakbij genen die nodig zijn voor erythroïde/rode bloedcel differentiatie 
en in stand houding alsook de synthese van haem. De herverdeling van het LDB1 complex tijdens 
de ontwikkeling wordt gefaciliteerd door “pioneer” TFs. Ik postuleer het bestaan   van twee soorten 
“pioneer” TFs op basis van de nieuw verkregen kennis; een groep die het LDB1 complex naar nieuwe 
genomische regio kan rekruteren en een groep die het LDB1 complex stabiliseert.
In latere ontwikkelingsstadia van pro-erythroblasten naar erythroblasten, vormt GATA1 complexen 
met verschillende TFs zoals FOG1 en GFI1B naast het LDB1 complex (hoofdstuk 7). Wanneer Het GATA1 
/ FOG1 complex, gebonden is aan regulerende elementen in het pro-erythroblast stadium, heeft het 
repressieve eigenschappen . Dit in tegenstelling tot GATA1/GFl1B gebonden regulerende elementen 
tijdens het erythroblast stadium, dat juist activerende eigenschappen heeft. Deze verschillende ei-
genschappen van GATA1 als het een complex vormt met ofwel FOG1 ofwel GFI1B, laat het dynamisch 
evenwicht zien van een combinatorisch TF netwerk en we stellen kandidaat TF’s voor die dit evenwicht 
mogelijk bepalen.
Tenslotte heeft hoofdstuk 8 een algemene discussie van de bevindingen gepresenteerd in dit 
proefschrift en highlights de belangrijke aspecten van dit werk. Verder bespreek ik het belang van het 
begrijpen van de ruimtelijke conformatie van het genoom en het belang van de dynamiek van de TF’s 
tijdens de ontwikkeling. Ten slotte beschrijf ik een aantal toekomstperspectieven voor de continuering 
en de ontwikkeling van de huidige bevindingen.
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